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ABSTRACT
Impaired lipid metabolism at rest has been linked to the development of insulin resistance
and an attenuation of plasma concentration of the hormone adiponectin. However, it has been
suggested that increasing fatty acid oxidation at rest, via exercise or otherwise, may increase
plasma adiponectin. The current literature addressing changes substrate utilization and possible
direct effects on adiponectin during and following exercise is not well established. Therefore,
the purpose of this dissertation was to examine concomitant changes in adiponectin and substrate
utilization both at rest and during various exercise modalities, as this may provide implications
for improving metabolic responses and in turn, affect insulin sensitivity. Pre-, mid-, and postexercise measurements were obtained for five separate studies. Each study incorporated a single,
unique exercise modality, which included: acute aerobic, chronic aerobic, acute resistance,
chronic resistance, or acute stretching exercise. Chronic resistance training significantly
increased adiponectin levels, although resting substrate utilization did not significantly change
pre- to post-exercise. All acute exercise modalities significantly increased glucose utilization
during exercise. However, none of the acute exercise modalities nor the chronic aerobic exercise
modality elicited significant changes in adiponectin. First degree family history of type 2
diabetes mellitus had a significant inverse correlation with adiponectin concentration, whereas
regular aerobic exercise had a significant direct correlation with adiponectin. Body fat
percentage and body mass index did not have significant inverse correlations with adiponectin.
These results suggest that substrate utilization does not directly affect adiponectin concentration
and that the regulation of this hormone is likely dependent on other factors. The results do,
however, highlight the importance of implementing a chronic exercise training program to limit
the development of insulin resistance, especially in populations genetically predisposed to type 2
diabetes mellitus.
vii

CHAPTER 1. INTRODUCTION
1.1 Overview
Regardless of the type, intensity, or duration of exercise, chronic has irrefutably been
shown to help to prevent, or at least limit several health disparities including, but not limited to
cardiovascular disease, cancer, obesity, and diabetes (1). The underlying biological mechanisms
responsible for the improvements in health parameters as a result of exercise are not fully
understood. Some of the possible metabolic mechanisms associated with lipid-induced insulin
resistance and the reversal of insulin resistance following exercise are discussed in depth in
Appendix 1. Determining the role of specific mechanisms associated with improvements in
insulin sensitivity, fitness, and overall health is critical to strengthen the evidence for
implementing specific exercise prescriptions among healthy and diseased populations.
Acute exercise, defined as a single bout of exercise, can elicit changes in the molecular
biology, biochemistry, and physiology of the human body. Acute exercise studies have
demonstrated changes in the expression of several genes (2, 3), the expression of lipid and
glucose metabolites (4), increased expression of some inflammatory markers, (5) and decreased
the expression of other inflammatory markers (6). Acute exercise also causes a variety of
vascular, neural, metabolic, and endocrine responses (7).
Chronic exercise, defined as consistently repeated acute exercise bouts over a given
period of time, yields adaptations which are much different to those seen following an acute
exercise bout. The adaptations which occur at the molecular, biochemical, and physiological
level following chronic exercise are primarily due to the cumulative effects of repeated acute
exercise responses (7), and therefore, distinctions must be made between adaptations to chronic
exercise and responses to acute exercise. While each response and adaptation to exercise is
1

important and evidently interdependent, the focus of this dissertation is centered on the
physiological aspects, specifically the metabolic and endocrine responses and adaptations to
various exercise modalities.
Metabolic activity in the human body is highly regulated and dependent on several feedforward and feedback mechanisms which are activated by numerous external and internal
environmental cues. The external cue of physical inactivity can lead to impaired substrate (lipid,
carbohydrate, or amino acid) metabolism and negatively affect exercise performance as well as
energy homeostasis and insulin sensitivity (8-10). Much like exercise, acute and chronic
inactivity results in numerous responses and adaptations via changes in molecular biology,
biochemistry, and physiology. The external cue of exercise, on the other hand, has been shown
to improve energy homeostasis and reverse several metabolic impairments in glucose
metabolism (11-13) and lipid metabolism (14-16) as seen in insulin resistant (17) and diabetic
patients (18, 19).
Changes in substrate metabolism have been demonstrated during and following acute
aerobic exercise studies (16, 20-22), chronic aerobic exercise studies (23, 24), acute resistance
exercise studies (25, 26), chronic resistance exercise studies (12, 13, 27), and combined exercise
studies (28, 29). Some studies have shown increases in glucose oxidation (30), while others have
shown decreases in glucose oxidation (31). Some studies have shown increases in fat oxidation
(32), some have shown no increases in fat oxidation (33), and others have shown increases in
both glucose and fat oxidation (4). These equivocal results have made it difficult to identify the
exact underlying mechanisms responsible for the improvements in insulin sensitivity observed
following exercise.
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Similarly, the variability in the adipose tissue-derived hormone, adiponectin, responses
have been highly variable following exercise. Adiponectin has been shown to play an important
role in insulin sensitivity as well as glucose and lipid metabolism (2), thus changes in
adiponectin should theoretically be seen as a result of changes in substrate utilization. Currently
however, there are few studies that have examined the role of substrate utilization on plasma
adiponectin during and following exercise. Several studies have examined changes in glucose
kinetics (12, 30) and free fatty acid (FFA) oxidation (14, 34) following exercise; though, none
have measured these changes concomitantly with changes in plasma adiponectin nor compared
the differences in plasma adiponectin concentration following aerobic versus resistance training
exercise. The effects of any type of exercise on the expression of adiponectin have shown
variable results. Some suggest exercise yields increased adiponectin levels following acute (35)
or chronic training (36), while other studies suggest no change following acute (37) or chronic
training (38).
Due to the variability in methodology and analysis between these studies, it has been
difficult to establish which variables play the most significant roles in altering substrate
utilization and improving insulin sensitivity. Not only can the measurement technique (gas
analysis, tracers, biopsy) and experimental model (cell cultures, animal models, humans) affect
the results of a study, but gender, training status, diet, muscle fiber type, muscle glycogen and
lipid content, exercise intensity, exercise duration, exercise type, all affect substrate metabolism
differently during and following exercise, making it difficult to compare the effects between
studies. Exercise intensity and intramuscular glycogen and fat stores have been studied
extensively and have been shown to greatly affect substrate utilization and exercise performance
(4); however, further research is needed to determine the role of various exercise modalities on
3

substrate utilization. It is currently unknown if a specific form of exercise, or exercise modality,
generates superior changes compared to other modalities. Therefore the focus of this dissertation
was on exercise modality, which included acute aerobic, acute resistance, chronic aerobic,
chronic resistance, and acute stretching exercise.
Purpose:
The purpose of this dissertation was to:
1.)

Examine changes in substrate metabolism during and following various
exercise training modalities to determine how specific exercise modalities
affect fuel utilization during and following exercise.

2.)

Examine changes in adiponectin levels following various exercise training
modalities to determine if adiponectin is directly linked to changes in substrate
metabolism and determine if altered substrate utilization (via supplementation)
directly affects plasma adiponectin concentration.

3.)

Provide implications for which modality, if any, produces the greatest changes
and how these changes may lead to improved exercise performance and insulin
sensitivity.

1.2 Substrate Metabolism
Acute Exercise
A single bout of exercise is known to affect systemic metabolism and consequently cause
a shift in energy homeostasis in an intensity-dependent fashion (30, 39). Adiponectin has been
implicated in the regulation of energy homeostasis, which suggests that substrate metabolism
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may be tightly linked with adiponectin concentration. Numerous factors contribute to the shift in
energy homeostasis following acute exercise; however, the likely initial factor is a result of
skeletal muscle contraction. Muscle contraction, whether through resistance or aerobic exercise
mitigates the adenosine triphosphate / adenosine monophosphate (ATP/AMP) ratio, which in
turn activates 5’ AMP activated protein kinase (AMPK) (40). The extent of AMPK activation
appears to be directly related to exercise intensity (40, 41). Higher exercise intensity yields a
lower ATP/AMP ratio, greater AMPK activation, and thus, greater substrate oxidation.
Numerous studies have suggested AMPK phosphorylates and inhibits acetyl-CoA carboxylase
(ACC), which inhibits the production of malonyl-CoA and relieves the inhibition of carnitine
palmitoyltransferase 1 (CPT1) to transport long-chain fatty acids into the mitochondria to allow
increased FA oxidation (40). AMPK also increases skeletal muscle glucose uptake, increases
citrate levels, and increases levels of nicotinamide adenine dinucleotide (NAD+) and Sirtuin-1
(SIRT-1), both of which increase peroxisome proliferator-activated receptor gamma coactivator
1-alpha (PGC-1α) expression. Some studies have suggested that SIRT-1 may regulate the
expression of adiponectin (42) via NAD+ (43) further supporting the notion that exercise-induced
changes in substrate metabolism can alter plasma adiponectin. Chronically, this signaling
cascade acts to induce mitochondrial biogenesis, improve glucose and lipid transport, and in turn,
alter substrate utilization and protect against insulin resistance (40, 41). Thus, the intensitydependent shift in energy balance appears to be dependent on the activation of AMPK and its
subsequent signaling cascade.
Muscle contraction also induces calcium release from the sarcoplasmic reticulum, which
in turn, activates calcineurin (40). Calcineurin has been shown to up-regulate the expression of
insulin receptor, protein kinase B (Akt), glucose transporter type 4 (GLUT-4), and PGC-1α
5

expression in the glycolytic extensor digtorum longus (EDL) muscle of transgenic mice given a
high fat diet (44), indicating increased substrate oxidation in skeletal muscle. In normal
functioning muscle cells, calcineurin is activated by increased levels of cytoplasmic calcium,
thus, muscle contraction alone does indeed improve insulin sensitivity and glucose uptake via an
insulin-independent mechanism. Adiponectin appears to up-regulate the expression of several of
these signaling molecules involved in acute muscle contraction and improved insulin sensitivity
(45); however, the current literature examining acute muscle contraction and changes in plasma
adiponectin are equivocal and will be discussed further in the next section.
Exercise is the product of continually repeated muscle contraction and as a result of this
repeated contraction, the associated signaling cascade and the replenishment of ATP is amplified
to meet the necessary energy demands. ATP replenishment is achieved via the creatine
phosphate pathway, anaerobic glycolysis, glucose oxidation, amino acid deamination, or FFA
oxidation (7). Untrained individuals participating in less than one hour of moderate- to highintensity aerobic exercise are highly dependent on blood glucose to provide fuel for the increased
energy demand (46). In fact, it has been shown that glucose oxidation may account for 30-50%
of substrate metabolism during exercise in untrained populations (47). During short-duration
exercise, blood glucose is replenished 3-5 fold by liver glycogenolysis, and glucose uptake is
increased 20-35 fold. Exercise intensity and duration appear to have a direct linear relationship
with the extent of glucose uptake as a result of the muscle contraction signaling cascade
described above. A greater percentage of glucose uptake has been observed with shorter
duration, higher intensity exercise (46). Thus, performance during short-duration, high-intensity
aerobic exercise in untrained individuals is highly dependent on glucose oxidation (11). Not
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surprisingly, this type of exercise has been shown to be effective in improving insulin sensitivity
(48).
The role of fat metabolism during and following short-duration acute aerobic exercise;
however, is quite complex and should not be overlooked. Coggan et al. (16) demonstrated a
small, but significant percentage of fat is oxidized during 30 minutes of high-intensity aerobic
exercise (75-80% VO2 max) in recreationally active individuals. This finding suggests that if the
ability to utilize fat becomes impaired, then exercise performance may be compromised for both
trained and untrained individuals, even for short-duration, high-intensity aerobic exercise.
Similarly, 30 minutes of resistance training has been shown to activate lipolysis, the degree of
which is dependent on the availability of intramyocellular lipids (IMCL) (4). The authors
suggested that if IMCL stores are available, they will be utilized regardless of exercise intensity
in order to spare muscle glycogen. More recently, Koopman et al. (26) found that IMCL content,
as well as muscle glycogen content, significantly decreased following 45 minutes of highintensity resistance training. The authors suggested that both lipid and glucose oxidation are
important for exercise performance and improved insulin sensitivity but that substrate utilization
is dependent upon muscle fiber type.
Thus substrate oxidation may be more dependent on availability than intensity. This
notion is supported by the idea that although the body primarily oxidizes substrates during acute
exercise, a single aerobic exercise session has been shown to augment IMCL synthesis,
particularly when fat availability is high (22), and consequently prevents the accumulation of
deleterious metabolites such as diacylglycerol (DAG) and ceramides, which are known to
activate pro-inflammatory pathways associated with insulin resistance. Similar results have been
seen in rats. When given the drug Thiazolidinedione, IMCL synthesis increased while
7

metabolite accumulation decreased and subsequent pro-inflammatory pathways were inactivated
(49), suggesting that an acute bout of aerobic exercise can act to down-regulate proinflammatory pathways (21). Given that the pro-inflammatory cytokine, tumor necrosis factoralpha (TNF-α) has antagonistic effects to adiponectin, these findings further suggest that
adiponectin expression is up-regulated following acute aerobic exercise, which is supported by
some studies (35), but not others (37), thus further research is still necessary.
It is currently unknown if acute stretching has similar effects on lipid metabolism to those
seen with resistance training. Recent studies have demonstrated that stretching exercise elicits
many of the same benefits of resistance training including increased flexibility and maintained
strength (50), improved exercise performance (51), and improved glucose transport (52). Acute
resistance training exercise has been shown to increase lipid oxidation for up to 24 hours postexercise, but it is unknown if stretching yields similar results. Acute resistance training has also
been shown to improve insulin sensitivity via improvements in glucoregulatory function (44) and
lipid metabolism (40). It is likely that the mechanisms responsible for these changes following
acute resistance training and the changes following acute stretching exercise are due to different
mechanisms than those seen following acute aerobic exercise since resistance training is known
to activate, rather than repress, pro-inflammatory pathways (53). Thus the expression of
adiponectin may not be the same with this type of training and deserves further investigation.
Currently, no studies have examined changes in substrate utilization or adiponectin levels
following acute stretching exercise.
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Chronic Exercise
It has been clearly demonstrated that chronic aerobic exercise training leads to increases
in the size and number of mitochondria, in addition to increases in mitochondrial enzymes
involved in fatty acid oxidation, the citrate cycle, respiratory chain, ATP synthesis, and insulin
sensitivity (54). It has been suggested that these changes are due to muscle fibers switching to
more oxidative type, increasing mitochondrial density, GLUT-4 concentration, glycogen
synthase activity (23) and increased reliance on more on IMCL stores for fat oxidation during
exercise (16). Even independent of weight loss, exercise seems to elicit improvements in insulin
sensitivity. One study involving obese girls showed that twelve weeks of aerobic exercise
improved insulin sensitivity without any changes in body weight, percent body fat, or markers of
inflammation (23). This further suggests that changes such as increased oxidative muscle fiber
type, increased mitochondrial density, GLUT-4 concentration, and glycogen synthase activity,
and decreased IMCL are more responsible for changes in insulin signaling as a result of exercise
rather than changes in hormone and inflammatory signaling seen with acute aerobic exercise
studies. These results also imply that adiponectin expression may not change following chronic
aerobic exercise, which has been demonstrated in some studies (38), but not others (36), thus
further examination is necessary.
A lack of physical activity or excess caloric intake leads to excess lipid storage in adipose
tissue and within skeletal muscle. This excess lipid storage has been linked to an increased
reliance on glucose oxidation (55) and increased insulin resistance as reviewed by Samuel et. al
(56). Impaired lipid metabolism not only limits aerobic performance during exercise (57), but
has also been linked to the development of insulin resistance (17). Impaired FFA oxidation
during exercise leads to several changes in metabolism including increased reliance on other
9

substrates via muscle and liver glycogenolysis, increased blood glucose utilization, increased
amino acid deamination, or increased ketogenesis, all of which hasten fatigue and negatively
affect exercise performance. Conversely, improved lipid metabolism, as seen following aerobic
exercise (58), leads to improved exercise performance and improved insulin sensitivity.
Substrate utilization in working skeletal muscle is highly regulated by several feed-forward and
feedback mechanisms, many of which are affected as a result of chronic exercise training or lack
thereof. Aerobically trained individuals are able to oxidize a high percentage of fat, even during
high-intensity exercise (58). This is because aerobic exercise leads to up-regulation in IMCL
storage, lipolysis, lipid oxidation, improvements in exercise performance (58) and improvements
in insulin sensitivity, (23).
Much like chronic aerobic exercise, chronic resistance training augments GLUT-4
protein, insulin receptor protein, and glycogen synthase protein and activity, thereby improving
skeletal muscle glucose uptake and glycemic control (12). This may be partially due to changes
in muscle fiber type characteristics. A study on chronically resistance trained powerlifters and
recreationally active controls observed significant differences in the composition of skeletal
muscle fibers, with trained lifters demonstrating a greater percentage of type II fibers, suggesting
that muscle fiber type shifting as a result of chronic resistance training may contribute to changes
in substrate metabolism during exercise (59). This hypothesis is supported by another study
which observed elevated post-prandial carbohydrate oxidation in resistance trained males
compared to sedentary controls (60). Area under the curve for both blood glucose and insulin
(over time) was lower in resistance trained males compared to sedentary males, suggesting better
insulin sensitivity in the resistance trained group and as previously suggested, the increase in
type II fiber expression in resistance trained individuals could explain the difference in post10

prandial carbohydrate metabolism. Interestingly, resistance training has also been shown to
attenuate mitochondrial content following chronic high-volume, resistance training (61), due to
an augmentation in type II fiber area, suggesting a decreased ability to oxidize lipids. Therefore,
it can be suggested that the mechanisms responsible for improved insulin sensitivity following
chronic resistance training are significantly different than those seen following chronic aerobic
training.
Chronic resistance training has also shown improvements in glycelated hemoglobin
(HbA1C levels), (12) insulin sensitivity, and increased levels of adiponectin in diabetic men (62)
without changes in plasma glucose, insulin, or lipid levels. This may suggest adiponectin does
not play a role in changes in substrate utilization following resistance training. However, a
recent study showed that augmented levels of adiponectin are associated with improvements in
fat oxidation and insulin sensitivity and that plasma adiponectin concentration is up-regulated
with aerobic exercise (35). Further research is needed to confirm these findings following
resistance training and to determine if aerobic training is superior to resistance training in terms
of adiponectin expression.
1.3 Adiponectin
Adiponectin is an adipocyte-derived hormone that plays an important role in insulin
sensitivity as well as glucose and lipid metabolism (2). There are three different isoforms of
adiponectin, including low molecular weight (LMW), medium molecular weight (MMW) and
high molecular weight (HMW). HMW appears to be the more active form of adiponectin
compared to MMW or LMW (63) and greater expression of this isoform has been implicated in
greater insulin sensitivity (64). However, the HMW form has not been shown to change
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following exercise in lean, healthy individuals (65) and is not associated with acute
improvements in insulin-sensitivity (66) whereas total adiponectin has been shown to change
following exercise in some studies in lean, healthy individuals (67). All participants for the
current dissertation were lean and insulin-sensitive and therefore, total, rather than HMW
adiponectin was measured. There are two types of adiponectin receptors, AdipoR1 receptors are
expressed in skeletal muscle cells, AdipoR2 receptors are expressed in skeletal muscle and liver
cells, and both receptor types are expressed in adipose tissue (68).
Adiponectin functions to regulate glucose and lipid storage as well as transport and
oxidation, which in turn, affects and insulin sensitivity (69). Some research suggests that
adiponectin mitigates hepatic gluconeogenesis while hepatic glycolysis and glucose uptake are
unaffected (70). Other research suggests that adiponectin may act to increase FFA oxidation via
activation of AMPK, and in turn, reduce the concentration of FFAs in the blood and the
concentration of lipid metabolites in skeletal muscle and liver (71). Further research suggests
that in addition to increased fat oxidation, adiponectin may act to increase lipogenesis and lipid
transport, and to increase glycolysis. The liver adiponectin knock-out (KO) mice have
demonstrated down-regulated mRNA expression of: glycolytic enzymes, TCA cycle enzymes,
lipogenic enzymes, fatty acid activation enzymes, and beta-oxidation enzymes (69). Expectedly,
the KO mice exhibited less fat accumulation in white adipose tissue (WAT) and lower total body
weight compared to wild-type (WT) after 16 weeks of high-fat diet (HFD) feeding. After only
30 days of HFD, WT and KO mice did not exhibit differences in WAT or skeletal muscle, but
liver had significantly less lipid droplets due to decreased lipogenesis. Thus adiponectin appears
to function as a mediator to clear lipids from plasma via increased β-oxidation through upregulation of the AMPK pathway as well as increased expression of rate-limiting enzymes
12

involved in lipogenesis. The down-regulation of lipogenesis, lipid transport, and oxidation will
result in delayed clearance of lipids from plasma, which may contribute to the development of
insulin resistance and lipotoxicitiy associated with low expression of adiponectin.
Currently, the mechanisms responsible for the regulation of adiponectin are a matter of
debate. There are several genetic factors which likely influence adiponectin regulation and
adipocyte mRNA expression including differences in PGC-1α, nuclear respiratory factor-1
(NRF1) (72), SIRT-1 (42), and peroxisome proliferator-activated receptor- gamma (PPARγ) (73)
gene expression, among others. First degree family history of type 2 diabetes, defined as a firstdegree relative (mother or father) having type 2 diabetes is a major risk factor for the
development of insulin resistance and type 2 diabetes in the offspring (74). This risk factor may
be partially due to differences in several key metabolic genes as mentioned above, but is also
likely due to lifestyle factors including habitual physical inactivity and poor diet (75). Further
investigation is necessary to determine if first degree family of type 2 diabetes is correlated with
plasma adiponectin concentration. If so, this correlation could highlight the importance of
regular physical activity for this population to maintain insulin sensitivity.
Aside from genetic factors, there are several other proposed mechanisms responsible for
the regulation of adiponectin. Despite the apparent role of adiponectin in lipid clearance from
the blood, postprandial and post-absorptive states do not appear to affect plasma adiponectin
concentration. Studies in human models have demonstrated that HMW adiponectin
concentration fluctuates in healthy, lean males by approximately 40 percent from late night to
early morning, whereas the fasted versus fed state appears to have no significant effect on
adiponectin (76). Therefore, circadian rhythm appears to be involved, at least to some extent, in
the regulation of adiponectin. In rats, adiponectin messenger ribonucleic acid (mRNA) was
13

down-regulated following fasting or stimulation of beta-adrenergic receptors in WAT and brown
adipose tissue (BAT), likely due to a combination of an increased rate of lipolysis, lipid
transport, and less lipid storage; however, serum adiponectin was unaffected. Refeeding
normalized mRNA expression (77), which suggests that insulin may be an agonist to adiponectin
mRNA expression in the short-term, but insulin does not appear to have an immediate effect on
plasma protein expression. Conversely, chronic overfeeding has been shown to down-regulate
the secretion of adiponectin from the adipocyte (78). Combined, these results suggest that the
secretion of adiponectin may be regulated by chronic, rather than acute changes, namely the
development of insulin resistance in adipocytes.
Insulin appears to regulate adiponectin mRNA expression in adipocyte cell culture as
well (79). In addition, Motoshima et. al (80) suggested that adiponectin secretion from visceral,
but not subcutaneous, fat in humans is regulated by insulin and correlates with obesity, in vitro.
Degawa-Yamauchi et al. (78); however, did not find any correlation between serum adiponectin
and serum insulin, suggesting insulin does not regulate adiponectin expression. Combined, these
results may indicate that insulin initiates alterations in mRNA expression; however, protein
expression of adiponectin may be regulated by unknown secondary mechanisms or as previously
suggested, the secretion may become impaired in an insulin-resistant state.
Motoshima et al. (76) also noted that adiponectin secretion from visceral fat was higher
than from subcutaneous fat, and the secretion of adiponectin from visceral fat had a stronger
negative correlation with body mass index (BMI) compared to the secretion of adiponectin from
subcutaneous fat. This is an apparent paradox given that numerous studies have found negative
correlations between plasma adiponectin and waist-to-hip ratio (WHR), body fat percentage, and
BMI (81). In contrast to these ideas, Degawa-Yamauchi et. al (82) found that subcutaneous
14

adiponectin mRNA negatively correlated with BMI and positively correlated with serum
adiponectin, while there was no correlation between omental adiponectin mRNA and BMI or
serum adiponectin. In addition, the secretion of adiponectin from subcutaneous versus omental
adipose was not different over a 24 hour period. These conflicting results demand further
research.
Gender differences could potentially explain some of these discrepancies; though, the
aforementioned studies did not separate results based on gender. Men generally have more
omental fat compared to women and tend to have lower levels of adiponectin, although some
researchers suggest these differences are due to testosterone levels (83). Another study found
that growth hormone may act to regulate the expression of adiponectin (84), and still others
suggest glucocorticoids significantly decrease adiponectin release from subcutaneous, but not
omental adipose (82). This suggests that adiponectin is directly regulated by changes in glucose
metabolism. Most studies; however, have suggested that hormones, such as leptin, testosterone,
growth hormone, and cortisol have no correlation with adiponectin (77, 81). It may be that the
metabolic state has a greater influence on plasma adiponectin, but this too deserves further
investigation. Furthermore, additional research is needed to determine if a first degree family
history of type 2 diabetes, which is a major risk factor in the development of insulin resistance,
(74) is linked to lower plasma adiponectin concentration.
Exercise
Despite the clear improvements in insulin sensitivity following exercise, study results
examining the effects of exercise on adiponectin have shown equivocal results. Most studies
have demonstrated that HMW form of adiponectin tends to increase with higher intensities or in
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the presence of weight loss, while no change or a decrease occurs following low- to moderateexercise intensities (85); however, the reasoning for this remains unclear. It may be partially due
to the exercise intensity-dependent activation of AMPK and an increased accumulation of NAD+
(41), as this has been shown to increase SIRT-1 expression and in turn, regulate the expression of
adiponectin (42).
Exercise appears to elicit changes in the expression of adiponectin receptors, though this
regulation is a matter of debate. When a wide range of normal weight, overweight, and obese
individuals with normal glucose tolerance, impaired glucose tolerance, and type II diabetes were
placed on a four-week physical training regimen, (2) exercise increased the expression of
adiponectin and its receptors (AdipoR1 & AdipoR2). This increased expression may act to
mediate improvements in insulin sensitivity, glucose metabolism, and lipid metabolism seen as a
result of exercise. However, the authors also found that the more insulin resistance that a given
participant had, the higher the expression of the AdipoR2, regardless of body fat percentage. In
an earlier study, this research lab also found that an increased expression of AdipoR1 and
AdipoR2 mRNA positively associated with obesity, plasma glucose, plasma lipid levels, and
insulin resistance. The same four week exercise regimen increased serum adiponectin, and
AdipoR1 & AdipoR2 mRNA in skeletal muscle. They also found that three hours of exercise
was sufficient to increase mRNA expression of AdipoR1 & AdipoR2, phosphorylation of
AMPK, but did not have an effect on serum adiponectin. (36). These results suggest that both
insulin resistance and exercise mediate up-regulation in adiponectin receptor expression, thus
further research is needed to clarify these findings.
It is possible that exercise may cause an initial decrease in plasma adiponectin due to
increased free fatty acid concentration in the plasma, thereby increasing the expression of
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adiponectin receptor mRNA. The increased clearance of lipid metabolites from the plasma as a
result of chronic exercise may be responsible for higher levels of plasma adiponectin and lower
expression of adiponectin receptors. This hypothesis is supported by (67) who found that 20
minutes of rowing in elite male rowers decreased adiponectin immediately post-exercise, but
adiponectin levels increased above resting levels 30 minutes after exercise. Conversely,
adiponectin significantly decreased 30 minutes after exercise in non-elite rowers. Growth
hormone, leptin, insulin, and glucose were not different from resting levels, further supporting
the previously mentioned notion that adiponectin changes independently of these hormones. The
initial decrease in adiponectin seen in the elite rowers may have been due to increased lipolysis
and lipid transport into plasma, while an increase in FFA oxidation and lipid clearance from
plasma 30 min post-exercise may explain increase in adiponectin, given that trained individuals
are able to oxidize lipids post-exercise more quickly than untrained individuals. This study,
along with a more recent acute aerobic exercise study have shown an increase in adiponectin
(35), but others (38, 86), have shown no change. Similarly, chronic aerobic exercise has been
shown to increase adiponectin (36) or cause no change in adiponectin (38). Chronic resistance
training has been shown to increase adiponectin (87) or cause on change in adiponectin (88).
The acute effects of acute resistance training or stretching on adiponectin are relatively unknown.
It appears that the regulation of substrate utilization and adiponectin share similar signaling
molecules and thus, may be dependent on one another. The combination of these equivocal
results and the unknown regulation of adiponectin warrant further investigation.
1.4 Effects of Supplementation
Several supplements are known to affect exercise performance, substrate utilization,
plasma glucose concentration, plasma lipid levels, and plasma adiponectin concentration.
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Therefore, two exercise intervention modalities in the current study incorporated
supplementation to determine if the combination of a supplement plus exercise would amplify
the effects of the supplement on exercise performance, substrate utilization, and adiponectin
concentration.
Caffeine
In several studies, caffeine has been shown to enhance fatty acid mobilization from
adipose tissue, and in turn lower the respiratory exchange ratio (RER) and spare muscle
glycogen in submaximal acute exercise lasing 30-60 minutes (7, 89). This mechanism is likely
due to an increase in catecholamine concentration, which blocks glucose uptake, thereby
increasing FFA oxidation. Increased catecholamine release also enhances glucose release from
the liver and FFA release from adipose tissue (7). If plasma adiponectin is regulated by plasma
lipid levels as hypothesized, this supplement should mitigate plasma adiponectin expression.
Despite the proposed mechanism of increased FFA oxidation with caffeine ingestion,
some studies have seen no effect of caffeine on aerobic function, RER or FFA uptake into
skeletal muscle (90-92). Untrained individuals tested at 75% VO2max elicited no benefit from
caffeine supplementation (92). Overall however, caffeine ingestion appears to be effective for
improving low- to moderate-intensity aerobic exercise performance regardless of training status,
(93, 94) whereas caffeine ingestion prior to high-intensity exercise may only be beneficial to
trained athletes (95); however, more studies are needed to verify these outcomes and further
research is needed to determine whether a caffeine-induced substrate shift is associated with
changes in plasma adiponectin expression.
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Niacin
Nicotinic acid, also known as niacin, is pharmacologically used to improve cholesterol
levels by blocking fat breakdown in adipose and liver tissue. As a consequence of this action,
very low density lipoprotein (VLDL) formation decreases in the liver, thus less low density
lipoprotein (LDL) and more high density lipoprotein (HDL) are formed, thereby lowering blood
lipids (162). Consequently, this supplement should increase plasma adiponectin concentration,
and indeed that has been demonstrated (96).
Recently, Plaisance et al. (92) demonstrated that an acute dosage of niacin decreased
plasma non-esterified fatty acid (NEFA) levels by decreasing lipolysis in adipocytes. Niacin
administration also increased adiponectin, primarily HMW adiponectin, but not other adipokines
such as leptin or resistin in lean mice. The authors suggested that NEFA may inhibit adiponectin
secretion by acting on adipocyte receptors. It was also suggested that beta-hydroxybuterate,
which is up-regulated during starvation, acts on one of the adiponectin receptors (AdipoR1 or
AdipoR2) to decrease serum FFA and decrease ketogenesis while increasing adiponectin
concentration. Thus, it appears that adiponectin is inhibited by high concentrations of NEFA and
is stimulated by low concentrations of NEFA. Based on this evidence, it can be hypothesized
that adiponectin is a catabolic hormone, which may partially explain why it is inhibited in
diabetic and insulin resistant individuals, which demonstrate high levels of the anabolic
hormone, insulin (63); however, insulin regulation of adiponectin remains a matter of debate.
Other studies, such as the recent study by Kelley et al. (35) in which exercise training increased
HMW adiponectin while increasing fat oxidation, support the findings that the adiponectin
hormone is up-regulated by low levels of NEFA, which activates PPARγ, and in turn, stimulates
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mitochondrial biogenesis and increases fat oxidation; although, this theory has not been directly
measured therefore further investigation is needed.
Given that HMW adiponectin may be directly affected by NEFA concentration, it is
possible that there may be a direct link between substrate utilization and adiponectin
concentration in the plasma. Following fasting, NEFA concentration will rise; however, the
fasted state appears to have no effect on adiponectin. Time of day does have a significant effect
on adiponectin and therefore, participants were not fasted for the current research studies
examining adiponectin, but measurements were taken at the same time of day.
Melatonin
Also of interest, melatonin supplementation has been shown to increase glucose transport
(97), increase liver and muscle glycogen content, maintain homeostatic blood glucose
concentrations, and increase lipid utilization immediately following aerobic exercise (98).
Whether or not melatonin affects substrate utilization following resistance or stretching exercise
and what effect melatonin has on plasma adiponectin concentration following resistance or
stretching exercise is currently unknown. A recent study by Nelson et al. (103) demonstrated
that acute melatonin supplementation increases glucose oxidation during aerobic exercise, which
suggests the supplement acts to improve insulin sensitivity.
Melatonin supplementation has been shown to attenuate body weight gain in rats given a
high fat diet, decrease plasma glucose, insulin and triglycerides, while reducing adiponectin
concentration (99). These results suggest that the regulation of adiponectin may not be regulated
by blood glucose or lipid concentration and are supported by earlier studies which demonstrated
that melatonin leads to an inhibition in the accumulation of lipid droplets in pre-adipocytes
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(100). However, if melatonin does indeed increase lipid utilization, it could encourage free fatty
acid availability and oxidation, in other words, high NEFA concentration in plasma. As
previously mentioned, this has been proposed to cause a reduction in adiponectin expression, as
was seen in high-fat fed rats given melatonin. The extent of change in substrate utilization and
plasma adiponectin concentration following melatonin supplementation in humans is largely
unexplored and deserves further investigation.
Rationale
Considering exercise modality may have a large effect on substrate utilization, plasma
adiponectin concentration and exercise performance, various exercise modalities were examined
in the current study. Higher intensity exercise, whether acute, chronic, aerobic, resistance, or
stretching, should theoretically augment plasma adiponectin and alter substrate utilization.
Therefore all modalities were performed at moderate-to-high intensities. Acute aerobic exercise
was performed to complete exhaustion, chronic aerobic exercise was performed at an average
high rating of perceived exertion, acute resistance training was performed at 75% one-repetition
maximum (1RM), chronic resistance training was performed at an average of > 75% 1RM, and
acute stretching exercise was performed by stretching each muscle to its maximal threshold.
Furthermore, limiting or enhancing lipid or glucose metabolism via supplementation during
high-intensity chronic or acute aerobic exercise in untrained individuals should diminish or
improve plasma adiponectin concentration, respectively. Finally, first degree family history of
type 2 diabetes, high body fat percentage, high BMI, high waist-to-hip ratio, and lifestyle habits
including physical inactivity, caffeine consumption, and high-fat diet are all major risk factors in
the development of insulin resistance (74, 75, 101). Each of these variables will be correlated
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with plasma adiponectin concentration to determine if any relationships exist between lower
levels of adiponectin and variables known to decrease insulin sensitivity.
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CHAPTER 2. METHODS
2.1 Acute Aerobic Exercise
Subjects
Untrained males (n = 17) and females (n = 8) between the ages of 18-26 were recruited to
participate in the study. All participants were non-smokers, were not taking any medication,
with the exception of oral contraceptives, and did not regularly perform any type of cycling
exercise more than one time per week. Subject characteristics are shown in table 1. All
participants were healthy as indicated by the Physical Activity Readiness Questionnaire (PARQ). Informed consent was obtained from all participants prior to the onset of the first exercise
trial and the study protocol was approved by the Institutional Review Board of Louisiana State
University.
Table 1. Subject Characteristics for the acute aerobic exercise modality.
Subject Characteristics
Men
Women
n = 17
n=8
Age (yr)
21.3 ± 2.2
20.8 ± 1.7
Weight (kg)
78.0 ± 13.9
60.1 ± 5.1 *
Height (cm)
177.9 ± 6.7
167.9 ± 4.6 *
BMI
24.5 ± 2.2
21.5 ± 2.3 *
Body Fat %
19.3 ± 6.1
22.4 ± 2.6
Fat Mass (kg)
15.1 ± 0.9
13.5 ± 0.3
Fat Free Mass (kg)
63.0 ± 13.0
46.7 ± 4.7 *
Reg. Caffeine Consumption (%)
17.6
50.0
Reg. Aerobic Exercise (%)
35.3
75.0
Reg. High Fat Diet (%)
41.8
37.5
* Denotes p < 0.05 between groups. BMI Body Mass Index.
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Experimental Protocol
Participants were asked to abstain from caffeine and alcohol consumption 48 hours prior
to each trial and were asked to abstain from exercise for 24 hours prior to each trial. In addition,
participants entered the lab three hours postprandial and were asked to consume a standard meal
of approximately 270 kilocalories (60% CHO, 15% PRO, 25% Fat) prior to each exercise trial to
ensure consistent results across all participants and between each trial. It should be noted that
studies have demonstrated that an overnight fast does provide valid and reliable responses to
exercise; however, by examining participants three hours postprandial, the current study
provided responses that are more applicable to real-world settings. Presumably, most of the
population does not exercise on a regular basis following an overnight fast, rather exercise takes
place after some form of nutrients have been consumed. Additionally, several studies have
shown that the ingestion of carbohydrates prior to exercise enhances endurance performance
(102). Thus, by examining lipid metabolism three hours postprandial, we were able to provide
much more useful information as it applies to the general public, and as previously mentioned,
the fasting state has no effect on plasma adiponectin concentration (76).
Upon arrival to the testing site, all baseline measures were obtained (table 1). Each
participant sat quietly for five minutes, after which resting heart rate was obtained. Heart rate
data was obtained through a Polar heart rate monitor (Polar Electro, Kempele, Finland). Height
and weight were measured using a Detecto medical scale (Cardinal Scale Manufacturing Co.,
Webb City, MO), body fat was measured via the seven-site skinfold technique using Lange
skinfold calipers (Beta Technology, Inc., Cambridge, MD), and a questionnaire regarding
exercise and dietary habits was completed and analyzed using My Diet Analysis software
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(Pearson Education Inc., Upper Saddle River, NJ). A sample questionnaire is provided in
Appendix 2. Regular caffeine consumption was considered a combination of any of the
following equating to ≥ five per week: eight ounces of coffee/tea, twelve ounces of caffeinated
soda, and one energy shot/drink. Regular aerobic exercise was considered ≥ 150 minutes of total
aerobic exercise per week. Regular high fat diet was considered ≥ an average of 35% of total
daily caloric intake from fat.
Exercise Protocol
Following the completion of baseline testing, resting respiratory exchange ratio (RER)
data was obtained through indirect calorimetry (Moxus Modular VO2 System, Pittsburgh, PA).
Heart rate, volume of oxygen consumed (VO2), and respiratory exchange ratio (RER) were
monitored for the duration of the study. All exercise protocols were performed on a
mechanically braked cycle ergometer (Monark Exercise AB, Norrbotten, Sweden). Before each
exercise session, male participants completed a 10 minute warm- up at a 50 watt (W) power
output maintaining 50 revolutions per minute (rpm). Female participants completed a 10 minute
warm-up at a 25 W power output, then began the initial workload at 50W, increasing the
workload by 25 W every 6 minutes until exhaustion. This was done to compensate for the
reduced muscle mass and aerobic capacity seen in the female group. A pedal frequency of 50
rpm was maintained for the entirety of the warm-up and exercise phases for both males and
females. In addition, rating of perceived exertion (RPE) and signs and symptoms of possible
cardiopulmonary dysfunction was monitored every 2-3 minutes throughout the test. Participants
then began the initial workload at 100W. The workload then increased by 50W every 6 minutes
until the participant could no longer maintain his or her pedal frequency. This time point was
deemed exhaustion and time to exhaustion for the exercise trial was recorded.
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Supplement Dosage
Supplements were administered using a balanced, randomized, double-blind, crossover
design. Upon arrival to the research site, each participant was randomly assigned to a placebo,
caffeine, or nicotinic acid supplement. For each subsequent visit, the participant was
administered a different supplement, ensuring that each of the three supplements were ingested
for three different exercise trials. A one-week washout period separated each exercise trial to
eliminate any carry-over effect. For the niacin trial, each participant was administered 1000
milligrams (mg) of niacin, for the caffeine trial, each participant was administered five
mg/kilogram (kg) of body weight, and for the placebo trial, each participant was administered a
methylcellulose placebo supplement capsule. Each supplement was ingested at least 30 minutes
prior to the onset of the exercise protocol.
Plasma Analysis
For each trial, the participant sat quietly for 30 minutes after ingesting the supplement,
after which ten milliliters (ml) of blood was drawn from the cubital vein to determine initial
plasma adiponectin values. Immediately following the completion of each exercise trial, an
additional ten ml of blood was drawn from the same location to determine post-exercise plasma
adiponectin levels. Blood was collected into sodium heparin vacutainers and immediately
centrifuged. Plasma was then separated and stored at -80 degrees Fahrenheit until further
analysis. All plasma samples were analyzed to determine the concentration of total plasma
adiponectin via western blot. Protein was quantified for each sample, as determined by
bicinchoninic acid (BCA) assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein
from each sample were subjected to electrophoresis. Proteins were separated in 7.5%
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polyacrylamide (acrylamide from National Diagnostics) gels containing sodium dodecyl sulfate
(SDS) and transferred to nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20%
methanol. Following transfer, the membrane was blocked overnight in 4% milk at 4°C then
probed with human-anti-adiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween).
Results were visualized with horseradish peroxidase (HRP)-conjugated mouse-anti-human
secondary antibody (1:1000 in 1% nonfat milk in 1X Tris-buffered saline-tween) and enhanced
chemiluminescence. Each membrane was probed with anti- α Tubulin as a loading control
(1:1000 in 1% BSA in 1X Tris-buffered saline-tween) and densitometric analysis of blots was
performed using Image J software.
Statistical Analysis
All data were analyzed using a repeated-measures analysis of variance (ANOVA) to
compare differences in RER, time to exhaustion, and plasma adiponectin and alpha-tubulin
concentration between and within subjects as well as between and within trials. Correlations of
co-variables were tested using simple linear regression and significant differences were
identified using Tukey post-hoc tests. p < 0.05 was considered significant. All values are
presented as mean ± SD. All statistical analysis was completed using SAS v9.2 (SAS Institute,
Inc. Cary, NC).
2.2 Chronic Aerobic Exercise
Subjects
Recreationally active females (n = 38) ages 18-24 were recruited to participate in the
study. All participants were non-smokers and were not taking any medication, with the
exception of oral contraceptives. Subject characteristics are shown in table 2. All participants
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were healthy as indicated by the Physical Activity Readiness Questionnaire (PAR-Q). Informed
consent was obtained from all participants prior to the onset of the first exercise trial and the
study protocol was approved by the Institutional Review Board of Louisiana State University.
Table 2. Subject Characteristics for the chronic aerobic exercise modality.
Baseline Subject Characteristics
Exercise
Control
n = 18
n = 20
Age (yr)
21 ± 0.8
21 ± 1.3
Weight (kg)
62.9 ± 6.3
61.5 ± 9.2
Height (cm)
166.0 ± 5.1
164.9 ± 4.2
BMI
22.79 ± 2.1
21.87 ± 3.1
Body Fat %
32.4 ± 5.1
29.7 ± 6.1
Fat Mass (kg)
20.5 ± 3.8
18.6 ± 6.3
Fat Free Mass (kg)
42.8 ± 5.7
42.8 ± 4.3
* No statistical differences between groups at baseline. BMI Body Mass Index.

Experimental Protocol
At the onset of the study, participants were randomly assigned to an aerobic exercise
group (E) or a control group (C). In order to minimize subject variability, participants were
asked to abstain from alcohol and caffeine consumption as well as strenuous physical activity for
48 hours prior to baseline testing. Baseline measurements were established for height and body
weight using a Detecto medical scale (Cardinal Scale Manufacturing Co., Webb City, MO), body
fat percentage was determined by duel energy x-ray absorptiometry (DXA), and estimated VO2
max

was determined by a 1.5 mile run.
Participants then completed the 15-week exercise intervention. A week-by-week

description for the exercise intervention is described in table 3. Participants were required to
participate in a minimum of 80% of the exercise sessions to be included in the analysis.
Following training, and prior to running a full marathon, all baseline measurements were re-
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tested. This was done to minimize confounding inflammatory responses that are associated with
completing a full marathon (26.2 mile) race.
Table 3. Training Protocol for the chronic aerobic exercise modality.
Week

Mon

Tues

Wed

Thur

Fri

Sat

Sun

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Rest
Rest
Rest
Rest
Rest
Rest
Rest
Rest
Rest
Rest
Rest
Rest
Rest
Rest
Rest

3
3
3
Rest
6
Cross
3
4
3
Rest
7
Cross
3
4
3
Rest
8
Cross
3
4
3
Rest
7
Cross
3
5
3
Rest
10
Cross
3
6
3
Rest
12
Cross
3
5
4
Rest
11
Cross
4
7
4
Rest
14
Cross
4
8
5
Rest
16
Cross
4
9
5
Rest
18
Cross
5
9
5
Rest
20-22
Cross
5
10
5
Rest
20
Cross
5
10
5
Rest
12
Cross
5
6
5
Rest
8
Cross
3
4
2
Rest
RACE
Numbers= number of miles run; cross= cross training.

Total
(miles/wk)
15
17
18
17
21
24
23
29
33
36
39-41
40
32
24

Plasma Analysis
During initial baseline testing at the onset of the study, an overnight fasting blood sample
was drawn from the cubital vein of each participant. Prior to the blood draw, participants were
asked to abstain from caffeine and alcohol consumption as well as exercise for 48 hours. This
procedure was repeated at the conclusion of the study and a second fasting blood sample was
obtained 48 hours after the final exercise testing; this was done to minimize any carry-over
effects from an acute exercise bout. Blood was collected into sodium heparin vacutainers and
immediately centrifuged. Plasma was then separated and stored at -80 degrees Fahrenheit until
further analysis. All plasma samples were analyzed to determine the concentration of total
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plasma adiponectin via western blot. Protein was quantified for each sample, as determined by
bicinchoninic acid (BCA) assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein
from each sample were subjected to electrophoresis. Proteins were separated in 7.5%
polyacrylamide (acrylamide from National Diagnostics) gels containing sodium dodecyl sulfate
(SDS) and transferred to nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20%
methanol. Following transfer, the membrane was blocked overnight in 4% milk at 4°C then
probed with human-anti-adiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween).
Results were visualized with horseradish peroxidase (HRP)-conjugated mouse-anti-human
secondary antibody (1:1000 in 1% nonfat milk in 1X Tris-buffered saline-tween) and enhanced
chemiluminescence. Each membrane was probed with anti- α Tubulin as a loading control
(1:1000 in 1% BSA in 1X Tris-buffered saline-tween) and densitometric analysis of blots was
performed using Image J software.
Statistical Analysis
All data were analyzed using a repeated-measure ANOVA and paired t-tests where
appropriate. Correlations of co-variables were tested using simple linear regression and
significant differences were identified using Tukey post-hoc tests. p < 0.05 was considered
significant. All values are presented as mean ± SD. All statistical analysis was completed using
SAS v9.2 (SAS Institute, Inc. Cary, NC).
2.3 Acute Resistance Training
Subjects
Untrained healthy males (n = 17) and females (n = 12) age 18-35 with a body mass index
(BMI) of less than 30 were recruited to participate in the study. All participants were non30

smokers, were not taking any medication, with the exception of oral contraceptives, and did not
regularly perform any type of resistance training exercise more than one time per week. Subject
characteristics are shown in table 4. All participants were healthy as indicated by the Physical
Activity Readiness Questionnaire (PAR-Q). Informed consent was obtained from all participants
prior to the onset of the first exercise trial and the study protocol was approved by the
Institutional Review Board of Louisiana State University.
Table 4. Subject Characteristics for the acute resistance exercise modality.
Subject Characteristics
Men
Women
n = 17
n = 12
Age (yr)
23.1 ± 4.1
20.6 ± 1.36
Weight (kg)
78 ± 10.3
62.0 ± 8.8 *
Height (cm)
176.5 ± 6.4
163.7 ± 4.7 *
BMI
25.0 ± 2.8
23.1 ± 2.9 *
Body Fat %
17.9 ± 5.9
24.3 ± 5.7 *
Fat Mass (kg)
14.3 ± 6.5
15.4 ± 5.2
Fat Free Mass (kg)
63.7 ± 6.1
46.6 ± 4.7 *
Reg. Caffeine Consumption (%)
36.4
35.0
Reg. Resistance Exercise (%)
27.3
60.0 *
* Denotes p < 0.05 between groups. BMI Body Mass Index. BMI Body Mass Index.

Experimental Protocol
Participants were asked to abstain from vigorous physical activity, caffeine and alcohol
consumption 48 hours prior to each trial. In addition, participants came in a minimum of three
hours postprandial and were asked to consume the same meal (60% CHO, 15% protein, 25% fat)
prior to each trail to ensure consistent results across all participants and between each trial.
Upon arrival to the research site, height and weight were measured using a Detecto medical scale
(Cardinal Scale Manufacturing Co., Webb City, MO), body fat was measured via the 7-site
skinfold technique using Lange skinfold calipers (Beta Technology, Inc., Cambridge, MD), and a
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questionnaire regarding exercise and dietary habits was completed and analyzed using My Diet
Analysis software (Pearson Education Inc., Upper Saddle River, NJ). A sample questionnaire is
provided in Appendix 2. Regular caffeine consumption was considered a combination of any of
the following equating to ≥ 5 per week: cups of coffee/tea, 12 oz caffeinated sodas, and energy
shots/drinks. Regular aerobic exercise was considered ≥ 150 minutes of total aerobic exercise
per week. Regular high fat diet was considered ≥ an average of 35% of total daily caloric intake
from fat.
Each participant was then randomly assigned to the control or exercise trial. On the
subsequent visit, the participant was assigned to whichever trial was not administered during the
first visit. Each exercise trial was separated by a minimum of one week. Each participant
completed a total of three trials. The first trial was used to determine a one repetition maximum
(1RM) for box squat and bench press exercises. The next trial consisted of either a highintensity resistance training protocol lasting approximately 30 minutes or a control trial, in which
the participants sat quietly for 30 minutes.
Venous blood samples were collected immediately before and after each protocol and
dermal punctures were administered pre- and post-exercise to determine changes in blood
glucose concentration.
Exercise Protocol
The exercise intervention set, rep, and rest scheme was based off of previous acute
resistance training studies that have demonstrated increases in lipid oxidation, decreases in
intramyocellular lipid (IMCL) stores, decreases in glycogen stores (26), and increases in plasma
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glycerol (4). Therefore it can be assumed that lipid utilization was increasing with this type of
exercise.
A 1RM for the box squat and bench press exercises were determined during the first trial.
On one of the two subsequent trials, participants completed 6 sets of 12 repetitions on squats and
bench press at 75% 1RM following a pre-exercise blood draw. 60 seconds of rest were allotted
between sets. For the box squat exercise, participants lowered themselves down onto the box in
a slow, controlled manner to prevent injury. Boxes were used as a depth cue so participants
know when they have reached the proper depth (approximately 90 degree angle at the knee).
The boxes also ensured that there were separate eccentric and concentric phases of the squat.
Once the proper depth had been reached, participants raised themselves to an upright, standing
position, and then repeated this process for the allotted number of repetitions. For the bench
press exercise, participants lowered the bar down onto their chest in a slow, controlled manner to
prevent injury. Once the bar had touched the chest, participants pressed the bar upward until
their arms were fully extended, and then repeat this process for the allotted number of
repetitions. If necessary, the weight lifted was decreased to ensure all sets and reps were
completed and that the allotted 60 second rest period was maintained for the entirety of the
exercise protocol.
Plasma Analysis
Blood glucose concentration measurements were taken to via dermal puncture
immediately pre- and post-exercise to determine the extent of glucose utilization and uptake.
Prior to the exercise intervention, 10 ml of blood was drawn from the cubital vein to determine
initial plasma adiponectin values. Immediately following the completion of each exercise trial,
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an additional 10 ml of blood was drawn from the same location to determine post-exercise
plasma adiponectin levels. Blood was collected into sodium heparin vacutainers and
immediately centrifuged. Plasma was then separated and stored at -80 degrees Fahrenheit until
further analysis. All plasma samples were analyzed to determine the concentration of total
plasma adiponectin via western blot. Protein was quantified for each sample, as determined by
bicinchoninic acid (BCA) assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein
from each sample were subjected to electrophoresis. Proteins were separated in 7.5%
polyacrylamide (acrylamide from National Diagnostics) gels containing sodium dodecyl sulfate
(SDS) and transferred to nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20%
methanol. Following transfer, the membrane was blocked overnight in 4% milk at 4°C then
probed with human-anti-adiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween).
Results were visualized with horseradish peroxidase (HRP)-conjugated mouse-anti-human
secondary antibody (1:1000 in 1% nonfat milk in 1X Tris-buffered saline-tween) and enhanced
chemiluminescence. Each membrane was probed with anti- α Tubulin as a loading control
(1:1000 in 1% BSA in 1X Tris-buffered saline-tween) and densitometric analysis of blots was
performed using Image J software.
Statistical Analysis
All data were analyzed using repeated-measures ANOVA and paired t-tests where
appropriate. Correlations of co-variables were tested using simple linear regression and
significant differences were identified using Tukey post-hoc tests. p < 0.05 was considered
significant. All values are presented as mean ± SD. All statistical analysis was completed using
SAS v9.2 (SAS Institute, Inc. Cary, NC).
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2.4 Chronic Resistance Exercise
Subjects
Untrained, healthy men (n=40) age 18-35 with a body mass index (BMI) of less than 30
were recruited to participate in the study. All participants were non-smokers, were not taking
any medication, and did not regularly perform any type of resistance training exercise more than
one time per week. Subject characteristics are shown in table 5. All participants were healthy as
indicated by the Physical Activity Readiness Questionnaire (PAR-Q). Informed consent was
obtained from all participants prior to the onset of the first exercise trial and the study protocol
was approved by the Institutional Review Board of Louisiana State University.
Table 5. Subject characteristics for the chronic resistance exercise modality.
Subject Characteristics
Exercise
Control
n = 18
n = 22
Age (yr)
20.4 ± 2.1
22.9 ± 4.7 *
Weight (kg)
82.1 ± 11.3
82.1 ± 13.9
Height (cm)
177.2 ± 7.7
176.2 ± 5.6
BMI
26.1 ± 3.4
26.8 ± 5.5
Body Fat %
20.4 ± 6.4
24.4 ± 8.8
Fat Mass (kg)
17.3 ± 7.4
20.3 ± 11.6
Fat Free Mass (kg)
64.8 ± 6.1
61.9 ± 5.9
Reg. Caffeine Consumption (%)
55.0
45.5
Reg. Resistance Exercise (%)
25.0
41.0
* Denotes statistically significant differences between groups, p < 0.05. BMI Body Mass Index.

Experimental Protocol
Students currently enrolled in a beginning weight training course and a lecture course at
Louisiana State University were recruited to participate as the exercise (E) and control (C)
groups, respectively. In order to minimize subject variability, at the onset of the study,
participants were asked to abstain from alcohol and caffeine consumption as well as strenuous
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physical activity for 48 hours. Following this time period, participants completed an overnight
fast and 10 ml of blood was drawn from the cubital vein, height and weight were measured using
a Detecto medical scale (Cardinal Scale Manufacturing Co., Webb City, MO), body fat was
measured via the 7-site skinfold technique using Lange skinfold calipers (Beta Technology, Inc.,
Cambridge, MD), and a questionnaire regarding exercise and dietary habits was completed and
analyzed using My Diet Analysis software (Pearson Education Inc., Upper Saddle River, NJ). A
sample questionnaire is provided in Appendix 2. Regular caffeine consumption was considered
a combination of any of the following equating to ≥ 5 per week: cups of coffee/tea, 12 oz
caffeinated sodas, and energy shots/drinks. Regular aerobic exercise was considered ≥ 150
minutes of total aerobic exercise per week. Regular high fat diet was considered ≥ an average of
35% of total daily caloric intake from fat.
Exercise Protocol
As outlined in table 6, following a familiarization phase, the initial strength of each
participant was determined by one-repetition maximum (1RM) for free weight squat, free weight
bench press, and free weight deadlift. Following the exercise intervention, all baseline
measurements and strength measurements were re-tested.
Participants completed the twelve-week exercise intervention. A week-by-week
description for the exercise intervention is described in table 6. Resistance training was
performed three times per week for 40-50 minutes per exercise session. Each exercise session
was separated by a minimum of 48 hours. Participants were required to participate in a
minimum of 80% of the exercise sessions to be included in the analysis.
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Table 6 Week-to-week periodization training protocol for the chronic resistance training
protocol.
Week
Sets
Reps Intensity (%1RM)
1
Familiarization/Baseline Testing
N/A
2
4
3
60
3
4
6
60
4
12
2
80
5
1 RM Testing
1
100
6
3
8
60
7
3
6
70
8
4
2
85
9
5
5
80
10
4
4
85
11
3
12
55
12
3
6
70
13
1 RM Testing
1
100
14
Repeat Baseline Testing
N/A
N/A
1RM one-repetition maximum.
Total work volume varied from week to week, each day consisted of three-to-five
exercises depending on the number of sets and reps. Three exercises were used for higher set
and rep schemes whereas four or exercises were used for lower set and rep schemes. Specific
exercises varied from week-to-week and included free weight box squats, back squats, flat bench
press, incline bench press, conventional deadlifts, Romanian deadlifts, sumo deadlifts, bent over
rows, upright rows, good mornings, glut/ham raises, pull ups, lat pull downs, and push press. To
minimize the risk of overtraining and injury, no single muscle group was targeted on back-toback exercise sessions. Each of the baseline variables were re-assessed at week twelve following
the baseline testing procedures discussed.
Plasma Analysis
At the onset of the study, ten ml of blood was drawn from the cubital vein to determine
initial plasma adiponectin values. Following a 48-hour rest period, in which participants
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abstained from vigorous exercise, caffeine, and alcohol for 48 hours, an additional ten ml of
blood was drawn from the same location to determine post-exercise intervention plasma
adiponectin levels. Blood was collected into sodium heparin vacutainers and immediately
centrifuged. Plasma was then separated and stored at -80 degrees Fahrenheit until further
analysis. All plasma samples were analyzed to determine the concentration of total plasma
adiponectin via western blot. Protein was quantified for each sample, as determined by
bicinchoninic acid (BCA) assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein
from each sample were subjected to electrophoresis. Proteins were separated in 7.5%
polyacrylamide (acrylamide from National Diagnostics) gels containing sodium dodecyl sulfate
(SDS) and transferred to nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20%
methanol. Following transfer, the membrane was blocked overnight in 4% milk at 4°C then
probed with human-anti-adiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween).
Results were visualized with horseradish peroxidase (HRP)-conjugated mouse-anti-human
secondary antibody (1:1000 in 1% nonfat milk in 1X Tris-buffered saline-tween) and enhanced
chemiluminescence. Each membrane was probed with anti- α Tubulin as a loading control
(1:1000 in 1% BSA in 1X Tris-buffered saline-tween) and densitometric analysis of blots was
performed using Image J software.
Statistical Analysis
All data were analyzed using repeated-measures ANOVA and paired t-tests where
appropriate. Correlations of co-variables were tested using simple linear regression and
significant differences were identified using Tukey post-hoc tests. p < 0.05 was considered
significant. All values are presented as mean ± SD. All statistical analysis was completed using
SAS v9.2 (SAS Institute, Inc. Cary, NC).
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2.5 Acute Stretching Exercise
Subjects
Recreationally active, healthy men age 18-35 with a body mass index (BMI) of less than
25 were recruited to participate in the study. All participants were non-smokers, were not taking
any medication, and did not regularly participate in vigorous exercise more than one time per
week. Subject characteristics are shown in table 7. All participants were healthy as indicated by
the Physical Activity Readiness Questionnaire (PAR-Q). Informed consent was obtained from
all participants prior to the onset of the first exercise trial and the study protocol was approved by
the Institutional Review Board of Louisiana State University.
Table 7. Subject characteristics for the acute stretching exercise protocol.
Subject Characteristics
Men
n = 23
Age (yr)
22.5 ± 4.3
Weight (kg)
78.8 ± 11.4
Height (cm)
177.9 ± 5.7
BMI
25.0 ± 3.9
Body Fat %
16.2 ± 5.9
Fat Mass (kg)
13.4 ± 6.5
Fat Free Mass (kg)
65.5 ± 7.1
Reg. Caffeine Consumption (%)
30.0
Reg. Resistance Exercise (%)
48.0
Reg. Aerobic Exercise (%)
65.0
BMI Body Mass Index.
Experimental Protocol
Each participant completed a total of four trials. Participants were asked to abstain from
caffeine and alcohol consumption 48 hours prior to each trial. In addition, participants came into
the lab a minimum of three hours postprandial and were asked to consume the same meal (60%
CHO, 15% protein, 25% fat) prior to each trail to ensure consistent results across all participants
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and between each trial. Upon arrival to the research site, height and weight were measured
using a Detecto medical scale (Cardinal Scale Manufacturing Co., Webb City, MO), body fat
was measured via the 7-site skinfold technique using Lange skinfold calipers (Beta Technology,
Inc., Cambridge, MD), and a questionnaire regarding exercise and dietary habits was completed
and analyzed using My Diet Analysis software (Pearson Education Inc., Upper Saddle River,
NJ). A sample questionnaire is provided in Appendix 2. Regular caffeine consumption was
considered a combination of any of the following equating to ≥ 5 per week: cups of coffee/tea,
12 oz caffeinated sodas, and energy shots/drinks. Regular aerobic exercise was considered ≥ 150
minutes of total aerobic exercise per week. Regular high fat diet was considered ≥ an average of
35% of total daily caloric intake from fat.
Supplement dosage
Following baseline measurements, participants were administered a methylcellulose
placebo or melatonin (6mg) supplement, utilizing a counterbalanced randomized double blind,
crossover design. This ensured that each participant was administered each supplement twice
over the course of the four exercise trials, one placebo and one melatonin supplement for each of
the exercise trials, and one placebo and one melatonin supplement for each control trial. At the
onset of each trail and for the duration of each trial, respiratory gases were monitored using
indirect calorimetry. This was done to determine changes in substrate utilization during the
exercise protocol.
Exercise Protocol
Two exercise trials consisted of a 30 minute passive resistance stretching protocol, the
other two trials consisted of a 30 minute mock stretching protocol, meaning no tension was
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applied to the muscle, but participants went through the same motions as the passive resistance
protocol. The order of the trials was randomized and balanced for each participant. Each
exercise trial was separated by a minimum of one week.
The passive resistance stretching exercise protocol was done in the following order:
Hamstring stretch, quadriceps stretch, shoulder stretch, triceps stretch, hip adductor stretch, and
hip flexor stretch. Each stretch was held for 30 seconds followed by 20 seconds rest, then
repeated 2 more times (three sets of 30 seconds for each exercise per leg/arm). 6 exercises X 2
limbs X 2.5 minutes/exercise = a total time of 30 minutes. The details of each exercise are
outlined and diagramed below, however some of these stretches were modified to have the
participants lying in the supine position. This allowed for more accurate measurements of the
respiratory gases. For each exercise, the range of motion was increased until the participant
acknowledged a stretch-induced mild tightness in the muscle similar to that normally felt during
a stretching activity. For the control trials, participants completed these same motions for the
same period of time, but no tension will be applied to the muscle.
Stretching Illustrations and Descriptions
Hamstring stretch: Participants were in a supine position on a table with one leg fully
extended. The other leg was ﬂexed at the hip (45 degrees), with the knee fully extended. From
this position, the extended leg was raised (hip ﬂexion) to the vertical position or beyond to the
point of stretching. During the stretch, the buttocks remained in complete contact with the
ground, and the knee of the stretched leg was fully extended.
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Quadriceps stretch: Participants were in a supine position with one leg hanging off the
edge of the table and knee flexed at approximately 90 degrees. The hip was then hyperextended
by pushing down on the thigh and the foot was pushed upward to increase tension on the
quadriceps muscle. This was done to the point of stretching.

Shoulder stretch: Participants were in a supine, anatomical position on a table. The
shoulder was then adducted; the arm was rotated to a pronated position. The arm was then
hyperextended to the point of stretching, keeping the opposite shoulder flat on the table.
Chest stretch: Participants were in a supine, anatomical position on a table. The
shoulder was then adducted and the arm remained in a supinated position. The arm was then
pressed down toward the floor to the point of stretching, keeping the opposite shoulder flat on
the table.
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Glutes stretch: Participants were in a supine position on a table with one leg ﬂexed at the
knee (90 degrees) and the hip (45 degrees), with the foot placed firmly on the table. The ankle of
the opposite leg was placed on the knee of the flexed leg. From this position, the hip of the first
leg was flexed back to the point of stretching in the gluteus maximus muscle.
Low back stretch: Participants were in a supine position on a table with one leg fully
extended. The other leg was flexed at the knee (90 degrees) and the hip (45 degrees), with the hip
placed firmly on the table. From this position, the flexed leg was adducted and brought across
the body. The leg was then pushed upward toward the head until the point of stretching in the
low back.
Plasma Sample Analysis
For each trial, the participant sat quietly for 30 minutes after ingesting the supplement,
after which ten ml of blood was drawn from the cubital vein to determine initial plasma
adiponectin values. Immediately following the completion of each exercise trial, an additional
ten ml of blood was drawn from the same location to determine post-exercise plasma adiponectin
levels. Blood was collected into sodium heparin vacutainers and immediately centrifuged.
Plasma was then separated and stored at -80 degrees Fahrenheit until further analysis. All
plasma samples were analyzed to determine the concentration of total plasma adiponectin via
western blot. Protein was quantified for each sample, as determined by bicinchoninic acid (BCA)
assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein from each sample were
subjected to electrophoresis. Proteins were separated in 7.5% polyacrylamide (acrylamide from
National Diagnostics) gels containing sodium dodecyl sulfate (SDS) and transferred to
nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20% methanol. Following
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transfer, the membrane was blocked overnight in 4% milk at 4°C then probed with human-antiadiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween). Results were visualized with
horseradish peroxidase (HRP)-conjugated mouse-anti-human secondary antibody (1:1000 in 1%
nonfat milk in 1X Tris-buffered saline-tween) and enhanced chemiluminescence. Each
membrane was probed with anti- α Tubulin as a loading control (1:1000 in 1% BSA in 1X Trisbuffered saline-tween) and densitometric analysis of blots was performed using Image J
software.
Statistical Analysis
All data were analyzed using repeated-measures ANOVA and paired t-tests where
appropriate. Correlations of co-variables were tested using simple linear regression and
significant differences were identified using Tukey post-hoc tests. p < 0.05 was considered
significant. All values are presented as mean ± SD. All statistical analysis was completed using
SAS v9.2 (SAS Institute, Inc. Cary, NC).
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CHAPTER 3. RESULTS
3.1 Acute Aerobic Exercise
In males, the niacin treatment had significantly higher (p < 0.05) respiratory exchange
ratio (RER) compared to the placebo and caffeine treatments (N = 0.95 ± 0.05, P = 0.88 ± 0.05,
C = 0.88 ± 0.06) (mean ± SD.) (Fig. 1.1a). Females, however, did not demonstrate significant
differences in RER when given the niacin treatment compared to the placebo treatment, while
the caffeine treatment yielded a significantly lower RER compared to the placebo treatment (C =
0.84 ± 0.09, P = 0.88 ± 0.04) (Fig. 1.1b). Males demonstrated a significantly higher RER when
given niacin compared to females (males = 0.95 ± 0.05, females = 0.85 ± 0.08). When all
exercise trails were combined, fat utilization did not significantly differ between males and
females for stages one and two of exercise; however, the utilization of fat at the third stage of
exercise was significantly lower in males (males = 0.97 ± 0.06, females = 0.90 ± 0.08).
In males, the percentage of carbohydrate (CHO) utilization was higher for the niacin
treatment compared to placebo and caffeine treatments (N = 80% ± 13, P = 61% ± 17, C = 62%
± 20) (Fig. 1.2a) while there were no significant differences in CHO utilization in females (Fig.
1.2b). Similar to absolute RER, males demonstrated a significantly higher %CHO utilization
when given niacin compared to females (males = 80% ± 13, females = 51% ± 26) and when all
exercise trails were combined, %CHO during the third stage of exercise was significantly higher
in males (males = 85% ± 14, females = 60% ± 27), while there were no significant differences in
%CHO utilized during stages one and two.
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Time to exhaustion was significantly different for all three trials for both males (N = 24.4
± 3.8, P = 25.5 ± 3.1, C = 27 ± 3.4) (Fig. 1.3a) and females (N = 29.7 ± 5.6, P = 31.3 ± 5.0, C =
32.8 ± 5.1) (Fig.1.3b).
The caffeine and niacin supplements did not significantly alter plasma adiponectin preexercise compared to the placebo trial. (Fig. 1.4) Exercise did not significantly alter plasma
adiponectin in the placebo or caffeine trials, however, plasma adiponectin significantly decreased
following the niacin trial (Pre = 1.00 AU, Post = 0.74 AU). (Fig. 1.5).
Simple linear regression was used to determine correlations between average plasma
adiponectin concentration (Adpn) and: first degree family history of type 2 diabetes mellitus
(FH+), regular aerobic exercise (Reg. Aex), regular resistance training exercise (Reg. Rex),
regular caffeine consumption (Reg. Caff), body fat percentage (BF%), BMI, and average RER
during exercise for each subject (Table 8). Regular aerobic exercise (r = 0.28) and regular
caffeine consumption (r = .32) were both statistically significant correlations (p < 0.05), no other
correlates were significant. No subjects for this intervention were FH+ and therefore no values
are given for this variable.
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Acute Aerobic Exercise: RER (Males)
1.2
1

*#

RER

0.8
Stage 1

0.6

Stage 2

0.4

Stage 3
0.2
0
Niacin

Caffeine

Placebo

Supplement

A.

Acute Aerobic Exercise: RER (Females)
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Figure 1.1. Comparison of respiratory exchange ratio (RER) during three stages of exercise for
niacin, placebo, and caffeine exercise trials (means ± SD) for males (A) and females (B).
* p < 0.05 compared to placebo treatment. # p < 0.05 compared to caffeine treatment.
(Males: N = 0.95 ± 0.05, P = 0.88 ± 0.05, C = 0.88 ± 0.06; Females: N = 0.87 ± 0.07,
C = 0.84 ± 0.09, P = 0.88 ± 0.04).
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Acute Aerobic Exercise: % CHO Utilized (Males)
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Acute Aerobic Exercise: % CHO Utilized (Females)
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Figure 1.2. Comparison of %CHO utilization during three stages of exercise for niacin, placebo, and
caffeine exercise trials (means ± SD) for males (A) and females (B). *p > 0.05 compared to placebo
treatment. # p > 0.05 compared to caffeine treatment. (Males: N = 80 ± 13%, C = 62 ± 20%,
P = 61 ± 17%; Females: N = 51 ± 26%, C = 48 ± 29%, P = 47 ± 26%).
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Acute Aerobic Exercise: Time (Males)
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Acute Aerobic Exercise: Time (Females)
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Figure 1.3. Comparison of time to exhaustion for niacin, placebo, and caffeine exercise trails in
minutes (min) (mean ± SD) for males (A) and females (B). *p < 0.05 compared to placebo
treatment. # p < 0.05 compared to caffeine treatment. (Males: N = 24.4 ± 3.8 vs. P = 25.5 ± 3.1
vs. C = 27 ± 3.4; Females: (N = 29.7 ± 5.6 vs. P = 31.3 ± 5.0 vs. C = 32.8 ± 5.1).
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Adiponectin

α- Tubulin

Figure 1.4. Acute Aerobic Exercise. Western blot comparison of plasma adiponectin (~ 31
kda) for placebo, niacin, and caffeine exercise trials pre- and post- exercise for subject 2. αTubulin (~ 55 kda) served as a loading control. - Pre-Exercise Intervention; + Post-Exercise
Intervention.

Arbitrary Units

Acute Aerobic Exercise: Quantification of
Plasma Adiponectin
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Figure 1.5. Quantitative comparison of plasma adiponectin for placebo, niacin, and caffeine
exercise trials. Area under the curve for each plasma sample was calculated and normalized
against the loading control. Results are given in arbitrary units (mean ± SD) for all male subjects
(n = 17). (P Trial: Pre = 0.91 ± 0.28, Post = 0.87 ± 0.48; N Trial: Pre = 1.01 ± 0.44, 0.74 ± 0.36,
C Trial: Pre = 0.99 ± 0.43, Post = 0.78 ± 0.25).
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Table 8. Acute Aerobic Exercise.
Adiponectin Correlations
FH+
Reg. AEX.
r = .28
p = 0 .05
Reg. Rex
r = -.08
NS
Reg. Caff.
r = .32
p = 0.03
BF%
r = -.14
NS
BMI
r = -.06
NS
RER
r = -.14
NS

Average plasma adiponectin concentration compared to various correlates. Reg AEX. Regular
Aerobic Exercise; BMI Body Mass Index; RER Respiratory Exchange Ratio; Reg. Caff. Regular
Caffeine Consumption; NS non-significant; statistics represent data from all subjects (n = 17).

3.2 Chronic Aerobic Exercise
There were no significant differences among the groups for any of the measured
parameters at baseline. Significant improvements were observed for estimated VO2max in the E
group (37.38 ± 2.39 ml/kg/min pre-intervention to 42.32 ± 7.67 ml/kg/min post-intervention)
(mean ± SD) p = 0.02, but not the C group (36.85 ± 2.98 ml/kg/min pre to 39.79 ± 4.46
ml/kg/min) (Fig 2.1). The 1.5 mile run time changed 8.5% from 13.57 ± 1.3 to 12.41 ± 2.7
minutes (mean ± SD), and the C group changed from 14.24 ± 1.7 to 13.31 ± 2.0 minutes (mean ±
SD) neither of which reached significance (p > 0.05).
The E group decreased body fat significantly from 29.4% ± 8.3 to 27.7% ± 8.7 (mean ±
SD) p = 0.04 (Fig. 2.2). The percent change for this reduction in body fat was 1.7%; however,
the reduction in total body weight was not significant. There was no significant change in body
fat for the C group. The C group and E group had no significant changes in lean tissue mass preto post- exercise.
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Plasma adiponectin was not significantly different pre- to post-intervention in the E group
or the C group (Fig 2.3), however, plasma adiponectin was significantly lower in the C group for
both pre- and post-intervention time points p = 0.05 (Fig 2.4).
Simple linear regression was used to determine correlations between average plasma
adiponectin concentration (Adpn) and: VO2max, waist-to-hip ratio (WHR), body fat percentage
(BF %), BMI, android percent fat (And.), and gynoid percent fat (Gyn.) for each subject (Table
9). No correlates were found to be significant (p > 0.05).

Chronic Aerobic Exercise: Estimated VO2Max
VO2 (ml/kg/min)

60

*

50
40
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20
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10
0
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exercise

Figure 2.1. Comparison of estimated VO2max pre- to post-exercise between C and E groups
(mean ± SD). * p = 0.02 compared to pre-exercise intervention. (E Group: pre = 37.38 ± 2.39
ml/kg/min, post = 42.32 ± 7.67 ml/kg/min; C Group: pre = 36.85 ± 2.98 ml/kg/min, post = 39.79
± 4.46 ml/kg/min).
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Chronic Aerobic Exercise: Body Fat Percentage
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Figure 2.2. Comparison of body fat percentage pre- to post-exercise between C and E groups
(mean ± SD). * p = 0.04 compared to pre-exercise intervention. (E Group: pre = 32.36 ± 5.09,
post = 30.62 ± 5.5%; C Group: pre = 30.17 ± 5.9, post = 28.9 ± 6.0%).
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Adiponectin
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Figure 2.3. Chronic Aerobic Exercise. Western blot comparison of plasma adiponectin
(~ 31 kda) for pre- and post- exercise time points for subject 25, 19, and 2. α-Tubulin (~ 55 kda)
served as a loading control. - Pre-Exercise Intervention; + Post-Exercise Intervention.
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Chronic Aerobic Exercise: Quantification of
Plasma Adiponectin
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Figure 2.4. Quantitative comparison of plasma adiponectin for C and E group pre- and postintervention. Area under the curve for each plasma sample was calculated and normalized
against the loading control. Results are given in arbitrary units (mean ± SD) for all subjects
(n = 11 for both groups). * p = 0.04 compared to control group. (E Group: pre = 1.41 ± 0.66,
post = 1.51 ± 0.69; C Group: pre = 1.06 ± 1.06, post = 0.88 ± 0.95).

Table 9. Chronic Aerobic Exercise.
Adiponectin Correlations
VO2max
r = .17
WHR
r = -.21
BMI
r = -.12
BF %
r = .09
And.
r = -.15
Gyn.
r = -.15

NS
NS
NS
NS
NS
NS

Average plasma adiponectin concentration compared to various correlates. WHR Waist-to-hip
ratio; BMI Body Mass Index; BF% Body Fat Percentage; And. Android percent fat; Gyn.
Gynoid percent fat; NS non-significant; statistics represent data from all subjects (n = 22).

3.3 Acute Resistance Exercise
Blood glucose significantly increased pre-to post-exercise (pre = 4.72 mmol/l ± 0.45,
post = 5.21 mmol/l ± 0.49). The increase in blood glucose immediately following exercise was
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10.4 %. There was no significant difference in blood glucose 24-hours post-exercise compared
to pre-exercise levels (24 = 4.71 mmol/l ± 0.43) (Fig. 3.1). The control trial did not yield any
significant differences in blood glucose from pre- to immediately post- or 24 hours post-exercise
(pre = 4.70 mmol/l ± 0.41, post = 4.70 mmol/l ± 0.44 vs. 24 = 4.72 mmol/l ± 0.45) (mean ± SD).
Despite apparent changes in glucose utilization, plasma adiponectin was not significantly
different pre- to post-intervention for the exercise trial nor was adiponectin significantly different
24 hours post-exercise or between pre- post- and 24 hours post-control trial (Fig 3.2).
Simple linear regression was used to determine correlations between average plasma
adiponectin concentration (Adpn) and: resting blood glucose, relative strength (RS), body mass
index (BMI), body fat percentage (BF%), regular caffeine consumption (Reg. Caff), regular
aerobic exercise (Reg. Aex), regular resistance exercise (Reg. Rex), and first degree family
history of type 2 diabetes mellitus (FH+). Reg. Aex (r = 0.44) and RS (r = 0.43) were
significantly correlated with average plasma adiponectin (p < 0.01) and FH+ (r = -0.56) was
significantly inversely correlated with average plasma adiponectin (p < 0.01). No other
correlates were significant (Table 10).
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Acute Resistance Exercise: Blood Glucose
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Figure 3.1 Blood glucose concentration pre-exercise, immediately post-exercise, 24 hours post
intervention. * p < 0.01 compared to the pre-exercise time point. (E Trial: pre = 4.72 ± 0.45, post
= 5.21 ± 0.49, 24 = 4.71 ± 0.43; C Trial: pre = 4.70 ± 0.41, post = 4.70 ± 0.44, 24 = 4.72 ± 0.45
mmol/l).

Subject 3 (E)
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+

Subject 9 (E)
24
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Figure 3.2. Acute Resistance Exercise. Western blot comparison of plasma adiponectin
(~ 31 kda) for pre-, post-, and 24 hours post- exercise time points for subject 3 and 9. α-Tubulin
(~ 55 kda) served as a loading control. - Pre-Exercise Intervention; + Post-Exercise Intervention;
24 24 hours-post intervention.
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Acute Resistance Exercise: Quantification of
Plasma Adiponectin
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Figure 3.3. Quantitative comparison of plasma adiponectin for pre- post- and 24 hours postintervention. Area under the curve for each plasma sample was calculated and normalized
against the loading control. Results are given in arbitrary units (mean ± SD) for all subjects
(n = 17). (E Trial: pre = 0.69 ± 0.43, post = 0.75 ± 0.51, 24 = 0.72 ± 0.45; C Trial:
pre = 0.74 ± 0.39, post = 0.76 ± 0.48, 24 = 0.81 ± 0.46 AU).

Table 10. Acute Resistance Exercise.
Adiponectin Correlations
RBG
r = -.03
NS
RS
r = .42
p < 0.01
BMI
r = -.12
NS
BF%
r = -.20
NS
Reg. Caff.
r = .45
p < 0.01
Reg. Aex.
r = .22
NS
Reg. Rex
r = .18
NS
FH+
r = -.56
p < 0.01

Average plasma adiponectin concentration compared to various correlates. RBG Resting Blood
Glucose; RS Relative Strength; BMI Body Mass Index; BF% Body Fat Percentage; Reg. Caff.
Regular Caffeine Consumption; Reg Aex. Regular Aerobic Exercise; Reg. Rex Regular
Resistance Exercise; FH+ First Degree Family History of Type 2 Diabetes Mellitus; NS nonsignificant; statistics represent data from all subjects (n = 17).
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3.4 Chronic Resistance Exercise
Strength, as measured by 1RM increased significantly following training (Fig 4.1).
Bench press increased from 97.7±18.4 kilograms (kg) to 101.8±16.2 kg, an 8.2% increase. Squat
increased from 129.6±30.3 kg to 143± 28.3 kg, a 13.4% increase. Deadlift increased from
126.3±35.7 kg to 137.2±33.2 kg, a 12.2% increase.
Resting blood glucose did not change significantly in the E group (pre = 4.87 ± 0.34
mmol/l, post = 4.84 ± 0.36 mmol/l) or the C group (pre = 4.94 ± 0.43 mmol/l, post = 4.83 ± 0.42
mmol/l) (Fig 4.2).
Body fat percentage did not change significantly in the E group (pre = 18.38 ± 4.94%,
post = 17.73 ± 5.42%) or the C group (pre = 21.49 ± 2.02, post = 21.19 ± 3.04) and neither group
had significantly different body fat percentage at the pre- nor post-intervention time points (Fig.
4.3).
Plasma adiponectin did change significantly in the E group (pre = 0.90 ± 0.48 AU, post =
1.00 ± 0.59 AU) but not the C group (pre = 1.04 ± 0.37, post = 1.15 ± 0.53 AU) and neither
group had significantly different concentrations of plasma adiponectin at the pre- or postintervention time points (Fig. 4.4).
Simple linear regression was used to determine correlations between average plasma
adiponectin concentration (Adpn) and: resting blood glucose (RBG), relative strength (RS), body
mass index (BMI), body fat percentage (BF%), regular caffeine consumption (Reg. Caff), regular
aerobic exercise (Reg. Aex), regular resistance exercise (Reg. Rex), and first degree family
history of type 2 diabetes mellitus (FH+). Reg. Aex (r = 0.32) was significantly correlated with
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average plasma adiponectin (p < 0.05) and FH+ (r = -0.58) was significantly inversely correlated
with average plasma adiponectin (p < 0.01). No other correlates were significant (Table 11).

Chronic Resistance Exercise: 1RM
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Figure 4.1. Absolute weight lifted in kilograms (kg) for a one-repetition maximum lift effort
(1RM) (means ± SD). * P < 0.01 vs. baseline measurements. Dark bars, pre-intervention; Light
bars, post-intervention (n = 18).
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Chronic Resistance Exercise: Resting Blood
Glucose
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Figure 4.2. Comparison of resting blood glucose between E and C groups pre- and postintervention. There were no significant differences pre- to post-exercise for the E or C group and
there were no significant differences between groups.
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Figure 4.3. Comparison of body fat percentage between E and C groups pre- and postintervention. There were no significant differences pre- to post-exercise for the E or C group and
there were no significant differences between groups.
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Figure 4.4. Chronic Resistance Exercise. Western blot comparison of plasma adiponectin (~
31 kda) for pre- and post-exercise time points for subjects 15, 16, and 20. α-Tubulin (~ 55 kda)
served as a loading control. - Pre-Exercise Intervention; + Post-Exercise Intervention.
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Figure 4.5. Quantitative comparison of plasma adiponectin for pre- and post-intervention. Area
under the curve for each plasma sample was calculated and normalized against the loading
control. Results are given in arbitrary units (mean ± SD) for all subjects (n = 36). *p < 0.05
compared to control.
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Table 11. Chronic Resistance Exercise.
Adiponectin Correlations
RBG
r = .14
NS
RS
r = .27
NS
BMI
r = -.08
NS
BF %
r = .08
NS
Reg. AEX.
r = .36
p = 0.02
Reg. Caff.
r = .25
NS
FH+
r = -.58
p < 0.01

Average plasma adiponectin concentration compared to various correlates. RBG Resting Blood
Glucose; RS Relative Strength; BMI Body Mass Index; BF% Body Fat Percentage; Reg. Caff.
Regular Caffeine Consumption; Reg Aex. Regular Aerobic Exercise; Reg. Rex Regular
Resistance Exercise; FH+ First Degree Family History of Type 2 Diabetes Mellitus; NS nonsignificant; statistics represent data from all subjects (n = 18).

3.5 Acute Stretching Exercise
Stretching did significantly increase RER. Post-hoc analysis revealed that
supplementation did not significantly affect RER, regardless of whether subjects were stretching
or not. The average RER for the placebo stretching trial was 0.72, average RER for the
melatonin stretch trial was 0.70, average RER for the placebo control trial was 0.66, and average
RER for the melatonin control trail was 0.64 (Fig 5.1).
Plasma adiponectin did not change significantly as a result of supplementation pre- or
post-exercise, (M Trial: 0.99 ± 0.37; P Trial: 1.01 ± 0.38 AU) (Fig. 5.2 & 5.3a) nor as a result of
exercise (pre = 0.99 ± 0.40; post = 1.02 ± 0.36 AU) (Fig 5.3b) and there was no interaction effect
for supplement and exercise on plasma adiponectin concentration (p = 0.25). (PC Trial: Pre =
0.91 ± 0.47, Post = 1.18 ± 0.34; PS Trial: Pre = 0.90 ± 0.76, Post = 0.74 ± 0.59; MC Trial: Pre =
1.00 ± 0.49, Post = 1.02 ± 0.56; MS Trial: Pre = 1.18 ± 0.30, Post = 1.22 ± 0.47) (Fig 5.3c).
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Simple linear regression was used to determine correlations between average plasma
adiponectin concentration (Adpn) and: respiratory exchange ratio (RER), body mass index
(BMI), body fat percentage (BF%), regular caffeine consumption (Reg. Caff), regular aerobic
exercise (Reg. Aex), regular resistance exercise (Reg. Rex), and first degree family history of
type 2 diabetes mellitus (FH+). FH+ (r = -0.14) was significantly inversely correlated with
average plasma adiponectin (p = 0.04). No other correlates were significant (Table 12). No
participants regularly consumed caffeine and therefore, no values are provided for the variable.

RER

Acute Stretching Exercise: RER
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Figure 5.1. Respiratory exchange ratio (RER) measured via indirect calorimetry (means ± SD)
for placebo and melatonin trials (n = 21). *p < 0.05 vs. control trial. PS, placebo stretch trial; PC,
placebo control trial; MS, melatonin stretch trial; MC, melatonin control trial.
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Figure 5.2. Acute Stretching Exercise. Western blot comparison of plasma adiponectin (~ 31
kda) for pre- and post-exercise time points for subjects for PS, PC, MS, and MC trials. αTubulin (~ 55 kda) served as a loading control. - Pre-Exercise Intervention; + Post-Exercise
Intervention.
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A. Figure 5.3. Comparison of plasma adiponectin between supplements (A). No significant
differences were found for supplement. M Melatonin; P placebo; statistics represent data from all
subjects (n = 21).
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Arbitrary Units

Acute Stretching Exercise: Quantification of
Plasma Adiponectin Pre vs. Post
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Acute Stretching Exercise: Plasma
Adiponectin Interaction Effects
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Figure 5.3. Comparison of plasma adiponectin between supplements (A), pre- to post-exercise
(B), and the interaction effect of supplement and exercise (C). No significant differences were
found for supplement, exercise, or interaction. - Pre-Exercise Intervention; + Post-Exercise
Intervention; S Stretch; C Control; M Melatonin; P placebo; statistics represent data from all
subjects (n = 21).
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Table 12. Acute Stretching Exercise.
Adiponectin Correlations
RER
-0.19
NS
BMI
-0.11
NS
BF %
-0.15
NS
Reg. Caff
Reg. Aex
0.24
NS
Reg. Rex
-0.20
NS
FH+
-0.14
p = 0.04
Average plasma adiponectin concentration compared to various correlates. RER Respiratory
Exchange Ratio; BMI Body Mass Index; BF% Body Fat Percentage; Reg. Caff. Regular
Caffeine Consumption; Reg Aex. Regular Aerobic Exercise; Reg. Rex Regular Resistance
Exercise; FH+ First Degree Family History of Type 2 Diabetes Mellitus; NS non-significant;
statistics represent data from all subjects (n = 21).
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CHAPTER 4. DISCUSSION
4.1 Substrate Metabolism and Adiponectin
Changes in substrate utilization during exercise do not appear to directly regulate plasma
adiponectin concentration. Despite significant changes in substrate metabolism, measured via
RER and BG, during and immediately following exercise, plasma adiponectin concentration was
largely unaltered. It is worth noting that changes in metabolism may still alter plasma
adiponectin but not immediately post-exercise. Previous research has demonstrated that niacin
supplementation suppresses lipolysis in adipocytes (103), mitigates plasma FA, and increases
plasma adiponectin (96). The current study did not yield any significant increases in adiponectin
following niacin supplementation; in fact, the combination of niacin and aerobic exercise
significantly attenuated plasma adiponectin post-exercise. The aforementioned study was
performed on mice and the dosage of niacin was 30 mg/kg of body weight, which was
approximately twice the dosage administered in the current study. It is likely if a higher dose of
niacin had been administered, adiponectin would have significantly increased.
Niacin supplementation negatively affected acute aerobic exercise performance in the
current study, which may be partially attributed to changes in substrate utilization, as indicated
by changes in RER, though there are clearly other factors, such as catecholamine release
involved as well. Carlson et al. (103) suggested that niacin supplementation does not directly
affect free fatty acid (FFA) uptake or oxidation, rather it inhibits norepinephrine from binding at
its receptor site, which in turn, inhibits FFA mobilization. Therefore, niacin has directly
opposing mechanisms to those of caffeine to alter substrate utilization, as discussed below.
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Taken together, these results suggest that even for high-intensity aerobic exercise lasting less
than 30 minutes, impaired lipid metabolism negatively affects exercise performance.
The reasons for the significant attenuation in plasma adiponectin following niacin
supplementation post-exercise in the current study are not readily apparent, but may have been
due to decreased lipid oxidation or increased plasma glucose concentration. During the niacin
trial, RER was significantly higher compared to the placebo trial, which suggests decreased lipid
utilization and increased glucose utilization. Increased plasma lipids are a likely candidate for
decreasing the expression of adiponectin. In addition, increased plasma glucose is a major
characteristic of insulin resistant and diabetic populations expressing low levels of plasma
adiponectin (69). Thus, a combination of these two factors may have driven down the
expression of adiponectin. Although high-intensity exercise elicits significant increases in
growth hormone and glucocorticoids, the placebo and caffeine trials did not yield significant
changes in plasma adiponectin. These findings support previous research which suggests
adiponectin is not directly regulated by endocrine responses (77, 81).
In contrast to the effects of niacin, previous research has indicated that caffeine augments
lipolysis and possibly lipid oxidation as well (89, 93). Caffeine supplementation has been shown
to elicit a greater benefit for aerobic performance compared to placebo in the current and
previous studies (94, 104), as measured by time to exhaustion. A study by Graham & Spriet
(89), suggested that 6 mg/kg of body weight of a caffeine supplement improved exercise
performance and increased plasma epinephrine concentration. Epinephrine acts to increase both
lipid and glucose substrate availability; although, epinephrine seems to have a greater effect on
lipolysis than glycogenolysis (105). Previous studies have also demonstrated that caffeine
supplementation increased FFA mobilization from adipose tissue, lowered RER, and spared
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muscle glycogen during submaximal acute exercise lasing 30-60 minutes (89). Since plasma
lipid metabolites were not elevated in the study by Grahm & Spriet (89), it is likely that FFA
mobilization as well as uptake and oxidation were up-regulated. Compared to the placebo trial,
the caffeine trial of the current study did not demonstrate significantly lower RER values during
exercise, which suggests that caffeine increases lipolysis, but not necessarily lipid oxidation.
These results may also explain why plasma adiponectin did not significantly change postexercise for the caffeine trial. These conflicting results are likely due to differences in exercise
intensity. The current study incorporated higher intensity exercise compared to previous studies.
Untrained individuals primarily oxidize glucose at high exercise intensities and therefore, the
effects of increased catecholamines may have been overridden by other factors such as lactate
accumulation and decreased blood flow to adipose tissue, thereby limiting lipid oxidation.
The current study revealed that regular caffeine consumption was significantly correlated
with adiponectin. This is in agreement with a previous research study involving both diabetic
and non-diabetic women which found habitual coffee consumption correlated with higher levels
of adiponectin (106). This is an interesting finding given that caffeine increases lipolysis but not
necessarily lipid oxidation (91). Although the cellular mechanisms responsible for increased
expression of adiponectin with caffeine consumption are currently unknown, it has been
suggested that regular consumption of caffeine may act to down-regulate inflammatory markers
associated with low levels of adiponectin (107). It is also possible that habitual caffeine
consumption may down-regulate β-adrenergic receptor sensitivity, and consequently attenuate
the lipolytic effects of caffeine; however, more research needed to fully investigate these
hypotheses.
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Melatonin supplementation has been shown to decrease plasma glucose, increase glucose
transport, and increase glucose oxidation during and post-exercise (98, 108). Melatonin has also
been shown to decrease plasma adiponectin in rats given a high fat diet (99). Therefore it seems
feasible that melatonin may decrease lipid uptake and oxidation, thereby decreasing plasma
adiponectin. The current study; however, did not demonstrate any significant changes in plasma
adiponectin following melatonin supplementation nor did the combination of exercise and
melatonin have any significant effect on plasma adiponectin. The discrepancies in these findings
may be explained by the lack of a high fat diet in the current study, which may have eliminated
any detectible changes in plasma adiponectin. Interestingly, melatonin supplementation did not
significantly affect RER in the current study, suggesting that substrate utilization was not altered
following the administration of this supplement. Since previous melatonin supplement research
has revealed changes in substrate utilization during and following exercise, it seems likely that
the stretching exercise modality was not metabolically challenging enough to elicit any
significant changes in substrate utilization. Whether or not other exercise modalities, in
combination with melatonin supplementation, are sufficient to alter plasma adiponectin
concentrations remains to be determined.
4.2 Effects of Chronic Exercise Modalities
During exercise, substrate metabolism is primarily dependent upon training status,
exercise intensity, and duration (39); however, the current study suggests that substrate
metabolism following chronic training is affected, at least to some extent, by exercise modality
as well. Plasma adiponectin concentration following chronic training also appears to be
somewhat dependent on exercise modality, although the link between substrate metabolism and
adiponectin remains unclear.
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The current study revealed that chronic resistance training significantly increased plasma
adiponectin concentration whereas chronic aerobic training did not significantly increase
adiponectin. Combined, these results further suggest that substrate metabolism does not directly
regulate plasma adiponectin concentration. Chronic exercise modality; however, does have a
significant effect on substrate utilization. The present study did not reveal any significant
changes in resting blood glucose; however, the participant population for both the E and C
groups were young, active, and insulin sensitive, therefore detecting significant changes in this
variable was difficult. Although not directly measured for this exercise modality, it is likely that
glucose utilization during exercise was up-regulated following chronic training. Previous studies
have demonstrated that resistance-trained individuals appear to have a high percentage of type II,
glycolytic fibers, and thus few mitochondria and a low capacity to oxidize fatty acids (61), but
increased glycolytic enzyme activity (12) and capacity to oxidize carbohydrates (60).
Conversely, endurance-trained individuals demonstrate a high percentage of type I,
oxidative fibers, and thus, an increased size and number of mitochondria and an elevated
capacity to oxidize fatty acids (14). However, unlike resistance training, which exclusively
increases the body’s ability to utilize carbohydrate sources for energy, endurance training
increases the body’s ability to use all substrates. Following endurance training, GLUT-4 (109)
and hexokinase (110) activity increase, gluconeogenic capacity has been shown to increase in rat
liver (111), and glycogen is spared to a greater extent compared to sedentary controls (39). It has
been suggested that this glycogen sparing in endurance-trained individuals is due to increased
blood glucose availability and uptake, not increased lipid utilization and that catecholamines and
glucagon raise less while insulin falls less following training, thereby sparing glycogen by
increasing blood glucose utilization at low exercise intensities (39).
71

Despite the increased blood glucose utilization, lipid oxidation has been shown to
significantly increase following chronic aerobic training (14). Lipid oxidation has also been
shown to increase during long duration (> 1 hour) aerobic exercise (30). Participants for the
current study’s chronic aerobic training modality were training for a marathon and therefore,
one-to-two sessions per week were greater than an hour in duration, on average. Although
duration is a confounding variable for the present study, several studies have shown that chronic
aerobic training of less than one hour elicits an up-regulation in lipid metabolism (16), thus, a
chronic aerobic exercise training modality will increase the body’s dependence on lipid
metabolism during exercise. It is likely that this shift in lipid metabolism may partially account
for the observed significant reduction in body fat following the chronic aerobic exercise
modality, despite the lack of overall body weight reduction in the present study. While a shift in
energy balance will result in total body weight reduction, body fat reduction in the absence of
weight loss may be dependent on increased lipid oxidation.
In the present study, regular aerobic exercise weakly, but significantly correlated with
adiponectin, which may suggest that this type of exercise limits plasma lipid concentration via
increased lipid transport and storage, as previous research has suggested (69). Specifically, there
may be increased lipid synthesis in the form of IMCL, given that this form of lipid storage is
increased following endurance exercise (22). Further research examining lipogenic enzymes and
transporters concomitantly with plasma adiponectin is needed.
Despite the correlation with regular aerobic exercise and plasma adiponectin, the chronic
aerobic exercise intervention did not significantly increase adiponectin. Conversely, regular
resistance training exercise did not significantly correlate with plasma adiponectin, whereas the
chronic resistance training intervention did significantly increase adiponectin. The reasoning for
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this apparent disconnect is likely due to both training status as well as exercise intensity and is
consistent with the literature which shows an augmentation in adiponectin following some
chronic exercise studies (87), but no changes in adiponectin following other chronic exercise
studies (88). The less trained an individual and the higher the exercise intensity, the more likely
it is that adiponectin will significantly increase as a result of training. In the present study, the
chronic aerobic training modality was high-intensity marathon training; however, all participants
were previously engaged in habitual, recreational aerobic exercise, and therefore these
participants exhibited significantly higher levels of plasma adiponectin compared to the control
group both at the onset of the study and following the exercise intervention, limiting the degree
of change in this hormone as a result of exercise. Conversely, participants for the chronic
resistance training modality did not engage in habitual physical activity prior to the exercise
intervention. The chronic resistance training modality was high-intensity, well above the typical
intensity for individuals that regularly engage in this type of exercise. Combined, these variables
readily explain why plasma adiponectin increased following chronic resistance, but not aerobic
training. The mechanisms for this change remain unknown. Further research examining
lipogenic or glycogenic enzymes and plasma adiponectin in sedentary individuals may reveal
specific mechanisms responsible for the changes in adiponectin concentration.
4.3 Effects of Acute Exercise Modalities
It should be noted that most studies examining complete substrate utilization during and
following acute exercise consist of protocols that are upwards of two hours in duration (30, 47,
112) yet most individuals that participate in regular exercise for health purposes are not likely to
engage in any type of exercise activity exceeding an hour in length in a given day. Thus, it was
important to examine substrate utilization during and following less than one hour of activity.
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Similar to chronic exercise modalities, the present study demonstrated that substrate
metabolism during and following acute exercise modalities was primarily dependent upon
intensity and habitual training modality. In contrast to chronic exercise modalities, acute
exercise modality did not appear to have any effect on substrate utilization. The acute aerobic,
acute resistance, and acute stretching modalities for the current study were similar in duration
(approximately thirty minutes each) and the intensity for each modality was considered highintensity, according to the 2011 American College of Sports Medicine (ACSM) position stand
for exercise guidelines (113). This approach minimized potential confounding variables.
As expected, the acute aerobic exercise modality revealed that as exercise intensity
increases, the body’s dependence on glucose oxidation increases while the body’s dependence on
lipid oxidation decreases. Independent of the addition of supplements, this change in substrate
metabolism as a result of exercise did not significantly change plasma adiponectin concentration.
Previous acute aerobic exercise studies have shown decreases in plasma adiponectin (67),
increases in HMW adiponectin (35), and no change in plasma adiponectin (86). However,
decreases in total adiponectin were seen in elite athletes immediately post-exercise, increases in
HMW adiponectin were seen in obese individuals, and no changes in total adiponectin were seen
in healthy, untrained individuals. Therefore, the current results support the existing research on
plasma adiponectin responses to acute aerobic exercise and further suggest that acute changes in
adiponectin may be dependent on plasma lipid content, which is elevated in elite endurance
athletes immediately post-exercise and is suppressed in sedentary, obese individuals immediately
post-exercise.
The incorporation of supplements in concert with acute aerobic exercise revealed that
caffeine enhances aerobic performance while niacin negatively affects aerobic of performance.
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The underlying cause for this response is partially attributed to changes in substrate utilization as
previously suggested, though the current study suggests that these changes are different between
males and females. Previous studies have also demonstrated greater fat oxidation and higher β
oxidative enzyme content in female skeletal muscle compared to male counterparts (114).
However, the study also revealed that there were no significant differences between males and
females for the transcription factor PPAR, which plays a major role in several genes involved in
lipid metabolism and the regulation of adiponectin. Interestingly, females have exhibited higher
plasma HMW adiponectin concentration (53) as well as total plasma adiponectin concentration
(115) compared to males matched for BMI. It is likely that increased lipid oxidation in females
may be partially responsible for the gender differences in adiponectin; therefore further research
is warranted to investigate these issues.
The acute stretching exercise modality of similar duration and intensity (30 minutes at
high-intensity) significantly increases RER compared to the control trials; however, plasma
adiponectin did not significantly change post-exercise. This appears to be the first study to
examine the effects of passive resistance stretching on adiponectin. Similar to acute aerobic
exercise, it seems that even in the presence of substrate shift, plasma adiponectin is unaffected in
young, healthy populations. The increase in RER and subsequent increase in glucose oxidation
is likely due to increased muscle contraction. Increased muscle contraction alone does improve
insulin sensitivity (40), although this improvement appears to be independent of adiponectin.
Therefore, it may be suggested that while improvements in insulin sensitivity as a result of
chronic exercise training are partially due to increased plasma adiponectin, improvements in
insulin sensitivity as a result of acute exercise appear to be independent of plasma adiponectin.
Acute high-intensity, passive-resistance stretching exercise will result in only minimal increases
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in overall energy expenditure and elevation in metabolism as seen in the present study; therefore;
further research investigating the effects of chronic stretching exercise on plasma adiponectin in
sedentary populations may be useful given that habitual exercise is correlated with increased
insulin sensitivity and increased adiponectin. This exercise modality could be an attractive
alternative form of exercise for individuals unwilling or unable to engage in aerobic exercise
modalities.
The acute resistance exercise modality of the present study was similar in duration and
intensity to both the acute aerobic and acute stretching modalities (30 minutes, high-intensity)
and resulted in significantly increased blood glucose immediately post-exercise. Not
surprisingly, blood glucose levels 24-hours post-exercise were similar to those seen at baseline.
An augmentation in hepatic glycogenolysis, and to a lesser extent, gluconeogenesis, are
responsible for the observed increases in blood glucose immediately post-exercise (39),
indicating that glucose utilization is up-regulated following an acute resistance exercise regimen.
The increased utilization of glucose; however, was not associated with any changes in plasma
adiponectin immediately post-exercise. Previous research has indicated that acute resistance
training leads to an up-regulation of lipolysis from adipose tissue post-exercise (116) and an
increase in lipid oxidation for up to 24 hours post-exercise (26). Importantly, immediately
following exercise, the activation of lipolysis is delayed in obese populations compared to lean
populations and fat oxidation during acute resistance exercise is lower. This may help to clarify
why sedentary or obese populations continually demonstrate improvements in plasma
adiponectin following acute exercise while lean populations do not. Limited lipolysis and
consequently, limited plasma lipids may up-regulate plasma adiponectin immediately following
exercise. To date, no studies have examined plasma adiponectin responses to acute resistance
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exercise. It seems likely that, similar to other acute exercise modalities, changes in adiponectin
are more likely to occur in sedentary or obese populations. Further research is needed to
examine plasma adiponectin responses to acute resistance exercise in these populations.
It should be noted that plasma adiponectin concentration is lower in patients with
coronary artery disease as well as patients with type 2 diabetes, and is inversely correlated with a
poor lipid profile (117) and elevated inflammatory markers such as TNF-α (118). Acute aerobic
exercise has been shown to increase TNF-α in healthy populations without any concomitant
increase in plasma adiponectin (86). Combined, these results suggest that inflammatory markers
do not regulate adiponectin, but rather they are a likely byproduct of chronic elevated plasma
lipids, which as suggested by the current study, acts to drive down the expression of adiponectin.
Also, while plasma lipids are controlled in large part by diet and exercise, genetic predisposition
to high plasma TAG levels, high LDL, or low HDL may contribute to lower levels of plasma
adiponectin (119) and may help explain why some individuals are more susceptible to the
development of insulin resistance and type 2 diabetes.
The most significant and striking correlation of the current study was the strong inverse
correlation between plasma adiponectin and first degree family history of type 2 diabetes. This
finding further suggests genetic predisposition to the development of insulin resistance may be a
direct result of low levels of adiponectin. Elevated plasma lipids likely drive down the
expression of plasma adiponectin via down-regulated expression of mRNA in the adipocyte (82).
It has also been suggested that adiponectin mRNA is directly regulated by insulin (79). The
specific regulation of various gene transcription factor activation is beyond the scope of this
study, but this area of investigation can potentially provide more in-depth explanations for the
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link between first degree family history of type 2 diabetes and low expression of plasma
adiponectin.
Previous findings combined with the current findings on adiponectin and exercise
indicate that exercise-mediated improvements in insulin sensitivity following chronic training
may be partially due to increased plasma adiponectin; however, short-term improvements in
insulin sensitivity are likely due to other factors. It is worth investigating substrate utilization
and plasma adiponectin several hours post-exercise as lipid oxidation and lipid storage both
increase following exercise (22) while plasma lipids decrease, potentially leading to an upregulation in adiponectin.
4.4 Limitations
The participant population for the current study was young, active, and insulin sensitive.
It is likely that this population had high levels of adiponectin at the onset of the study; therefore,
eliciting significant changes in this hormone may have been compromised in this population. If
sample sizes for both of the chronic exercise modalities had been larger, it would have been
useful to stratify participants based on percent decrease in body fat pre- to post-exercise to
determine potential correlations with changes in adiponectin and total body fat percentage.
Studies have shown that plasma adiponectin concentration significantly increases following
weight loss (118), however the number of participants in the current studies that demonstrated
significant decreases in percent body fat following exercise intervention were too few to
determine statistical significance. Additionally, relative concentration of plasma adiponectin was
measured using a western blot technique, as opposed to the measurement of absolute
concentration of adiponectin via enzyme-linked immunosorbent assay (ELISA) or
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radioimmunoassay (RIA). While specific concentration cannot be determined from a western
blot technique, it does account for plasma volume shift which is not accounted for in numerous
exercise studies involving plasma adiponectin. Also, plasma adiponectin concentration in
humans varies considerably in healthy populations. Some studies report concentrations as low as
6 µg/ml (88) while other studies report concentrations as high as 20 µg/ml (86). Thus the current
study eliminated this issue by determining relative change.
The current study did not incorporate muscle or adipose tissue biopsies. While muscle
biopsies would have provided useful information in regards to changes in adiponectin mRNA,
AdipoR1, and AdipoR2 receptor expression, the use of biopsies were beyond the scope of the
current study and likely would have compromised the number of study participants. In addition,
skeletal muscle fiber composition, and likely receptor expression, at the origin may be different
than at the insertion (120), making it difficult to determine which changes are truly due to the
training adaptation.
Lastly, the HMW isoform of adiponectin, which has been correlated more strongly with
insulin sensitivity than total serum adiponectin (64), was not measured in the current study.
However, all subjects were insulin sensitive and the HMW form has not been shown to change
following exercise in lean, healthy individuals (65). Furthermore, this isoform is not associated
with acute improvements in insulin-sensitivity (66) whereas total adiponectin has been shown to
change following exercise in some studies involving lean, healthy individuals (67). Thus, the
focus of this dissertation was to determine if changes in substrate utilization directly affected
total plasma adiponectin concentration rather than a specific isoform of adiponectin.
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CHAPTER 5. CONCLUSIONS
The current study demonstrates that changes in substrate utilization during and following
exercise are not directly related to changes in plasma adiponectin. Furthermore, while both
chronic and acute exercise modalities affect substrate utilization during exercise, only highintensity chronic exercise appears to increase plasma adiponectin concentration. Substrate
oxidation may not be responsible for the shift in plasma adiponectin concentration following
chronic exercise training; rather the increase seen in the present and previous studies may be due
to increased lipid clearance from the plasma, as was evident following niacin supplementation.
Inducing significant changes in adiponectin via exercise appears to be dependent on
habitual activity as indicated by the lack of prior physical activity in the participants in the
chronic resistance training modality, which demonstrated significant augmentation in plasma
adiponectin post-exercise. On the other hand, the higher levels of prior physical activity in the
participants in the chronic aerobic training modality minimized improvements in plasma
adiponectin post-exercise, but demonstrated significantly higher plasma adiponectin compared to
the less active control group at both time points.
The results of this study provide important implications for exercise prescription to both
improve insulin sensitivity and increase plasma adiponectin. While high-intensity exercise
increases the body’s dependence on glucose oxidation acutely, lipid clearance appears to
improve following this type of training both acutely and chronically. Thus, engaging in highintensity exercise may provide greater benefits in improving insulin sensitivity compared to lowor moderate-intensity exercise.
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Whether or not aerobic or resistance training exercise elicits greater improvements in
plasma adiponectin remains to be determined. While aerobic exercise clearly has its benefits, if
patients do not regularly adhere to this type of exercise throughout their lives, plasma
adiponectin and overall health status is not likely to improve. With a limited aerobic capacity in
these patients, especially in the early stages of training, engaging in resistance training appears to
offer an attractive alternative to possibly help combat obesity and the development of insulin
resistance and type 2 diabetes; however, much more research is needed to establish specific
changes that occur from this type of exercise.
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CHAPTER 1: The problem with excess energy intake/insufficient energy expenditure

Introduction
Diabetes is a chronic disease that is characterized by elevated blood glucose levels. In
2005, the centers for disease control (CDC) estimated that approximately 20.8 million people
were suffering with diabetes, and of those, 90-95% had non-insulin dependent Diabetes Mellitus
(NIDDM or Type 2 Diabetes). The CDC also states that this disease leads to a variety of
secondary health problems including heart disease, stroke, hypertension, blindness, kidney
disease, nervous system damage, amputations, and dental disease.
Although the etiology of diabetes is far from being fully understood, there are several
known factors that contribute to the development of diabetes including genetics, lifestyle factors,
and levels of adiposity (18, 121), all of which must be taken into consideration when examining
this disease. Substantial evidence over the years has indicated that the one of the major
predictive causes of type 2 diabetes is obesity, the prevalence of which has increased
dramatically over the past 20 years (122) and is likely to continue to increase primarily due
modern lifestyle factors including an overconsumption of calories and lack of physical activity.
Therefore, gaining further insight into the development and prevention of diabetes is of high
importance to help minimize the prevalence of this disease. Research has overwhelmingly
indicated that type 2 diabetes is preceded by several years of insulin resistance, hyperglycemia,
and hyperlipidemia both in skeletal muscle and in the liver. In this review, the main focus for the
development of type 2 diabetes will revolve around this concept. The main focus for the
prevention of type 2 diabetes will be centered on various forms of acute and chronic exercise
given that numerous studies have shown that insulin resistance can be reversed with the addition
of acute or chronic exercise (15, 22).
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Insulin, which is one of the hormones responsible for maintaining blood glucose
homeostasis, is released at an elevated rate following feeding. Insulin signals skeletal muscle
and adipose tissue to uptake the circulating glucose, which is either stored in the form of
glycogen or it can be oxidized and used for energy (7). In either case, blood glucose levels are
maintained following feeding via insulin signaling. When an individual becomes insulin
resistant, the tissue’s ability to uptake glucose from the blood becomes impaired, resulting in
chronic elevated blood glucose levels. From a mechanistic standpoint, hepatic, adipose, and
skeletal muscle tissue insulin resistance do not develop following identical signaling pathways
nor is this insulin resistance reversed following the same pathways (34). This notion is
extremely important must be considered when examining the various mechanisms involved in
insulin resistance.
Although the liver and adipose tissue play critical roles in energy homeostasis and wholebody insulin sensitivity, the focus of this review will be on the role of skeletal muscle. There are
two critical reasons for this. The first is that skeletal muscle has a large relative mass which
requires a high amount of energy to maintain. In addition, skeletal muscle is responsible for all
mechanical work, and is thus metabolically active tissue with high energy demands. In fact,
when the body is at a relatively stable balance, the majority of ingested carbohydrates are either
stored in skeletal muscle or oxidized in skeletal muscle to provide immediate energy (123). The
second reason for investigating skeletal muscle in greater detail is that skeletal muscle plays a
critical role in fatty acid oxidation. At rest, approximately 60-80% of muscle energy production
is provided by fat oxidation (124). During exercise, there is a shift of substrate utilization and
the body becomes more dependent on glucose oxidation. Clearly, energy homeostasis is largely
dependent on the metabolic state of skeletal muscle. When the metabolism of skeletal muscle
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becomes impaired, fat oxidation is compromised and insulin resistance can result. Indeed, the
development of insulin resistance has been linked to impaired lipid metabolism in skeletal
muscle, although the mechanisms remain somewhat unclear.
Therefore, the purpose of this review is to address lipid metabolism in skeletal muscle, its
links to insulin resistance, and how this insulin resistance can be reversed with the addition of
exercise training or calorie restriction. Since there are numerous interacting factors that could
possibly contribute to insulin resistance, the first chapter will briefly address some of the current
major focus areas relating to lipid metabolism and cellular signaling. The second and third and
chapters will address lipogenesis and lipolysis, respectively, in healthy and insulin resistant
individuals. This will identify possible cellular mechanisms that may be responsible for
impaired insulin signaling as a result of lipid accumulation and lipid intermediate accumulation.
The fourth chapter will discuss the effects of exercise on lipid synthesis and degradation to
identify mechanisms that may be responsible for improved insulin signaling following exercise.
Based on these findings, the fifth and final chapter will offer future directions for this area of
research.
Energy Imbalance
During periods of starvation, the human body will readily break down energy stores,
mainly energy stores in the form of lipids, in order to sustain normal function. Similarly, during
periods of food abundance, the human body has an astounding ability store excess energy,
mostly in the form of triacylglycerols (TAG) in white adipose tissue (WAT) (125), which once
again can be used as an energy source during periods of starvation. This ability has been critical
to the survival of our species during times of famine. However, in more developed countries in
modern times, a combination of technology and societal norms has encouraged sedentary
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behavior and overconsumption (126). Thus, the body’s efficient ability to store excess energy
has recently lead to a wide range of health disparities. Over an extended period of time,
excessive physical inactivity in combination with overconsumption of food can result in an array
of chronic diseases including obesity, cardiovascular disease, and diabetes (127). As will be
discussed in detail in chapter four, many of these abnormalities can be reversed with the addition
of exercise although the mechanisms for these adaptations remain unclear.
It will become evident throughout this review that although many of the cellular
mechanisms responsible for changes in insulin sensitivity are currently unknown, the human
body will adapt regardless of the stress placed on the body in order to maintain a homeostatic
state. Much like the body becomes trained to utilize fats as a primary fuel following chronic
endurance training, in the case of chronic energy abundance, the body becomes trained to store
rather than oxidize excess fat. With a decreased ability to oxidize fats, the body must primarily
rely on glucose oxidization, even in a fasted state, to provide energy. This is what has been
observed in obese human subjects. A study by Kelley et. Al (55) revealed that when the
respiratory quotient (RQ) was measured across the leg muscles of obese subjects, RQ averaged
0.90 in a fasted state, indicating glucose was the primary fuel source. On the other hand, fasted
lean subjects had an RQ of 0.82 indicating a greater reliance on fatty acids for fuel (55). This
increased reliance on glucose for fuel has been linked to hyperlipidemia and metabolic
dysfunction. This makes sense given that if fat is not utilized for fuel, it will remain in the
circulation, raising lipid levels, or will be stored in adipose tissue which seemingly has no
maximal storage capacity. Conversely, although glucose can be stored to some extent in skeletal
muscle and liver in the form of glycogen, there is a limit to how much of this can be stored.
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Thus, the body may preferentially oxidize excess glucose first, while only minimally oxidizing
lipids, storing the rest in adipose, skeletal, and hepatic tissue.
It is likely that excess lipid storage, not only in adipose tissue, but also in skeletal muscle
and around organs such as the heart, liver, and kidneys can lead to metabolic dysfunction (8).
However, the exact mechanism(s) responsible for this abnormal metabolic regulation is not fully
understood. There are several current hypotheses to explain the development of insulin
resistance, many of which are interconnected as seen in figure A1.
Chronic ↑
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insulin
↓Fat oxidation

↑ Hepatic glucose
production
Production of
adipokines,
inflammatory
cytokines

Lipid storage in liver, skeletal
muscle, kidneys, heart
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↑ in blood
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Figure A1. A general overview of some of the proposed mechanisms linked to the development
of diabetes. G6P= glucose-6 phosphate; ER= endoplasmic reticulum; IRS-1= insulin receptor
substrate-1; DAG= diacylglycerol.
Recent research has suggested that specific peptide hormones and inflammatory
cytokines, specifically adipokines, which control the communication between various
metabolically active tissues and organs, including the liver, skeletal muscle, and fat (128) may
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play a role in regulating insulin sensitivity. Adipocyte signaling can greatly affect the
development of skeletal muscle insulin resistance and will be addressed briefly here.
Adipocyte-derived hormones
Peptide hormones including leptin, adiponectin (ACRP30), retinol-binding protein
(RBP4), and resistin have all been implicated in the development of insulin resistance (18). Each
of these hormones are secreted by adipocytes and play an active role in lipid storage and
mobilization. In healthy, normal-weight individuals, adiponectin and leptin act to regulate
energy storage and energy expenditure. As leptin levels increase, metabolism increases and
appetite decreases (129). However, as a result of obesity, individuals become leptin resistant,
resulting in higher levels of circulating leptin. This mechanism is similar to that seen in insulin
resistance, in which hormone signaling is impaired despite increased circulating levels.
Conversely, adiponectin, which plays a critical role in glucose and lipid metabolism, has been
shown to decrease with obesity (71). Since these two hormones appear to have complementary
actions and it has been suggested that both act to decrease TAG synthesis, increase β-oxidation,
and activate 5’-AMP-activated protein kinase (AMPK). Thus, they are said to be insulinsensitizing hormones, which are secreted preferentially from small adipocytes. RBP4 and
resistin on the other hand, have been deemed insulin-desensitizing and are secreted preferentially
from large adipocytes (8). RBP4 and resistin act to decrease glucose uptake and encourage
gluconeogenesis, which during fasting, helps maintain normal glycemic levels in the blood.
However, in a state of chronic overfeeding, the protective action of these hormones becomes a
plausible contributor to the development of insulin resistance and type 2 diabetes (128).
It has been demonstrated that fasting can lead to a down-regulation of adipose GLUT-4
mRNA expression in rats, (130) and several studies have shown that lower GLUT-4 levels are
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linked to the development of insulin resistance (131). Although there are several tissue-specific
glucose transporters, GLUT-4 is the primary transporter in skeletal muscle and adipose tissue
and appears to be the only one which is insulin-dependent (132). Thus, it is possible that chronic
depressed levels of the GLUT-4 protein in adipose tissue as a result of fasting can lead to
hyperinsulinaemia and eventual insulin resistance, although further research is still needed to
support these ideas.

This may seem counterintuitive considering that overwhelming evidence

points to overconsumption leading to insulin resistance. However, consider that in a fasted state
plasma insulin levels are low. In turn, to prevent hypoglycemia, GLUT-4 expression will be
down-regulated. This concept has been supported by adipose GLUT-4 knockout (KO) mouse
models, which demonstrate decreased glucose uptake into the cell and increased insulin
resistance in skeletal muscle and liver despite normal GLUT-4 function in these tissues (131).
It should be noted that excess body fat does not cause insulin resistance per se. Though
adipose tissue appears to have a limitless capacity, the formation of adipocytes is highly
regulated and it has been suggested by some that adipose tissue storage capacity is limited via
TNF-α or other inflammatory cytokine signaling molecules (133). Some researchers have
suggested that once this storage capacity is reached, excess lipids are forced to be stored in and
around organs that do not normally accumulate high lipid levels, this in turn, makes the organs
more susceptible to lipotoxicity and local insulin resistance (128). Therefore in theory, a
therapeutic strategy to combat insulin resistance could involve the expansion in the storage of
lipids in subcutaneous adipose tissue, blunting the metabolic deficiencies that are normally
associated with obesity, as long as lipid overflow into other tissues and organs is limited. The
problem with this idea, however, is that adipose tissue, as previously mentioned, is an endocrine
organ which secretes hormones and adipokines. In the presence of expanding adipose tissue,
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specific signaling molecules are likely to lead to systemic insulin resistance, similar to what has
been seen in mouse models (131).
Based off these findings, it is apparent that adipose tissue is a metabolically active
endocrine organ that responds to changes in energy demands. Excess energy intake results in
adipogenesis, however, this is not a passive process, rather it requires energy, is highly regulated,
and involves a complex array of transcriptional activation as well as inter- and intracellular
signaling (128) through hormones, as previously discussed, as well as adipokines.

Inflammatory Cytokines
While there are several pro-inflammatory cytokines that may be linked to obesity and
insulin resistance, tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6) are two of the
most studied and will be addressed briefly here. TNFα is involved in the regulation of immune
cells, it can induce apoptosis, inhibit tumor growth, and induce inflammation (134). However,
this cytokine has also been implicated in the development of insulin resistance. Over-expression
of this cytokine acts to inhibit insulin action and was demonstrated in obese mouse and human
models (135). TNFα also activates the c-Jun amino terminal kinases (JNKs), which promotes
the phosphorylation of the serine residue on insulin receptor supstrate-1 (IRS-1), which has been
shown to induce insulin resistance (136). Interestingly, TNFα also acts to promote lipolysis as
well as inhibit adipogenesis and adipocyte differentiation (133). Although this may seem
contradictive given that insulin resistance is highly correlated with excess lipid storage, as will
be discussed in chapters two and three, incomplete synthesis and degradation of lipids via TNF-α
or otherwise, is a plausible underlying mechanism which contributes to insulin resistance.
Increased lipids in the circulation due to increased lipolysis and decreased adipogenesis may also
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be partially responsible for impaired insulin signaling. Furthermore, inhibition of adipogenesis
also suggests that TNF-α may act to limit the storage capacity of adipose tissue. Thus as an
oversupply of calories continues, this creates a need for excess lipids to be stored in other organs
such as skeletal muscle and liver. As a result, lipotoxic intermediates such as diacylglycerol
(DAG) and ceramides are formed. The deleterious effects of these metabolites on the insulin
signaling cascade is well established (56) and will be discussed further in the next section of this
chapter.
IL-6, which much like TNFα, acts to stimulate immune response to injury, is another proinflammatory cytokine that has also been shown to induce insulin resistance. The accumulation
of fat deposits around organs appears to be responsible for this outcome through activation of the
transcription factor NF-κB, which is responsible for the production of several cytokines,
including IL-6 and TNFα (137). It is likely that these and other cytokines have additive effects;
however, the relative contribution of each of these cytokines is not readily apparent. What is
apparent is that adipokines play a significant role in the development of insulin resistance and
that there is a link between these adipokines and lipid accumulation in organs such as skeletal
muscle and the liver. The question becomes whether these cytokines are a cause or an effect of
abnormal lipid storage. The nature of cytokines would suggest the latter; however, further
research is still needed to support this notion.
The treatment of chronic inflammation has been targeted as a potentially novel strategy in
the prevention and treatment of type 2 diabetes. Non-steroidal anti-inflammatory drugs
(NSAID), particularly aspirin, which is an acetylated salicylate drug, has been shown to reduce
inflammation by irreversibly modifying the active site on cyclooxygenase (COX) 1 and 2 and in
turn, inhibiting prostaglandin formation. High doses of salicylates have also been shown
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directly lower blood glucose levels and improve insulin sensitivity in diabetic patients by direct
inactivation of IKKβ (138). When activated, IkB kinase-β (IKKβ) will activate NF-kB, which
produces pro-inflammatory markers such as IL-6, TNF-α, and resistin, which as mentioned in
chapter one, have been linked to insulin resistance. Also, macrophages may amplify this signal,
which demonstrates that the development of IR may have similar/parallel mechanisms to other
inflammatory diseases such as atherosclerosis. However, it is important to note that it is
assumed that adipocytes, not skeletal muscle cells, initiate inflammation-mediated IR since
accumulated lipid stores are predominantly in these types of cells (139). The inflammatory
cascades seen in adipose and liver cells from increased adiposity are not seen in skeletal muscle,
there is no activation of IKKβ/NF-kB or increases in macrophages. Inflammation in skeletal
muscle is only seen in lipid infusion models, which indicates again that skeletal muscle IR does
not cause inflammatory responses, rather skeletal muscle IR occurs as a result of inflammatory
responses.
Though a link appears to be established between insulin resistance and lipid accumulation
around organs, rather than in subcutaneous adipose tissue, the exact mechanism(s) responsible
for this dysregulation is currently a matter of debate and clearly requires further investigation.
There are two opposing theories, one suggesting decreased β oxidation, and the other suggesting
increased, but incomplete β oxidation, both of which will be addressed here.
Decreased β oxidation
The rationale for the popular theory which suggests reduced β oxidation leads to insulin
resistance follows a seemingly intuitive and logical line of reasoning. Feeding stimulates the
conversion of acetyl CoA to malonyl CoA by acetyl-CoA carboxylase (ACC). Malonyl CoA is
responsible for the inhibition of carnitine palmitoyltransferase 1 (CPT1), which controls entry of
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fatty acids into the mitochondria for β oxidation (18). Immediately following feeding, the
oxidation of fat stores is no longer necessary to provide energy. Thus, long chain acyl CoAs
(LC-CoAs) which are partitioned toward mitochondrial oxidation in a fasted state, are redirected
toward the synthesis of TAG, diacylglycerol (DAG), and ceramides in a fed state (140). Chronic
overfeeding, therefore, leads to decreased β oxidation and an accumulation of lipid
intermediates, particularly DAG, which phosphorylates several kinases, including several protein
kinase C (PKC) isoforms (54). This in turn, phosphorylates serine kinases on insulin receptor
substrate-1 and -2 (IRS-1 and IRS-2), which again, have been shown to negatively influence
insulin-induced glucose uptake (136). This is likely due to a decrease in GLUT-4 translocation
via a signaling cascade described elsewhere (54).
In addition, it has been demonstrated that patients with type 2 diabetes have smaller and
fewer number skeletal muscle mitochondrial as well as decreased mitochondrial enzyme activity
compared to healthy controls (141), thus the rate of oxidative phosphorylation is significantly
reduced, causing lipid accumulation within the muscle. However, it should be noted that in this
study, the diabetic subjects were approximately ten years older than the control subjects. It has
been shown that mitochondrial density and mitochondrial adenosine triphosphate (ATP)
synthesis are reduced with age (142), therefore it is possible that age may have influenced these
results and must be taken into consideration. However, other studies have revealed similar
results which point toward overall reduced fat oxidation in skeletal muscle of fasted insulin
resistant subjects (143). The activity of citrate synthase (CS) and cytochrome c oxidase, which
are thought to be the rate-limiting enzymes involved in the tricarboxcylic acid (TCA) cycle and
Electron Transport system (ETS), respectively were also down-regulated in insulin resistant,
obese subjects (144). It has also been shown that the expression of hormone sensitive lipase
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(HSL) and adipose triglyceride lipase (ATGL), both of which hydrolyze triglyceride stores, are
down-regulated in insulin resistance (145). Together, these results suggest that not only is β
oxidation decreased, but fatty acid hydrolysis may be down regulated as well. The extent of lipid
breakdown in insulin resistant individuals is yet to be determined and warrants further
investigation as will be discussed further in chapter three.
Another reason that decreased fatty acid oxidation is a popular theory to explain the
connection between lipid accumulation in skeletal muscle and insulin resistance is because of
changes in fatty acid transport and translocation. Initially, it may seem logical that decreases in
oxidative enzymatic activity as well as decreased expression of the fatty acid translocation
protein (FAT/CD36) could explain the lack of fat utilization as seen in some studies (9) (146).
However, given that insulin resistant individuals have elevated levels of intramyocellular lipids
(IMCL), more recent studies have shown that CD36 expression is actually increased in type-2
diabetics, yet the translocation of CD36 to the plasma membrane is impaired. This results in
increased fatty acid uptake, but decreased oxidation due to the decreased transport of fatty acids
to the mitochondria (147). Indeed, CD 36 KO mice have shown improvements in insulin
sensitivity in skeletal muscle (148). This is likely due to the lack of lipid accumulation in the
muscle; however, these KO mice had decreased insulin sensitivity in the liver. This was likely
due to increased lipid accumulation in the liver and suggests tissue-specific mechanisms
involved in the development of insulin resistance. It also suggests that there are significant
differences between the regulation of glucose versus lipid transporters. While increased lipid
transport is associated with insulin resistance, decreased glucose transport is associated with
insulin resistance.
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Incomplete β oxidation
In contrast to the theory of decreased β oxidation, recent studies have suggested that
insulin resistance leads to increased, but incomplete, β oxidation. No matter what type of stress
placed on the body, under normal conditions, the human body will adapt to better handle the
stress and maintain a homeostatic state, beginning with changes at the molecular level. Thus, the
theory of incomplete β oxidation is as follows:
Much like the changes seen in gene expression following chronic exercise training,
chronic exposure to elevated lipids in skeletal muscle up-regulates various genes involved in β
oxidation to compensate for this constant stress. However, unlike the changes seen with
exercise, exposure to high levels of lipids appears to have no effect on the TCA cycle or ETS
(140). This results in an accumulation of acetyl CoA, which is the end product of β oxidation.
When energy supply is greater than energy demand, these accumulated acetyl CoAs are
converted to acylcarnitines (8). A recent study demonstrated that high-fat feeding in mice
induces similar increases in even-chain acylcarnitines in skeletal muscle to those seen in fasted
standard chow-fed mice, however, acylcarnitine levels significantly decreased following feeding
in standard chow mice whereas they remained elevated in the high-fat fed mice (149). This
gives rise to two important outcomes. The first is that the mitochondria in high-fat fed mice are
unable to adapt to changes in fuel sources, this has recently been deemed “metabolic
inflexibility”. Studies have shown that there are direct links to metabolic inefficiency,
particularly in fat utilization in insulin resistant individuals (150, 151). Essentially what these
studies indicate is that insulin resistant individuals may not be able to switch from fat utilization
to glucose or vice versa under stress conditions, which leads back to mitochondrial dysfunction
or mitochondrial overload, which will be discussed further in chapter four.
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The second outcome from the acylcarnitine study indicates that both high fat feeding and
prolonged starvation can lead to incomplete β oxidation. These results were further supported by
examining malonyl-CoA decarboxylase (mcd) KO mice. As previously mentioned, malonylCoA inhibits CPT1 to prevent the import of fatty acids into the mitochondria. Mcd degrades
malonyl-CoA, thus reliving the inhibition of CPT1, allowing fatty acid entry into the
mitochondria for oxidation. Mcd KO mice have partial inhibition of CPT1 and were in turn,
protected from glucose intolerance and skeletal muscle remained insulin sensitive when fed a
high-fat diet (140). Thus, by limiting β oxidation, the build-up of metabolic byproducts such as
DAGs, ceramides, acylcarnitine, and non-esterified fatty acids (NEFAs) (121), all of which are
associated with the development of insulin resistance, are limited. This is an apparent paradox
given that these same intermediates accumulate in studies examining incomplete β oxidation and
decreased β oxidation.
Experimental Variation
There may be a wide range of explanations for the conflicting data between decreased β
oxidation and incomplete β oxidation. The most likely of these is tissue specificity. A recent
study showed that this incomplete β oxidation was more pronounced in white muscle compared
to red muscle in high-fat fed mice (140). This is likely due to the intrinsic properties of white
muscle, which has a much lower oxidative capacity than red muscle, and therefore fewer
mitochondria, leading to higher levels of incomplete oxidation. It should be noted here that
many insulin resistant individuals have a higher percentage of white, glycolytic fibers compared
to their insulin-sensitive counterparts (152) which may be attributed to a combination of genetics
and physical activity level. Therefore, it seems likely that this is a contributing factor to the
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development of insulin resistance. For that reason, when examining various mechanisms of
insulin resistance, muscle fiber type must be taken into consideration.
The examination of other tissues must also be considered. The previously mentioned
study which elicited changes in the skeletal muscle of mcd KO mice had no changes in β
oxidation in the liver. Likewise, CD36 KO mice were insulin sensitive in skeletal muscle, but
insulin resistant in the liver. Thus, insulin resistance appears to be tissue specific. Interestingly,
some of the currently investigated mechanisms involving LC-CoA’s, DAG’s, endoplasmic
reticulum (ER) stress, and inflammation have shown changes in hepatocytes while they have
shown little or no changes in myocytes. For example, acetyl-CoA carboxylase (ACC2) null mice
have lower levels of malonyl-CoA and are in turn, resistant to diet-induced diabetes. However,
these changes occur only in liver while adjustments in muscle lipid metabolism were minor
(153). This may suggest that the liver is the site of initiation of insulin resistance, whereas
skeletal muscle is a secondary target, or responder to insulin resistance (139).
Other factors, such as cell cultures versus animal models versus human models must also
be taken into consideration as cells behave differently in vitro compared to in vivo; likewise,
mouse models do not always respond in the same manner as human models. In the study by
Koves et al. (133), cell cultured myotubes exposed to insulin increased glycogen synthesis, but
only minor increases were seen in glucose oxidation. On the other hand, fatty acid exposure
decreased both glycogen synthesis and glucose oxidation by 40-50%. Insulin resistance
increased with higher exposure to carnitine, indicating fatty acids must enter mitochondria to
induce insulin resistance. This leads to the possibility that elevated carnatine levels may
contribute to insulin resistance. However, it is also possible that when cultured cells are exposed
to carnitine, they will preferentially utilize fatty acids rather than glucose due to the absence of
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systemic conditions and input, and in turn, these cells appear to be more insulin resistant. In situ,
body will preferentially oxidize glucose and store fat following feeding, thus it cannot be
concluded that elevated levels of carnitine alone subsequently increase β oxidation and lead to
insulin resistance. More studies done with animal or human models are needed to support these
outcomes seen in cell cultures.
Individual diet, total adiposity, and gender are also important considerations and can
greatly affect the outcome of a study. These variables, as well as others, will be examined in
greater detail in the remaining chapters of this review.
Athlete’s Paradox
Regardless of what the mechanism may be, it is evident that excess lipid storage,
especially within skeletal muscle, leads to insulin resistance, and therefore limiting this
accumulation may improve insulin sensitivity. Interestingly, insulin sensitive, endurance-trained
athletes have demonstrated IMCL stores comparable to, or even higher than sedentary, insulin
resistant individuals (16), which has been deemed the “athlete’s paradox”. One possible
explanation may be that these particular insulin sensitive individuals have a high rate of lipid
turnover as a result of endurance training (22) and store TAGs which consist mostly unsaturated
fatty acids. On the other hand, insulin resistant individuals tend to store IMCL as a result of an
energy surplus, have a low rate of lipid turnover, and store TAGs which consist of a higher
percentage of saturated fatty acids. In addition, unlike insulin sensitive individuals, those with
insulin resistance may not be able to completely synthesize triglycerides within the muscle or
within adipocytes, thus these lipids may not be fully synthesized TAG, rather they may be partial
lipid intermediates such as DAG or monoacylglycerol (MAG), which have been linked to
impaired insulin signaling and glucose transport (22); however, further research is needed to
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support these hypotheses. The cause for this dysfunction is still not fully understood and
warrants further investigation. Therefore, the remainder of this review will focus on differences
in lipid synthesis and degradation in healthy and insulin resistant individuals to determine
plausible mechanistic pathways linking incomplete lipid metabolism to insulin resistance and
how this metabolism changes with the addition of exercise in these two populations.
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CHAPTER 2: Lipid synthesis in healthy vs. insulin resistant skeletal muscle
Since lipid intermediates such as DAG, ceramides, and acylcarnitine appear to have
deleterious effects on insulin signaling pathways, it is necessary to examine both TAG
breakdown into FFA, also known as lipolysis, and TAG synthesis from FFA, also known as
lipogenesis, to determine exactly how these metabolites accumulate. Currently, both lipolysis
and lipogenesis within skeletal muscle are poorly understood. By gaining a better understanding
of the mechanisms involved in these processes and by understanding differences in lipolysis and
lipogenesis in healthy skeletal muscle compared to insulin resistant muscle, it may be possible to
determine more definitive causes that lead to a build-up of these lipid intermediates and
contribute to insulin resistance.
As mentioned in chapter one, insulin is a hormone which acts to control blood glucose
levels. It is also an anabolic hormone and therefore promotes the synthesis and storage of
various substrates, including lipids. Thus, following feeding, insulin is released activating
various enzymes involved in lipogenesis. It should be noted that most of the current knowledge
regarding lipogenesis comes from E.Coli or hepatic cell culture studies though it is assumed that
similar mechanisms occur in skeletal muscle. Briefly, the synthesis of fatty acids begins with
acetyl CoA, which is formed from the enzyme pyruvate dehydrogenase (PDH) (154). When
pyruvate is decarboxylated by PDH, the newly formed acetyl CoA can be converted to malonyl
CoA by acetyl CoA carboxylase (ACC). The carbon units from this malonyl CoA can then be
used to synthesize part of a fatty acid chain via the action of an enzyme complex called fatty acid
synthase (154). Both PDH and ACC are activated by insulin and as will be discussed, alterations
to these enzymes or variations in the level of substrate can greatly affect lipid metabolism and in
turn, insulin sensitivity.
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Once a fatty acid is formed, it, along with two other fatty acids must attach to a glycerol
molecule, which is derived from carbohydrate sources, to form TAG (154). Complete
lipogenesis involves both the formation of fatty acids and the partitioning of fatty acids into TAG
molecules. It should be noted that TAGs can be any permutation of various fatty acid chain
lengths (14-24 carbon atoms) and saturation level for each of the three fatty acids, thus the rate
and extent of degradation and esterification of TAGs have a large degree of variation.
TAG synthesis can result from one of two biochemical pathways, as seen in figure 2.
The MAG pathway is the predominant pathway following feeding and is likely responsible for
the storage of TAG in adipose tissue whereas the glycerol-3 phosphate (G3P) pathway is
responsible for de Novo synthesis of TAG in most tissues. In both pathways, monoacylglycerol
acyltransferase (MGAT) and glycerol phosphate acyltransferase (GPAT) act to acetylate the
substrate with fatty acyl-CoA. The G3P pathway requires an additional acetylation followed by
dephosphorylation. Each pathway produces DAG and thus the final step of converting DAG to
TAG by diacylglycerol acyltransferase (DGAT) is shared by both pathways and is considered to
be the rate-limiting step in TAG synthesis (155, 156).
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Figure A2. Lipid Synthesis Pathway. (155). MGAT=monoacylglycerol acyltransferase;
GPAT= glycerol-3-phosphate acyltransferase; LPAAT= lysopophosphatidic acidacyltransferase;
PAP= phosphatidic acid phosphorylase; DGAT=diacylglycerol acyltransferase; PC=
phosphatidic choline; PE= phosphatidic ethanolamine.
Variation in Lipid Storage
Multiple factors such as gender, training status, measurement used, muscle analyzed, and
most importantly, energy status all affect the synthesis and partitioning of lipids to various
storage sites. The storage of lipids in non-adipose tissues may contribute to insulin resistance,
but an overconsumption of calories will not result in the same gains in adiposity in all
individuals. In fact, a study done with overfeeding in twins revealed that there was a large
variation between pairs of twins in energy expenditure, weight gain, and regional adiposity
(157), all of which were thought to be due to genetic variation. These results highlight the
importance of acknowledging the differences in the expression of genes responsible for the
partitioning of lipids to adipose versus skeletal muscle. Further insight is still needed to explain
how lipids are synthesized within skeletal muscle and how insulin resistance develops as a result
of excess lipid storage. More visceral adiposity and lipid storage in and around organs and
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within skeletal muscle contribute to increased insulin resistance, yet endurance athletes remain
insulin sensitive despite high IMCL stores (16).
With that in mind, the question becomes, “what are the primary mechanistic differences
in lipogenesis between healthy and insulin resistant individuals”? It is likely that endurance
athletes store lipids in muscle for quick access to a lipid energy source as a result of training and
thus, have a high turnover of lipid storage and oxidation within the muscle. A high
mitochondrial density and increased oxidative fiber characteristics likely contribute to the lack of
intermediate metabolites, which may be the reason these athletes remain insulin sensitive(16).
Another major reason endurance athletes remain insulin sensitive despite high levels of IMCL
may be due to complete synthesis of triglyceride stores. NEFAs must be esterified to MAG,
DAG, and finally TAG by multiple enzymes including glycerophosphate, mitochondrial
glycerol-3 phosphate, sterol CoA desaturase 1 (SCD1), and DGAT. If any of these enzymes are
down-regulated, lipids may not be completely converted into TAG, causing intermediates to
accumulate and interfere with insulin signaling. Aside from genetic disturbances, numerous
dietary and supplemental factors can influence this lipogenesis. Therefore, some of the major
factors will be addressed here.
Following Feeding
Lipids within the body are stored in the body primarily as TAGs. Therefore having a
firm understanding of how TAGs are formed is critically important. Once food is ingested,
there are many enzymatic processes involved in the digestion of various food stuffs and eventual
transport into the circulation, the details of which are described elsewhere (158). Once in the
circulation via very low density lipoproteins (VLDLs) and chylomicrons, TAGs are hydrolyzed
into free fatty acids (FFAs) via lipoprotein lipase (LPL) (125), which is discussed in further
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detail in chapter three. The FFAs are transported into skeletal muscle, adipose, and liver cells
via fatty acid transport proteins (159). Once inside the cell, the fate of that fatty acid is highly
dependent on the cell type. In adipose tissue, fatty acyl-CoA’s are re-esterified to TAGs, in the
liver, fatty acids are re-esterified to TAGs or are packaged into VLDLs for export into the
circulation and eventual storage in adipose tissue as TAGs (8). In skeletal muscle, which is the
primary focus of this review, FFA are primarily oxidized to provide energy; however, some FFA
are stored as TAGs within the muscle cell, which is likely due to an increase in the expression
and activity of various lipogenic enzymes. The extent of this activation and expression may be
partially due to the type of macronutrient consumed.
Carbohydrate ingestion
In healthy and insulin resistant individuals, there are numerous factors that will ultimately
determine whether ingested carbohydrates will immediately be utilized for energy or stored in
various tissues. Both the amount and the type of carbohydrate consumed will affect the rise in
blood glucose concentrations. Simple carbohydrates as well as high amounts of carbohydrates
consumed at one time will increase blood glucose more rapidly, and in turn increase the rate of
insulin release. In insulin resistant individuals, glucose stimulated insulin secretion (GSIS) is
impaired, leading to chronic elevated levels of blood glucose (160). In healthy individuals,
insulin stimulates uptake of glucose and transport into numerous cell types including, skeletal
muscle, liver, and adipose (7), but again, this action is impaired in insulin resistant individuals
(161). This has major implications for the development of diabetes given that up to 90% of
insulin-stimulated glucose disposal is accounted for by skeletal muscle (162) which will either
immediately use the glucose to meet its energy needs, or it will store the glucose in the form of
glycogen. In healthy individuals, if skeletal muscle and the liver already have large amounts of
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glycogen stored, it is likely that this excess glucose will be partitioned toward adipose cells, the
presence of which stimulates lipogenesis. However, insulin resistant individuals have an
impaired ability to synthesize glycogen (161), which means even more lipogenesis is likely to
occur, further exacerbating signaling impairments associated with excess lipid storage and
increased reliance on glucose oxidation.
This is why the RQ is high in a fasted state in insulin resistant individuals and remains
that way following feeding (55). The authors from this study suggest that obese, insulin resistant
individuals oxidize proportionally more fat than lean individuals following insulin stimulation.
These conclusions cause a fair amount of confusion, as seen in chapter 1 (increased versus
decreased β oxidation) and deserve clarification. It is important to understand that while the RQ
of obese was approximately 0.91 and the RQ of lean was approximately 0.99 following insulin
stimulation, the RQ of obese in a fasted state was 0.90 compared to 0.82 in lean. Clearly the
obese subjects were metabolically inflexible (0.90 fasted versus 0.91 following insulin
stimulation), but they do not necessarily metabolize more fat than lean individuals as previously
suggested, rather they are unable to adapt or respond to insulin stimulation and are in a chronic
state of elevated glucose oxidation.
Fat ingestion
Similar to the ingestion of carbohydrates, the ingestion of fat, in the presence of an
energy surplus, can lead to increased fat synthesis within skeletal muscle, liver, and adipose
tissue. Some studies suggest increased fat oxidation following high fat feeding in insulin
resistant individuals compensate for the influx of fat while others suggest decreased fat oxidation
or an inability to adjust with fat overfeeding (163) (164). Differences are likely attributed to
skeletal muscle composition as well as dietary fat composition (saturated versus unsaturated) and
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total energy expenditure. Some of these discrepancies may also be due to reporting relative
changes seen in substrate utilization in insulin resistant individuals compared to lean
counterparts, not absolute changes in fat oxidation.
One particular study has suggested that fat over-feeding increases adiposity more so than
CHO over feeding (164). The authors showed that isocaloric carbohydrate overfeeding for 14
days in lean and obese humans led to an increased oxidation of carbohydrates with 75-85%
excess energy being stored. Fat overfeeding did not increase fat oxidation and 90-95% excess
energy was stored, indicating that excess dietary fat increased fat accumulation more so than
excess dietary carbohydrate. This seems logical given that glucose is the body’s immediate
preferred energy source there is a limitation to how much glycogen can be stored in skeletal
muscle and the liver. Contrasting results were seen in another study which demonstrated that RQ
was not significantly different in lean subjects given a high-fat diet compared to a high
carbohydrate diet or mixed (all isocaloric) on consecutive days, indicating that the metabolism of
these subjects were unable to immediately respond to changes in macronutrient intake (163).
Taken together, these results suggest that regardless of macronutrient consumption, continual
overfeeding will result in increased fat storage; however, unlike excess carbohydrate intake,
excess fat intake is not compensated for by an increased rate of fat oxidation, thus, lipids
accumulate and levels of adiposity become elevated.
Also of interest, in the study by Horton et al, (158), the obese subjects oxidized
proportionally more carbohydrates and less fat than the lean subjects, regardless of diet
composition, elucidating to the likelihood of metabolic inflexibility in obese individuals as seen
in previous studies (55). In addition, plasma insulin levels increased in carbohydrate overfeeding
in both lean and obese subjects, but insulin concentration decreased in fat overfeeding in lean
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subjects while it increased in obese subjects, which could explain why obese individuals often
exhibit hyperinsulimia. In contrast to these findings, a recent study demonstrated that muscle
mitochondrial number increases from a high fat diet in rats, which increases the capacity for fat
oxidation through post-transcriptional modifications for Peroxisome proliferator-activated
receptor gamma coactivator 1-alpha (PGC-1α), but insulin resistance increases as well (165).
This indirectly suggests that decreased mitochondrial content in muscle may not be directly
responsible for insulin resistance as previously suggested, rather it may be a result of an energy
imbalance (lack of physical activity) as suggested in chapter one combined with impaired lipid
transport and increased lipid accumulation. Chapter four will describe in greater detail how even
a single bout of physical activity can reverse some of the insulin desensitizing effects of physical
inactivity.
Lipid Storage
Ingesting a mixed diet, which consists of a percentage of both carbohydrates and fats is
much more applicable to the general public and does not suggest the preferred storage of one
substrate over another, especially in an isocaloric diet. It is likely that lipid storage in skeletal
muscle for this type of diet is largely dependent on the metabolic state of the muscle (energy
consumption versus energy expenditure). However, a recent study also demonstrated that dietary
fat composition can affect insulin sensitivity. Male Sprague-Dawly rats given a high-saturated
fat diet for eight weeks exhibited greater levels of saturated fatty acids incorporated into IMCL
compared to rats given a high-polyunsaturated diet, which incorporated more unsaturated fatty
acids into IMCL. However, IMCL content increased in both high-fat diets compared to the
control group. The high saturated fatty acid group also exhibited increased homeostasis model
assessment of insulin resistance (HOMA-IR) and glucose intolerance (166). In addition, L6
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myotubes treated with saturated fatty acids had decreased insulin-stimulated glucose uptake and
increased DAG and ceramide accumulation. On the other hand, myotubes treated with
polyunsaturated fatty acids had no changes in insulin-stimulated glucose uptake or
DAG/ceramide content, but TAG levels did increase significantly (166). Together, these results
indicate that high levels of dietary saturated fatty acids may directly contribute to the
development of insulin resistance independent of systemic hormone regulation or tissue crosstalk. Rather, saturated fatty acid-induced insulin resistance may occur via incomplete
degradation of TAG’s (DAG, MAG, or ceramides). The results may also partially explain the
athlete’s paradox given that obese individuals likely have a much higher intake and storage of
saturated fatty acids compared to lean endurance athletes.
Higher levels of unsaturated fatty acids incorporated into TAG stores may improve
insulin sensitivity by limiting lipid metabolite accumulation. This may be due to the fact that
one of the enzymes involved in lipogenesis (DGAT, discussed below) preferentially utilizes
unsaturated fatty acids rather than saturated fatty acids (167). Thus, not only is total TAG
storage important, but also the content of the TAG stores. Unfortunately, as previously
mentioned, this content can be quite variable given that fatty acids can range from 14-24 carbons
and have a variety of locations which may be unsaturated and each TAG can contain any
combination of these fatty acids (7).
Niacin
To gain a more complete understanding of lipid formation, it is helpful to examine
models in which this process is either accelerated or inhibited. Aside from exercise intervention,
which will be thoroughly examined in chapter four, one such way to accomplish this task in
human models is through pharmacological intervention. Nicotinic acid, also known as niacin or
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vitamin B3, is pharmacologically used to improve cholesterol levels by blocking fat breakdown
in adipose and liver tissue, but it also appears to play a role in lipogenesis. As a consequence of
this supplement’s actions, VLDL formation decreases in the liver, and in turn, less low-density
lipoprotein (LDL) is formed, and more high-density lipoprotein (HDL) is formed, thereby
lowering blood lipids (168). Niacin is also a precursor to the coenzymes NAD+/NADH as well
as NADPH. In addition to being involved in DNA repair and steroid hormone production, these
coenzymes are involved in fatty acid synthesis via NADPH, tissue respiration, and utilization of
carbohydrates via NADH in skeletal muscle (7).
Interestingly, the effect of niacin appears to have different effects in hepatocytes,
myocytes, and adipocytes, suggesting tissue-specific effects which must be taken into
consideration when examining the whole body effects of this supplement. One study
investigating the cellular mechanisms of niacin demonstrated an up-regulation in the degradation
of ApoB, which is a protein involved in LDL transport, in human HepG2 (hepatic) cell cultures,
thus lowering plasma LDL concentrations possibly by decreasing the synthesis and secretion of
TAG and VLDL into the blood stream. Supplementation also inhibited fatty acid synthesis and
esterification (169). Niacin also appears to limit the degradation of ApoA (a protein component
of HDL) in hepatic cells, thus increasing plasma HDL concentration. Niacin appears to elicit its
effects by acting on hormone sensitive lipase (HSL) to inhibit lipolysis in adipocytes and it
acting on diacylglycerol acetyltransferase (DGAT) to inhibit TAG synthesis (170). Thus it
appears that in skeletal muscle, niacin can contribute to fatty acid synthesis while inhibiting
lipolysis. On the other hand, niacin can also block fatty acid synthesis in adipose and liver cells.
This apparent disconnect may be explained by niacin’s effects on the various tissue-specific
enzyme isoforms involved in TAG synthesis, specifically DGAT.
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DGAT
Diacylglycerol acetyltransferase (DGAT) catalyzes the only committed step in TAG
synthesis using DAG and fatty acyl CoA as substrates (156). Thus, without proper expression
and activity of this enzyme, lipid intermediates will not be incorporated into TAG, rather they
will accumulate. Accumulation of these intermediates, as previously discussed, play an integral
role in the development of insulin resistance. There are two basic isoforms of DGAT, both of
which appear to be necessary for proper functioning in mammals (171). DGAT1, which is
considered “overt” and is involved in formation of TAG in cytoplasm of ER in liver cells and
DGAT2, which is “latent” and is involved in formation of TAG in lumen of ER in liver cells,
which are then involved in the formation of VLDL (172).
The DGAT reaction can come from multiple pathways (1) de novo synthesis catalyzed by
mitochondrial glycerol-3 phosphate acetyltransferase (mGPAT), (2) esterification of MAG
catalyzed by monoglyceride acetyltransferase (MGAT), or (3) hydrolysis of TAG or
phospholipids.
Given its critical role in TAG synthesis, it has been suggested that inhibiting DGAT1
may decrease the expression of genes involved in fatty acid oxidation (i.e. PPAR genes) and
decrease adiposity and diet-induced obesity (173). Indeed DGAT1 KO mice exhibited these
traits and improved insulin sensitivity, however, mice deficient only in skeletal muscle DGAT1,
rather than whole body DGAT1 deficiency exhibited decreased insulin sensitivity, again
demonstrating the importance of tissue-specific isoenzymes and tissue-specific development of
insulin resistance (156). In fact, DGAT1 gene expression has been shown to be up-regulated
following a single bout of moderate-intensity aerobic exercise in humans (56). This increased
expression of DGAT1 increased IMCL stores, while decreasing DAG concentration. As
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mentioned in chapter one, high levels of DAG are thought to activate pro-inflammatory
pathways as well as specific protein kinase C’s (PKC’s), which in turn phosphorylate serine
residues on insulin-receptor 1 (IRS-1), and decrease insulin sensitivity (22, 140). Thus, upregulating TAG synthesis is skeletal muscle may act to limit the development of insulin
resistance.
This hypothesis is supported by earlier findings in mice which showed that DGAT1 overexpression increases small lipid droplet accumulation around the cell periphery, whereas DGAT2
over-expression increases large lipid droplet accumulation in the cytosol (171). As mentioned in
chapter one, small adipocytes have been shown to secrete insulin-sensitizing hormones such as
adiponectin and leptin, whereas large adipocytes have been shown to secrete insulindesensitizing hormones such as retinol-binding protein (RBP-4) and resistin (8). In addition to
forming large lipid droplets, which may be linked to insulin resistance, the over-expression of
DGAT2 in mice has been shown to decrease insulin sensitivity due to storage of TAG in
glycolytic fibers (174). Oxidative fibers have many mitochondria and rely primarily on fatty
acid oxidation for energy. These types of fibers are capable of storing and utilizing TAG’s
within the muscle and are more predominant in aerobically trained individuals. Glycolytic
fibers, conversely, have few mitochondria and therefore cannot effectively oxidize stored TAG’s
to produce energy. Therefore, it seems plausible that in obese, insulin resistant individuals,
DGAT2 expression is increased in skeletal muscle. Since these individuals are less active, it is
likely that they have fewer oxidative fibers and more glycolytic fibers. Thus, the paradox
between IMCL storage in insulin resistant individuals and IMCL storage endurance trained
athletes could also be due to a combination of the inability of the glycolytic fibers to break down
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and oxidize stored TAG as well as an up-regulation in DGAT2, which furthers TAG storage in
these glycolytic fibers.
With the given information about DGAT2, it may seem plausible that inhibition of
DGAT2 may help limit the development of insulin resistance. Whether or not there is an upregulation in DGAT1 and a down-regulation of DGAT2 following chronic exercise is currently
unknown and warrants further investigation.
The over-expression of DGAT 1 and DGAT2 in mouse liver cells has been shown to
cause an excessive accumulation of lipid stores within the liver without inducing insulin
resistance or glucose intolerance (175). This may indicate that excess lipid storage in liver alone
may not be a direct cause of insulin resistance; rather it may be an effect of the development of
insulin resistance via inflammatory pathways.
Other Enzymes
Though DGAT is the rate-limiting enzyme and is the only committed step in lipogenesis,
the role of other possible enzymes involved in lipid synthesis, such as mGPAT and SCD1, which
desaturates fatty acids into monounsaturated fatty acids to be incorporated into TAG stores, must
also be examined. Alterations in the expression of these enzymes may also lead to a build-up of
fatty acid metabolites which have been linked to insulin resistance (155). Work on these
enzymes, particularly in skeletal muscle is limited, but studies examining whole organisms and
other tissues can provide possible future directions for study. For example, SCD1 KO mice are
resistant to diet-induced obesity, likely due to the inability to store saturated fatty acids (176). At
the other end of the spectrum, SCD1 protein expression and activity is up-regulated in rats
following a high fat diet, causing the rats to became more insulin resistant (166). This does not,
however, indicate that up-regulation of this enzyme induces insulin resistance per se; rather it
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may act as a protective mechanism to limit the formation of DAG and ceramides associated with
high levels of saturated fatty acids as seen in the study by Lee et al. (166). In contrast, GPAT
over-expression in rats directly contributes to DAG storage in the liver, increased IMCL storage
and increased hepatic, peripheral, and systemic insulin resistance (177).
With this in mind, it seems that increasing the expression of specific lipogenic enzymes
through dietary manipulations or otherwise can contribute to insulin resistance while the
increased expression of other enzymes may have no effect or may improve insulin sensitivity.
The reasoning for this is not entirely clear although it seems likely that the over-expression of an
enzyme such as GPAT, involved in the first step of TAG synthesis may take away from the FFA
pool that may have otherwise been utilized for oxidation. On the other hand, depending on the
tissue, increased expression of DGAT or SCD1 may limit the accumulation of DAG and
ceramides.
While it is apparent that variations in lipid synthesis can greatly affect insulin sensitivity,
variations in lipid mobilization, hydrolysis, and oxidation are just as critically important to
examine in order to gain a more complete understanding of lipid metabolism and its links to
insulin resistance. Though as seen with lipid synthesis, much remains unknown about lipid
utilization.
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CHAPTER 3: Lipid utilization in healthy vs. insulin resistant skeletal muscle
There are multiple enzymes involved in the complete process of degrading TAGs to FFA.
The extent to which each of these enzymes are complimentary versus redundant is still not clear.
Therefore it is important to examine some of the major enzymes involved in lipolysis and how
alterations in the expression or activity of these enzymes may contribute to insulin resistance.
Lipoprotein lipase (LPL), hormone sensitive lipase (HSL), and adipose triglyceride lipase
(ATGL) are three of the major enzymes contributing to the initial breakdown of TAGs. As
discussed in earlier chapters, numerous factors can affect the activity of these enzymes, and in
turn, the extent of lipid breakdown. This chapter of the review will examine the fasting state,
which activates these specific lipolytic enzymes, but to a different degree in healthy versus
insulin resistant individuals. Another aspect that will be examined is tissue specificity given that
lipolysis in liver, skeletal muscle, and different muscle fiber types are regulated by differing
mechanisms. Finally, the mobilization of lipids will be examined since the amount of lipolytic
enzymes and intermediates in the blood vary between insulin resistant and healthy, but also
depend on where the TAG are mobilized from (skeletal muscle, liver, or adipose tissue).
Major Enzymes
As its name suggests, LPL is involved in the lipolysis of TAG in lipoproteins. Following
feeding (high insulin levels), excess circulating TAG will be stored primarily in adipose tissue.
However, TAG must first be hydrolyzed from VLDL or chylomicrons via LPL into FFA and
then re-esterified into TAG. Adipose tissue and skeletal muscle have different isoenzymes of
LPL which are regulated by differing mechanisms (178) which helps explain why the storage of
TAG in adipose occurs readily while storage of TAG in skeletal muscle is more limited, at least
in healthy, untrained individuals.
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A second enzyme involved in lipolysis, which essentially has the opposite actions of LPL
hydrolyzes TAG, DAG, and MAG to be oxidized for fuel (rather than stored) and is sensitive to
the concentrations of insulin and glucagon (7). Therefore this lipase is often referred to as LPLHS or hormone sensitive lipase (HSL). Much like LPL, HSL is expressed in both adipose and all
types of skeletal muscle fibers, but the expression appears to be the highest in adipose, followed
by oxidative, then glycolytic muscle fibers (159). LPL hydrolyzes TAG from lipoproteins for
storage in adipose tissue and skeletal muscle whereas HSL hydrolyzes TAG from adipose or
IMCL reserves for oxidation (125). In the presence of insulin, HSL activity decreases in both
adipose and skeletal muscle, whereas LPL activity increases in adipose and skeletal muscle
tissue. As a result, lipid degradation increases, but lipid storage increases as well. This is due to
the anabolic action of insulin (179), which makes sense considering that the body always
attempts to be as energy efficient as possible. If both enzymes were up-regulated, there would be
a futile cycle between lipid storage and breakdown. Interestingly, skeletal muscle inactivity also
appears to decrease LPL activity in all muscle fiber types (180), suggesting a role of physical
activity in maximizing lipolysis, which will be discussed further in chapter four. However, more
recent studies have indicated that these two enzymes alone are not solely responsible for the
hydrolysis of TAG and that there may be numerous other complimentary or redundant enzymes
or pathways involved.
ATGL
One such enzyme involved in lipolysis is adipose triglyceride lipase (ATGL). Once
again, as its name suggests, it is involved in the hydrolysis and mobilization of TAG from
adipose tissue, however this enzyme is also expressed in skeletal muscle (145). ATGL has been
shown to be expressed exclusively in type I fibers, appears to play a role in converting TAG to
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DAG and may play a role in fatty acid handling, lipid storage and breakdown (145). Given the
deleterious effects of excessive plasma DAG, one school of thought is that if TAG degradation to
DAG is limited, insulin sensitivity will improve. This has been shown to be the case in ATGL
KO mice, which demonstrated increased glucose tolerance and insulin sensitivity despite TAG
accumulation in multiple tissues. Insulin-stimulated PI3K, Akt activity also increased and
phosphorylation of tyrosine residues on IRS-1 increased in skeletal muscle and adipose tissue in
vivo (10). While this could potentially be an attractive pathway for the prevention of diabetes, it
has been demonstrated that ATGL and HSL are needed for lipolysis in skeletal muscle and
adipose to sustain normal substrate metabolism both at rest and during exercise (57). ATGL
gene deletion in mice causes an increase in carbohydrate utilization, a decrease in circulating
FFA at rest. Decreased circulating FFA leads to an increased dependence on glucose oxidation,
thus, liver and muscle glycogen stores decrease. Interestingly, resting glycogen storage was not
affected in HSL KO mice nor was fatty acid transport affected in ATGL or HSL knockout mice
(57). However, the exercise-induced increase in FFA and glycerol mobilization was blunted in
both KO mice, indicating a decrease in lipolysis, an increase in CHO oxidation, and a reduced
endurance capacity. A similar study examining ATGL KO mice yielded similar results, again
indicating that ATGL is required for the hydrolysis of TAG from skeletal muscle and adipose
tissue, and thus, proper energy supply during exercise (181). Without this enzyme, the body
cannot utilize lipid for energy and is in turn, forced to rely on glucose metabolism. This will lead
to an up-regulation in glucose transport, which could help explain the improvement in insulin
sensitivity seen in these KO mice.
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Tri-di- and monoglycerides
Currently, the role of individual enzymes responsible for the conversion of TAG to
DAG, DAG to MAG, and MAG to FFA and glycerol has not been examined in great detail.
However, recent evidence suggests that these enzymes may play a key role in the accumulation
of DAG and ceramides, and in turn, contribute to the development of insulin resistance.
Triacylglycerol hydrolase, which converts TAG to DAG and diacylglycerol hydrolase, which
converts DAG to MAG was recently examined in lean and healthy male and female subjects, all
of which were sedentary. As seen in past studies, it was found that females exhibited higher
levels of IMCL than males, obese subjects exhibited higher IMCL, DAG and ceramides than
lean subjects (182). Expectedly, TAG hydrolase activity was higher in obese compared to lean,
and higher in females compared to males. Interestingly, despite elevated DAG and ceramide
levels in obese subjects, DAG hydrolase activity was actually lower for this population compared
to lean subjects (182). This is critical as it suggests that while TAG hydrolase activity may be
up-regulated in individuals with higher levels of IMTG storage, such as females or endurance
trained athletes, obesity appears to induce changes in DAG hydrolase in skeletal muscle, though
increased levels of adiposity are independent of this change in enzymatic activity. This
incomplete lipolysis could contribute to the formation of DAG seen in insulin resistance;
however, the mechanisms are not yet apparent.
It should be noted that ATGL acts as TAG hydrolase and HSL acts as both a TAG
hydrolase and a DAG hydrolase, at least in the white adipose tissue of murine models (183) and
therefore the activity of ATGL and HSL are often representative of these various hydrolases.
MAG lipase appears to be its own unique enzyme and may also play a role in incomplete
lipolysis although currently there are no studies examining the role of this enzyme in insulin
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resistance. This may be because this particular enzyme is neither rate-limiting nor a committed
step in lipolysis; however, examining this enzyme along with others could provide greater insight
into differences between insulin resistant and healthy skeletal muscle metabolism. A fasting
state (i.e. low insulin, high glucagon concentration) will clearly activate these enzymes in
adipose tissue and to some extent in skeletal muscle; however, there is limited research on the
extent that each of these enzymes truly function in healthy and insulin resistant human skeletal
muscle. This will be an important area of future research with regards to possible links between
incomplete lipolysis and insulin resistance.
The study by Schenk and Horowitz (22) is one of the few studies that have examined
DAG levels following an acute aerobic exercise bout. In the aforementioned study, DAG levels
were significantly reduced following exercise, but further study is clearly necessary to either
support or oppose this research and to further determine if mono- and diacylglycerol levels are
altered following chronic exercise. Even without the incorporation of exercise, few studies have
explicitly examined MAG and DAG levels. This is due largely to the fact that standard
enzymatic assays measure all partial acylglycerols as triacylglycerols. Fielding et al. (184) have
suggested that these partial acylglycerols may account for less than 3% of total acylglycerols in
fasted human subjects. Despite this low percentage, these partial acylglycerols may still play a
critical role in the development of insulin resistance. However, at this point it is unknown if, and
to what extent, those numbers may be altered as a result of acute aerobic exercise. It is possible
that there may be a link between changes these lipid intermediates and insulin sensitivity. In
both humans (16) and mice (57), increased fat oxidation in skeletal muscle has been shown to
improve insulin sensitivity.
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Fasting vs. Fed state
In a fasted state, the body will rely primarily on fat stores to supply energy and will
conserve glycogen stores for essential brain, kidney, and red blood cell function or sudden
increases in energy demand (7). However, the dependence on fat utilization in a semi-fed state
will depend greatly on diet. A recent study demonstrated that in a fasted state, serum NEFA
levels were not different in high fat (HF) and standard chow (SC) fed mice, indicating both were
able to utilize fatty acids as a fuel source. However, NEFA concentration was significantly
lower in fed SC mice compared to the fed HF mice, which suggests that SC mice were able to
uptake and store fatty acids then subsequently utilize the immediately available glucose for fuel.
On the other hand, the authors suggested that the mitochondria in HF fed mice apparently could
not adjust to the feeding and continued to oxidize fatty acids despite the increased available
glucose; indicating an impaired ability to switch which substrate is utilized for energy (140).
This could provide implications for testing in post-prandial state as well as in a fasted state. As
previously suggested, fasting lipid responses in healthy and insulin resistant individuals is
drastically different (55). In addition, the study by Koves et al. suggests differences following
feeding, therefore testing in a fed or semi-fed state may elicit more pronounced responses in lipid
metabolism and should be examined in addition to the fasted state.
The differences seen in the fasted state may, however, be tissue specific. In a study done
on diabetic and lean rats, fasting induced significant increases in IMCL storage in white tibialis
anterior (wTA) and extensor digitorium longus (EDL) in both groups, though to a greater extent
in the diabetic group (185). In addition, malonyl CoA concentrations decreased in these muscles
of both groups, but to a greater extent in the lean group. The red soleus (SOL) muscle on the
other hand did not exhibit changes in malonyl CoA concentrations in either group (185). This
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suggests that starvation does not induce changes in lipid metabolism to oxidative muscles, such
as the SOL, regardless of insulin sensitivity, whereas both lipid uptake and oxidation are
activated in more glycolytic muscles like wTA and EDL when FFA availability is high due to
starvation. However, since glycolytic fibers contain fewer mitochondria than oxidative fibers,
even if malonyl CoA levels are suppressed, β oxidation will still be limited by the number of
mitochondria and mitochondrial enzymes present. It may be that wTA and EDL muscles can reesterify FFA and store them as IMCL primarily to cope with elevated FFA levels during fasting
whereas the SOL muscles can cope with elevated FFA levels primarily via β oxidation. There
also appear to be CPT1 enzymes that are insensitive to malonyl CoA, (186) which may also help
partially explain why malonyl CoA levels were not altered in the SOL muscles for this study.
Gender Differences
Though lipolytic enzyme activity may be similar between men and women, lipid
metabolism is clearly different in men and women and is worth briefly addressing here. In
general, women tend to perform better at ultra-endurance events and there may be several
reasons for this occurrence. Women naturally store more fat, in the form of IMCL or otherwise,
and utilize a greater percentage of fat for energy compared to men. The role of estrogen likely
has an effect on both of these. Variations in fiber type percentages could help partially explain
why women tend to have higher gene expression for specific β-oxidative enzymes. In a recent
study comparing differences in fatty acid handling in men and women, results indicated that
there were no significant differences in mRNA content for β oxidative enzymes, yet there were
significant differences in protein content of β oxidative enzymes (114). However, this study did
not show any significant differences between men and women for the transcription factor PPAR.
Thus, it seems very likely not only that various systems are interacting, but there are several
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post-translational modifications taking place. If women do indeed preferentially utilize fat as a
fuel source, it would be expected that genes responsible for β oxidation as well as lipolysis and
the TCA cycle would be up-regulated. Further studies need to investigate additional
transcription factors as well as other proteins involved in fatty acid transport, binding, and
oxidation. It would also be useful to examine various key enzymes involved in the TCA cycle to
help determine if all components of fatty acid oxidation are higher in women or if it is just
specific enzymes, such as the ones involved in β oxidation. An interesting point, although not
significant was that short-chain hydroxyacyl co-A dehydrogenase (SCHAD), responsible for
short-chain oxidation, was slightly higher in men. This may indicate that men have the same or
slightly higher capacity than women to break down short-chain fatty acids. It may be possible
that there are gender differences in the percentage of short, medium, - and long-chain fatty acids,
all of which have unique lipolytic enzymes. It is important to remember that this study examined
only skeletal muscle and some if its respective β-oxidative enzymes. Adipocyte, skeletal muscle,
and hepatic lipolysis are all different and therefore, future studies are needed to examine these
aspects as well. From an observational perspective, it seems logical that if women naturally
store more fat than men, they should be able to utilize fat more readily as a fuel source, thus the
findings of this study seem plausible; however, the underlying mechanisms, particularly at a
transcriptional and translational level are not yet clear.
Though it is apparent that much work is still needed to gain a better understanding of
complete lipid hydrolysis, mobilization, and oxidation within skeletal muscle, even less is known
about how this pathway and its respective enzymes are affected by exercise. Though exercise
acts in a similar manner to fasting in order to provide energy to working muscles, it is evident
that there are several differences that separate the effects of exercise and the effects of fasting.
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Numerous studies have shown that exercise improves several health parameters, including
insulin sensitivity. However, the mechanisms for this improvement, specifically with regards to
lipid metabolism are still not fully understood. Chapter four will discuss these differences and
shed some light on possible mechanisms linking exercise to improved insulin resistance.
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CHAPTER 4: Effects of exercise on lipid synthesis/degradation in healthy vs. insulin
resistant
Weight loss, specifically a decrease of abdominal adiposity, through caloric restriction,
exercise, or a combination of the two, has been linked to improved insulin sensitivity (187)
through various mechanisms. In addition, a reduction of abdominal adiposity has been shown to
significantly increase insulin sensitivity. Interestingly, even without weight loss, exercise can
improve insulin sensitivity (23) though the mechanisms responsible for the improvements in
insulin sensitivity appear to be much different when weight loss is not present. Regardless of the
type, intensity, or duration of exercise, chronic or acute, exercise has irrefutably been shown to
help to prevent, or at least limit several health disparities including cardiovascular disease,
obesity, cancer, and diabetes. However, the mechanisms are apparently variable and are
dependent on numerous factors. This chapter will be broadly divided into acute aerobic, chronic
aerobic, acute resistance, and chronic resistance training to examine how the modality of
exercise affects changes in lipid metabolism and how a single bout of exercise can affect lipid
metabolism compared to several weeks of training.
Aerobic Exercise
Aerobic exercise has been shown to up-regulate lipolysis and improve insulin sensitivity
whereas excess lipid storage in adipose tissue as well as within skeletal muscle has been linked
to insulin resistance (56). In general, any form of exercise appears to improve insulin sensitivity;
however, the underlying mechanism is still largely unknown. It may be due to interconnections
of improved mitochondrial function and enzymatic activity, decreased lipid metabolites, and
decreased inflammatory cytokines. Due to the variability in methodology and analysis between
studies, it has also been difficult to establish which variables play the most significant roles for
increasing lipid breakdown and improving insulin sensitivity. Not only can the measurement
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technique used (gas analysis, tracers, biopsy, plasma) and experimental model (cell cultures,
animal models, humans) affect the results of a study, but gender, training status, diet, muscle
fiber type, muscle glycogen content, exercise intensity, exercise duration, exercise type, all affect
lipolysis and lipid synthesis differently during and following exercise, making it difficult to
compare the effects between studies and thus, all of these variables need to be taken into
consideration when conclusions are made regarding the effects of exercise on lipid metabolism.
Acute aerobic exercise
Before examining the literature, it should be noted that in general, most acute exercise
studies are carried out when participants are in a fasted state. It has been demonstrated that an
overnight fast does provide valid and reliable responses to exercise. However, examining
participants in a postprandial state may provide a more "real world response". Exercising,
especially at high intensities, immediately after consuming a meal may result in undesired
consequences, specifically vomiting. Therefore, allowing food to digest for a few hours prior to
exercise may be ideal. Presumably, most of the population does not exercise on a regular basis
following an overnight fast, rather exercise takes place after some form of nutrients have been
consumed. Additionally, several studies have shown that the ingestion of carbohydrates
enhances endurance performance (102). In addition, as mentioned in chapter three, one study
demonstrated that serum NEFA levels were not different in fasted high fat and standard chow
mice; however, NEFA concentration was significantly lower in the fed standard chow mice
whereas concentrations remained elevated in the high fat mice (140). This suggests an impaired
ability in the high fat fed mice to switch from utilizing primarily fats in the fasted state to
carbohydrates in the fed state. This provides clear implications for exercise testing in a fed or
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semi-fed state to see more distinguishable results between populations and to provide much more
useful information as it applies to the general public.
Timing
When examining the effects of an acute exercise bout, a very important consideration is
the timeline for which the measurements are taken. The rate of fat oxidation changes during
exercise compared to immediately, and several hours afterward. Changes in metabolite
concentration, enzymatic activity, or gene expression may be rapid, but changes in protein
expression or protein modification may be much more delayed.
Within skeletal muscle, an acute bout of aerobic exercise will increase cytosolic calcium
levels and decrease the ATP/AMP ratio, both of which result in the activation and increased
expression of PGC-1α (188). Several studies have demonstrated that increased levels of PCG-1α
result in mitochondrial biogenesis by means of a complex signaling cascade described elsewhere
(188, 189). However, previous studies have shown that exercise-induced mitochondrial
biogenesis is altered or reduced in both humans and rodents with obesity and insulin resistance
(54, 190). The question becomes whether the obesity caused the reduction of mitochondria or if
low mitochondrial density caused the obesity. Warram et al. (19) suggested it can be the latter
for some individuals. This predisposition to obesity can easily lead to insulin resistance and the
development of type 2 diabetes, both of which have been linked to the down-regulation in the
expression of several genes responsible for oxidative phosphorylation, several of which are
under the control of PGC-1α (191). A likely contributor to this down-regulation is a dysfunction
of the mitochondria (54). It may also be due to a loss of oxidative fibers and an increase in the
percentage of glycolytic fibers, which in turn decreases PGC-1α expression (190). It is likely a
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combination of several factors, each of which plays a role in the development of insulin
resistance.
Some authors have suggested that an incomplete breakdown of fatty acids may lead to an
accumulation of lipid intermediates such as DAG, ceramides, and acylcarnitine species,
increasing the likelihood of developing insulin resistance (8, 22). However, no studies to date
have examined specific enzyme activity of ATGL, HSL, and MAGL in a single study, all of
which are involved in the complete breakdown of lipids. Furthermore, while a sufficient number
of studies have looked a TAG levels and exercise, very few studies have reported information on
DAG or MAG following exercise.
Complete Synthesis
A single aerobic exercise session has been shown to increase IMCL synthesis,
particularly when fat availability is high (22). These increased levels of IMCL synthesis by
increasing protein expression of DGAT1, mGPAT, and SCD1, which in turn, prevented the
accumulation of metabolites like DAG and ceramides known to activate pro-inflammatory
pathways. Similar results have been seen in rats. When given the drug Thiazolidinedione,
IMCL synthesis increased while metabolite accumulation decreased and subsequent proinflammatory pathways were inactivated (49). Interestingly, the research shows that, at least in
rats, it is an acute bout of aerobic exercise, rather than chronic training, which can act to downregulate these pro-inflammatory pathways (21). As seen in the study by Nassis et al. (23),
improvements in insulin sensitivity from chronic aerobic training may be more attributed to fiber
type shifting, increased mitochondrial density, and improved glucose transport.
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Intensity
Another variable that greatly influences the relative contribution of fat versus glycogen
utilization is exercise intensity. High-intensity exercise results in, among other things, an
accumulation of ammonia, which activates phosphofructokinase (PFK), and thus accelerates the
rate of glycolysis (192). This results in a greater percentage of fuel utilization from anaerobic
glucose metabolism and in turn, the production of lactate of and H+ ions which decrease blood
pH. Lower pH levels have been shown to inhibit CPT I, thus limiting fat oxidation (193). This
indicates that the onset of lactate accumulation inhibits FFA release from adipose tissue. It has
been suggested that maximum fat oxidation in untrained individuals occurs between 35-48%
VO2max, which is considered to be low-intensity (188). This may be due to the fact that fast
twitch fibers are recruited more heavily during high-intensity exercise, which is when the
production of ammonia has been shown to be highest and product inhibition limits lipid
metabolism (192).
Caffeine
One way to increase lipid utilization during acute aerobic exercise is to ingest a caffeine
supplement. The extent of enhanced lipid utilization via caffeine can be altered by the dosage
taken, intensity, duration, and type of exercise being performed, whether the exercise is chronic
or acute, as well as the training status, and diet of the participants. Maximal fat oxidation in
trained individuals appears to occur around 62.5% VO2max, and minimal fat oxidation appears to
be around 86% VO2max. Untrained individuals tested at 75% VO2max elicited no benefit from
caffeine supplementation (92). It is likely that the intensity of this exercise necessitated a greater
reliance on glucose oxidation for these untrained individuals, and thus, the caffeine was
ineffective. In addition, the total duration of this study was only 30 minutes, subjects did not go
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until volitional fatigue and thus, it is possible that metabolism and rating of perceived exertion
(RPE) may have been different between trials. Prior to the exercise intervention, these
individuals did not participate in any regular physical activity. During and immediately
following exercise, participants demonstrated high levels of lactate, likely due to their untrained
status. High lactate levels are known to inhibit lipolysis and thus, the effects of caffeine may be
overridden by the action of lactate.
In several studies, caffeine has been shown to enhance FFA mobilization from adipose
tissue, and in turn lowering the respiratory exchange ratio (RER) and spare muscle glycogen in
submaximal acute exercise lasing 30-60 minutes (7, 89). This mechanism is likely due to an
increase in catecholamine concentration, which enhances glucose release from the liver, FFA
release from adipose tissue and FFA oxidation (7).
Despite this proposed mechanism, some studies have seen no effect of caffeine on
aerobic function, RER or FFA uptake into skeletal muscle (90-92). Although in these studies,
individual fatty acids were not examined nor was lipid breakdown examined. It is possible that
while total fatty acid uptake did not change, there may have been changes in individual fatty acid
uptake or breakdown. This was seen one a study where the authors showed increased
unsaturated fatty acid mobilization (c18:1) and decreased saturated fatty acids (16:0 and 18:0)
(194). This suggests that future studies involving changes in lipid synthesis and degradation
following exercise should include not only overall changes, but also changes in individual fatty
acid chain lengths and level of saturation. Another important consideration is whether the lipids
being utilized during exercise are hydrolyzed and utilized from IMCL or from liver or adipose
tissue.
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IMCL Stores and Muscle Fiber Type
The extent to which IMCL contributes to fuel utilization during exercise is not well
known though it seems likely that there is more contribution from these stores with longer
duration, lower intensity type exercise. In healthy untrained individuals, glycogen stores will
decrease with prolonged exercise and lipids will take over as main substrate. The extent of
glycogen depletion will vary depending on the type of muscle an extent of muscle activity.
Indeed, it has been shown that IMCL stores decrease with prolonged exercise and there is more
use of IMCL in oxidative muscles compared to glycolytic muscles (195) further supporting the
notion that lower intensity exercise maximizes fat utilization.
While low-intensity exercise will yield a greater percentage of fat utilization compared to
high-intensity exercise, high-intensity aerobic exercise has still been shown to improve fat
oxidation during exercise in recreationally active individuals (16, 24). An interesting note is that
lipolysis apparently was not up-regulated. These subjects had increased expression of fatty acid
binding protein (FABP), hydroxyacyl-CoA dehydrogenase, and citrate synthase, while fatty acid
translocase CD36 and HSL were not up-regulated. Although these results cannot be readily
explained, this may indicate that the oxidation of free fatty acids is up-regulated, as suggested in
chapter one, while the mobilization of stored triglycerides is not up-regulated following this type
of training. This may also indicate that lipid oxidation is more of a limiting factor than
hydrolysis or transport during exercise and thus, there was no need for an up-regulation in HSL
or CD36. During exercise, increased oxidation may be due to enhanced mitochondrial fatty acid
uptake through the up-regulation of carnitine transport system, allowing long-chain fatty acids
LCFA’s into the mitochondria, which in turn, results in more CPT1 activity (16).

150

Clearly, the type of activity, or lack thereof, in addition to genetics can greatly affect
muscle fiber type, and thus, influence the rate of lipid metabolism. In a comparison of ob/ob
mice to lean littermates, the cross-sectional area of the EDL and sternomastoid were significantly
reduced in the obese group. The obese mice also had smaller type II (glycolytic) fibers, and
more “hybrid” fibers, suggesting fiber type shifting in obese mice (196). Similar fiber type
shifting occurs following chronic aerobic training and will be discussed later in this chapter.
Altered Oxidative Gene Expression
Another change that occurs as a result of acute aerobic training is the up-regulation of
various genes involved in fat metabolism. Uncoupling protein 2 and 3 (UCP-2 & UCP-3) gene
expression has been examined in detail in both human and mouse models. UCP is responsible
for transforming substrates to ATP via uncoupling mitochondrial respiration and therefore plays
an important role in oxidative metabolism (197). UCP-3 in particular is expressed primarily in
human skeletal muscle and may act to help regulate thermogenesis as well as utilize lipids as
fuels by increasing fatty acid oxidation within the muscle (198). This FFA oxidation is seen with
endurance exercise as well as fasting. Because of this, it would make sense that endurance
exercise may act to increase UCP-3 mRNA. Noland et. al (197) discovered that an acute bout of
endurance exercise does, in fact, up-regulate UCP-3 in untrained humans, however, this upregulation was not seen in trained individuals. The exact reasoning for this is unclear. It may be
attributable to a lower body fat percentage in trained individuals and therefore less need for the
expression of UCP gene or it may be due to a higher initial expression of the UCP gene in
trained individuals and thus, less of a need to up-regulate gene expression.
Specific factors that regulate UCP gene expression are not well understood, however it is
evident that UCP-3 mRNA expression is dependent on the metabolic state of the skeletal muscle.
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Cortright et. al (199) for example, identified that fasting increases UCP-3 mRNA up to eight fold
and that re-feeding brings UCP-3 back down to basal levels or below. Part of the reasoning for
why it has been so difficult to establish specific mechanisms behind changes in gene expression
within skeletal muscle may be because skeletal muscle grown in culture lacks systemic input,
lacks a motor nerve, and exclusively relies on glycolytic metabolism, consequently making it
difficult to compare to fatty acid handling in intact, fully functioning adult myofibers within an
organism.
However, several studies have been done in vivo to gain a better understanding of fatty
acid metabolism. Hilderbrandt et. al (200) used a technique which involved isolating nuclei from
skeletal muscle in combination with real-time polymerase chain reaction techniques (RT-PCR)
to determine muscle fiber-specific and gene-specific changes in transcription rate of several
genes including UCP-3, LPL, muscle CPT I, long-chain acetyl-CoA dehydrogenase (LCAD),
and medium-chain acetyl-CoA dehydrogenase (MCAD), all of which are intricately involved in
fatty acid metabolism. The authors found that fasting induces increased expression of the UCP-3
gene as well as several other genes associated with lipid metabolism, specifically in fast-twitch
muscle fibers, which is intriguing given that fast twitch fibers are primarily glycolytic. However,
considering that oxidative fibers likely already express high levels of the UCP-3 gene, these
results suggest some level of fiber-type fuel shifting, reinforcing the notion that the body relies
heavily on fatty acid metabolism during starvation.
Interestingly, the addition of acute aerobic exercise, which increases metabolic demand
and glucose utilization, actually decreased the transcription of genes associated with lipid
metabolism, specifically in slow-twitch muscle fibers. This showed that the physiological
mechanisms responsible for these changes in gene expression due to fasting may oppose the
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mechanisms responsible for changes in gene expression due to exercise. This may help explain
why UCP-3 gene expression after acute bouts of exercise varies among trained and untrained
individuals. Trained individuals may have a more repressed UCP-3 gene due to the chronic
increased metabolic demand placed on the muscles. The important point to keep in mind is that
although individuals that exercise regularly (trained) appear to have specific genes which are
responsible for lipid metabolism to be repressed more than in those individuals that do not
exercise regularly (untrained), this does not mean a lack of exercise leads to increased fat
oxidation. It may simply indicate that trained individuals tend to carry a lower body fat
percentage, and hence, are more metabolically efficient and do not need to transcribe those genes
at such high rates. In addition, as mentioned in chapter one, increased β oxidation does not
necessarily indicate improved lipid metabolism. Without up-regulation of complete lipolysis, the
TCA cycle and ETS, increased fat oxidation may actually increase the concentration of
deleterious lipid intermediates associated with insulin resistance.
Understanding how exercise can regulate the transcription of specific genes is an
important first step in understanding the mechanisms of how exercise can help prevent metabolic
diseases such as diabetes. As previously discussed, skeletal muscle plays a central role in
metabolic homeostasis; however, other tissues such as liver and adipose tissue are involved as
well. Hoene et al. (20) demonstrated that hepatic gene expression PCG-1α and PDK4, both of
which are involved in lipid utilization hepatic gluconeogenesis, were up-regulated as a result of
60 minutes of aerobic exercise. This particular study also demonstrated that acute aerobic
exercise induces increased IRS-2 protein expression while decreasing serine residue
phosphorylation on the IRS residues known to interfere with proper insulin signaling (20). One
important note is that the expression of these genes was higher in the liver than in slow-twitch or

153

fast-twitch skeletal muscle, indicating that some of the immediate benefits of exercise on insulin
sensitivity take place in the liver. However, all tissues for this study were dissected and frozen
immediately following the completion of the exercise session. It is possible that transcriptional
changes in the liver may occur rapidly, whereas translational or protein expression changes in
skeletal muscle may be more delayed. In addition, protein expression of PGC-1α and PDK4
were not examined in this study. Therefore before any conclusions can be made regarding
differences in these genes in various tissues, further study examining protein expression at
various time points following the completion of acute aerobic exercise is deemed necessary.
Chronic Aerobic
It has been clearly demonstrated that aerobic exercise training increases the size and
number of mitochondria in addition to increases in mitochondrial enzymes involved in fatty acid
oxidation, TCA cycle, ETS, and ATP synthesis, and thus, insulin sensitivity (54). Even
independent of weight loss, exercise seems to elicit improvements in insulin sensitivity. One
study involving obese girls showed that twelve weeks of aerobic exercise improved insulin
sensitivity without any changes in body weight, percent body fat, or markers of inflammation
(23). This may suggest that changes such as muscle fibers switching to more oxidative type,
increasing mitochondrial density, GLUT-4 concentration, glycogen synthase activity, and
decreased IMCL are more responsible for changes in insulin signaling as a result of exercise
compared to changes in hormone and inflammatory signaling seen in acute aerobic studies.
In an untrained state, PGC-1α is expressed at a higher level in more oxidative muscles
and thus, has a greater ability to oxidize free fatty acids (201). Previous studies have shown that
following chronic aerobic exercise training, all fiber types increase their capacity to oxidize FFA
by increasing activation, transport and β oxidation of, among several others, LCFAs and
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components of the ETS (202). However, since fast-twitch muscle intrinsically has a lower initial
oxidative capacity, these types of fibers may have a greater ability to adapt to the exercise
stimulus (203), whereas a more oxidative muscle will not have to undergo any major
biochemical changes and therefore will not adapt to the same extent.
One study has shown that plasma FFA decreased in trained individuals following cycling
indicating that trained individuals rely more on intramuscular TAG stores for fat oxidation
during exercise (16). It also demonstrated that trained individuals have higher rate of FFA
uptake and oxidation during exercise compared to untrained, both of which were tested at 75%
VO2max (high-intensity). This indicates the important role of training status, as will be discussed
later in this chapter.
Regardless of the mechanisms involved, clearly chronic aerobic exercise improves
insulin resistance, although different exercise and measurement variables create different effects
on lipid metabolism. Some of those variables will be addressed here.
Muscle Tissue Variation
Another variable that must be taken into consideration when examining changes within
skeletal muscle following chronic exercise is muscle fiber type. The vast majority of studies
involving human models have taken muscle samples from the vastus lateralis, mainly because
this muscle is easily accessible. The vastus lateralis is more involved with short, quick
contractions and less involved with long, slow contractions. Therefore it generally has a higher
percentage of fast-twitch fibers and a lower percentage of slow-twitch fibers whereas the soleus
for example, is involved with standing and posture and therefore has a higher percentage of
slow-twitch fibers. If a researcher were to obtain muscle samples from the vastus lateralis and
the soleus of a trained athlete, the percentage of fast-twitch fibers in the soleus would likely not
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be the same as an untrained individual, making it difficult to infer that one individual may be
more effective at metabolizing lipids than another. The “in between” muscle fiber types must be
considered as well. Most, if not all muscles, are not purely fast-twitch or slow twitch, rather they
are on a continuum somewhere in between and the percentage of a specific fiber type can vary
within the same muscle. The percentage of fast-twitch fibers at the origin may be different than
at the insertion, so unless multiple samples are taken from the same muscle, it will be
challenging to assess how lipids are truly metabolized within a muscle, and even then, there are
other factors to consider.
Training Status
Endurance trained individuals rely more on intramuscular IMCL stores for fat oxidation
during exercise whereas untrained individuals will rely more heavily on muscle glycogen and
circulating FFA. As previously mentioned, plasma FFA concentration decreases in trained
individuals following cycling (16). In addition to utilizing a higher percentage of IMCL, this
also shows that trained individuals have higher rate of FFA uptake and oxidation during exercise
compared to untrained, even at 75% VO2Max (high-intensity). Also, the rate of appearance of
glycerol higher in trained men vs. untrained indicating that esterified fatty acids are being
hydrolyzed in the muscle. Though endurance trained individuals will store higher levels of
IMCL, skeletal muscle does not contain glycerol kinase, which is required to re-phosphorylate
glycerol into glycerol-3 phosphate (G3P), thus once stored TAGs have been hydrolyzed, glycerol
must be released from the muscle. Thus, although the FFA’s released via lipolysis was equal in
both groups, the trained individuals were clearly utilizing a greater percentage of lipid stores
(16). Fat oxidation was also twice as high in trained, likely due to the fact that that training
increases fat oxidation during exercise by enhancing mitochondrial density and thus, fatty acid

156

uptake through higher expression and activity of CPT1. Though not specifically measured in
this study, it may be concluded that aerobic exercise training up-regulates not only the number of
mitochondria which can be utilized for β oxidation, but the carnitine transport system for LCFAs into the mitochondria may be up-regulated as well though further research is needed to
confirm these findings.
Implications for Diabetes
Adiponectin, as mentioned in chapter one, is a cytokine secreted by adipose tissue, plays
an important role in insulin sensitivity as well as glucose and lipid metabolism (2). When a wide
range of normal weight, overweight, and obese individuals with normal glucose tolerance,
impaired glucose tolerance, and type II diabetes were placed on a four-week physical training
regimen, Bluher et al. (2) found that exercise increased the expression of adiponectin and its
receptors (AdipoR1 & AdipoR2). AdipoR1 receptors are expressed in skeletal muscle cells and
AdipoR2 receptors are expressed in skeletal muscle and liver cells. This increased expression
may act to mediate improvements in insulin sensitivity, glucose metabolism, and lipid
metabolism seen as a result of exercise. They also noted that the more insulin resistance that a
given participant had, the lower the expression of the AdipoR2, regardless of body fat
percentage, indicating that even if an individual is not obese, poor insulin sensitivity can drive
down the expression of important proteins needed for glucose and lipid metabolism.
Non-insulin dependent diabetes also induces several impairments, specifically in
mitochondrial function. This includes decreased lipid metabolism, decreased UCP-3, low and
mitochondrial density, which in turn, limits oxidative capacity (204). As discussed above,
exercise counteracts several of these imbalances although the physiological mechanisms remain
unclear. It has been determined by Lumini et al. (199) that exercise, in addition to restoring
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UCP-3 gene expression, may increase mitochondrial biogenesis by increasing the expression of
PGC-1α and heat shock proteins (HSPs) ultimately resulting in helping to prevent the
development of diabetes. Similar results were seen by Toledo, Watkins, and Kelly (205). They
demonstrated that when sedentary obese humans without diabetes were placed on a calorie
restricted diet in combination with an exercise regimen, there was a significant increase in both
the size and total number of mitochondria in the skeletal muscle. This increased oxidative
capacity, increased lipid metabolism, and improved insulin sensitivity. This demonstrated that
improvement in mitochondrial size and density as a result of exercise leads to not only improved
muscle metabolism, but improved insulin sensitivity as well, although changes in insulin
sensitivity were likely partially due to caloric restriction. Again, this may be a result of more
complete β oxidation as well as more complete breakdown of esterified fat stores.
Evidence in the literature clearly indicates the high correlation between obesity (lipid
accumulation) and type 2 diabetes (insulin resistance). Kelly, Goodpaster, Wing, and Simoneau
(55) made this correlation even more evident by showing that obese individuals express
diminished CPT activity as discussed earlier and they have a reduced oxidative enzyme capacity.
Improvements in insulin sensitivity and fat oxidation in these obese participants improved as a
result of a four month weight loss intervention using caloric restriction. Once again, insulin
sensitivity and metabolic flexibility improved following feeding, but no changes were observed
in a fasted state. It seems plausible that an exercise intervention, which clearly improves insulin
sensitivity, may act to limit lipid utilization following feeding while caloric restriction may act to
increase lipid utilization following fasting, though more research is needed to confirm this
theory.
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More recently, Haskell-Luevano et al. (206) looked at a melanocortin-4 receptor (MCR4)
knockout (KO) mouse model to see if exercise alone affected specific genes associated with
obesity, insulin resistance, and other metabolic syndromes. Altered MCR4 gene phenotypes
have been identified in obese human and mouse models and therefore mice without this gene
will express obesity, insulin resistance, and hyperleptinemia. Indeed, the study showed that eight
weeks of exercise improves insulin sensitivity and effects the expression of proopiomelanocortin
(POMC), orexin, melanocortin-3 receptor (MCR3), and neuropeptide Y (NPY), all of which are
important in maintaining energy homeostasis. Exercise intervention creates this homeostasis and
can, in turn, prevent obesity and diabetes, even in genetically predisposed MCR4 KO mice. It
can also help prevent hyperleptinemia, which is simply high levels of circulating leptin, a
hormone derived from adipocytes that is necessary for controlling body weight. Björnholm et al.
(207) demonstrated that mutations in leptin gene phenotype or leptin receptor expression results
in the inability of leptin to bind to its receptor site in the hypothalamus. When leptin is unable to
bind, this creates higher levels of circulating leptin and increases excess lipid storage.
Interestingly, following chronic aerobic exercise intervention these perturbations are reversed
only in the presence of weight loss (208). This demonstrates that levels of adiposity may be
directly responsible for changes in circulating leptin levels and that improvements seen following
exercise intervention independent of weight loss occur from mechanisms other than changes in
leptin levels. Indeed this has been seen in previous studies (23).
Clearly, aerobic exercise, whether acute or chronic, improves insulin sensitivity and some
of the cellular mechanisms are beginning to emerge. However, it is currently unknown if
resistance training has similar effects on lipid metabolism to those seen with aerobic training.
Since resistance training is an attractive alternative form of exercise for individuals that are
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unable or unwilling to perform aerobic exercise, understanding the effects of resistance training
on insulin sensitivity compared to those seen with aerobic training is critical.
Resistance Training
Much like aerobic exercise training, there are multiple variables that can affect lipid
metabolism responses following resistance exercise training (training status, gender, tissue type,
etc). However, there are far fewer studies that have examined this particular research area. This
is probably attributed to the fact that this type of exercise is not continuous and that the
variability between different types of exercises, number of exercises, muscle groups worked,
type of resistance used, sets, reps, rest between sets, relative intensity, and number of days per
week make this type of exercise much more difficult to control and measure compared to aerobic
type exercise. In addition, until fairly recently, resistance type exercise was not given much
consideration as to its effectiveness in improving insulin sensitivity, especially with regards to
lipid metabolism. Given that much of the United States population is now overweight or obese,
it is evident that most of these types of patients, especially those with type 2 diabetes, do not
engage in regular physical activity. While aerobic exercise clearly has its benefits, if patients do
not regularly adhere to this type of exercise throughout their lives, health status is not likely to
improve. With a limited aerobic capacity in these patients, especially at first, engaging in
resistance training offers and attractive alternative to possibly help combat obesity and the
development of diabetes; however it should appear evident by the end of this chapter that much
more research is needed in this area to establish specific changes that occur from this type of
exercise.
Acute resistance
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As previously mentioned, skeletal muscle accounts for the majority of glucose uptake,
therefore, by increasing the size of the muscle via resistance training, one should be able to
increase the capacity of whole-body glucose disposal and in turn, limit hyperglycemia. Muscle
contraction alone, whether through resistance or aerobic exercise requires the utilization of ATP
(energy expenditure) and induces calcium release. This alone may have some protective effects
against insulin resistance. This has been demonstrated in numerous studies. Transgenic
mice expressing activated calcineurin in skeletal muscle had improved insulin uptake in the
glycolytic extensor digtorum longus (EDL) muscle when fed a high fat diet. This was associated
with an up-regulated expression of insulin receptor, Akt, GLUT-4, and PGC-1α expression (44).
In normally functioning muscle cells, calcineurin is activated by increased levels of cytoplasmic
calcium, thus this study implies that muscle contraction alone does indeed improve insulin
sensitivity and glucose uptake via an insulin-independent mechanism.
Numerous studies have also suggested that AMP, which is a product resulting from ATP
hydrolysis, activates AMP activated protein kinase (AMPK), and in turn phosphorylates and
inhibits acetyl-CoA carboxylase (ACC), which stops the production of malonyl-CoA and
relieves the inhibition of CPT1 to transport long-chain fatty acids into the mitochondria (40).
AMPK also increases skeletal muscle glucose uptake, increases citrate levels, and increases
levels of NAD+ and Sirt-1, both of which increase PGC-1α expression. The extent of AMPK
activation appeared to be directly related to exercise intensity, and thus ACC inactivation appears
to be dependent on exercise intensity (40, 41).
However, other studies suggest insulin sensitivity appears to be independent of exercise
intensity with acute resistance training. One study examined glucose uptake and insulin
sensitivity in resistance trained individuals following a control (no exercise), low-intensity, or
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high-intensity workload and found no differences at the two intensities (209). All participants
for this study were trained individuals, which may have confounded the results. It seems likely
that if untrained or insulin resistant individuals were to complete this protocol, differences may
be observed.
Acute resistance training also improves post-exercise lipid oxidation for up to 24 hours,
although the mechanism is unknown. Some authors have attributed this improvement to
decreased IMCL stores (26), however, this alone is not likely responsible for these changes as
the literature points more toward the notion that changes in IMCL content and lipid turnover may
be altered.
In resistance trained men, caffeine supplementation increased 1RM but had no effect on
leg extension or muscle endurance. This may indicate again that lactate supersedes the effects of
caffeine. It could also suggest that caffeine elicits different effects in different muscle groups
(104). However, this study had no crossover and participants only consumed 200 mg of caffeine,
and habitual vs. non-habitual consumption was not taken into consideration. It is likely that if
more caffeine were ingested, there may have been more beneficial effects given that caffeine
dosages between 3-6 mg/kg of body weight have been identified as being optimal dosages for
improving performance (93).
Chronic Resistance Training
As seen with aerobic exercise, there are significant differences between the beneficial
effects of acute resistance training compared to chronic resistance training, however, there are
some similarities as well. A six-week study comparing untrained healthy men and type 2
diabetic men showed that 30 minutes of resistance training three days per week increased
strength and muscle mass, as expected (12). Since skeletal muscle is responsible for the majority
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of glucose disposal, a larger muscle mass allows for greater glucose uptake, and thus better
glycemic control. Although six weeks of resistance training will improve strength significantly
in untrained individuals, is not an adequate enough time period to see any significant changes in
muscle mass. Rather, the results of this study indicated that GLUT-4 protein, insulin receptor
protein, and glycogen synthase protein and activity increased as a result of training. This
suggests that although there may have been slight changes in muscle mass, changes in protein
expression were primarily responsible for the improved glucose uptake and insulin sensitivity.
This change in protein expression appears to be due to increased muscle contraction, as was seen
in acute resistance training. This makes sense given that resistance training is predominantly and
anaerobic activity and therefore the working muscles must predominantly rely on glucose
metabolism. Thus, the question becomes whether the effects seen in this study were truly due to
chronic adaptations or residual effects of an acute bout of exercise.
It is important to keep in mind that the time course in which measurements are taken can
factor into the outcomes. Measurements for the previously mentioned study were carried out 16
hours after the final exercise session. In another study, diabetic men were placed on a resistance
training plus weight loss protocol or just a weight loss protocol for three days per week for six
months. Measurements were taken 48 hours after the last exercise training session and it was
found that, similar to the study by Holten et al. (12) that resistance training increased strength
and muscle mass and had greater improvements in glycated hemoglobin (HbA1c) levels (13).
However, plasma insulin and glucose as well as blood lipid concentrations did not improve.
Thus, this study indicates that whole-body glycemic control improves as a result of chronic
resistance training whereas changes in plasma insulin glucose concentrations may only improve
transiently as a result of acute resistance training.
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A more recent study supports these findings but suggests that insulin sensitivity does
improve as a result of chronic resistance training. In measurements taken 72 hours after the
completion of a 16 week resistance training intervention in older type 2 diabetic Hispanic men
and women, whole-body insulin sensitivity and HbA1c levels improved (62). This correlated
with decreased inflammatory markers and increased adiponectin levels. Similar to Dunstan et al.
(13), plasma glucose and insulin did not change significantly, however, HOMA, determined as
[fasting glucose*fasting insulin/22.5] was significantly improved following training. This may
be due to improvements in glucose translocation, possibly via insulin-independent mechanisms
such as increased calcineurin activation as suggested by Ryder et al. (44).
While these, along with several other studies have shown clear improvements in insulin
sensitivity and glycemic control with resistance training, few have truly examined changes in
lipid handling. Some studies have examined parameters such as plasma TAG, HDL, LDL,
VLDL, and total cholesterol and seen improvements (27) whereas others have not seen
improvements in these parameters (25). The different results yielded in these studies and others
can likely be attributed to the heterogeneity of exercise modality, duration, and intensity.
Given the mostly anaerobic metabolic demands placed on skeletal muscle during
resistance training, chronic exposure will cause muscle fibers to shift to more fast-twitch,
glycolytic (type II fibers). As mentioned previously, this will affect the ability of the muscle cell
to oxidize fatty acids since this type of fiber contains fewer mitochondria compared to oxidative
fibers. Initially, this may seem detrimental to lipid metabolism, but it is important to keep in
mind that other factors such as complete synthesis and hydrolysis may have a larger impact on
insulin sensitivity, and other factors, such as fatty acid and glucose translocation also play a role,
which is why despite the fiber type shifting, resistance training can still improve insulin
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sensitivity. Also, other changes, such as increases in resting metabolic rate (RMR), following
resistance training results in greater daily energy expenditure, and thus there is less likelihood
that energy consumption will exceed energy expenditure, leading to less lipid storage, less lipid
intermediates, and improved insulin sensitivity.
Combined, these results suggest that exercise improves insulin sensitivity primarily by
increasing metabolic demand on skeletal muscle. This increases lipid turnover, improves
oxidative capacity, up-regulates GLUT-4 translocation, and increases glycogen storage capacity.
In turn, skeletal muscle can store more glycogen and utilize more fat. This in turn is likely to
lower fasting RQ and improve metabolic flexibility, however further research is needed to
confirm this theory.
Further study following both acute and chronic resistance training is clearly necessary to
examine parameters such as TAG, DAG, MAG, glycerol and their associated lipolytic and
lipogenic enzymes to gain a better understanding of changes in lipid handling following this type
of training. In addition, examining changes in the RQ in both the fasted and fed state of insulin
resistant individuals following resistance training may provide a more mechanistic insight as to
why exercise improves insulin sensitivity and metabolic flexibility.
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CHAPTER 5: Conclusions and Future Directions
Though there are several aspects involved in the development of insulin resistance,
including but not limited to lipid intermediate accumulation, inflammation, change in adipocytederived hormone expression, changes in oxidative gene expression, impaired glucose stimulated
insulin secretion, impaired glucose uptake, impaired glucose and fatty acid transport and
translocation, incomplete lipolysis, decreased or incomplete β oxidation, incomplete TAG
synthesis, the literature irrefutably shows that all of these aspects are interconnected and result
from an energy imbalance (8, 126, 155). Linking of all these aspects of insulin resistance has not
fully been established, due in large part to the fact that insulin resistance can develop from
numerous pathways. Furthermore, the improvement of insulin resistance through means of
calorie restriction, exercise, or otherwise can result in various metabolic changes depending on
the means utilized. Finally variation among populations (training status, age, gender, ethnicity,
diet, level of insulin sensitivity) along with measurements taken (enzymatic assays, mRNA,
protein expression, chromatography, glucose clamp, HOMA, biopsy, tracer) and the time course
for these measurements can all yield different outcomes. Thus, broad, general statements
regarding the development of insulin resistance as it relates to lipid metabolism cannot be made.
However, evidence in the literature has allowed for some more specific conclusions to be made.
Physical activity, or lack thereof, calorie restriction, calorie overconsumption, weight loss
and weight gain all lead to changes in gene expression, which in turn, affects the capacity to
hydrolyze, mobilize, oxidize, and synthesize lipids. Research has indicated that lipid
accumulation in general (i.e. obesity) is highly correlated with the development of insulin
resistance, but since high levels of lipids do not directly cause insulin resistance, these changes in
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gene expression may help partially explain how elevated lipid levels can lead to the development
of insulin resistance.
Altered gene expression and enzymatic activity is tissue-specific. Changes in the liver do
not necessarily represent changes in the muscle and vice versa. It seems likely that individual
organs and tissues are specifically regulated, but inter-organ communication creates a global
effect on lipid metabolism and insulin sensitivity, thus when examining possible mechanisms
linking lipid metabolism and insulin resistance, the state of each of these tissues and organs must
be considered. Also, the effects of exercise on lipid degradation and lipid synthesis is different
in healthy versus insulin resistant individuals and therefore, it is important to keep in mind that
simply because studies demonstrate improvements in lipid metabolism in healthy skeletal muscle
does not necessarily mean the same results will be seen in insulin resistant skeletal muscle.
Given the “athlete’s paradox” and the multiple studies directly linking excess IMCL
stores to insulin resistance, the composition TAGs themselves need to be considered. Fatty acid
chains can vary in length and level of saturation. A TAG consists of a glycerol molecule and
three fatty acids, all of which can contain short, medium, or long chains, and can be saturated or
unsaturated. TAGs consisting of more saturated fatty acids may be more difficult to metabolize
and may lead to incomplete degradation. This could partially explain why obese individuals
with high IMCL are more insulin resistant compared to their endurance-trained counterparts.
Future Directions
An important note for future studies is that the heterogeneity of exercise and
measurement variables have not allowed for any consistent results to be established. While it is
not possible to standardize one procedure given that each of these variables have their pros and
cons depending on resources, subject availability, and outcome measurements, following
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previously established effective exercise programs and measurement techniques will make
studies more comparable in the future.
Currently, few studies have examined aerobic exercise-induced changes in lipid synthesis
and degradation and its effects on insulin sensitivity and even fewer studies have examined
changes in lipid metabolism following resistance training. Given the numerous metabolic
changes that occur as a result of resistance training, it is likely that resistance training will elicit
changes in lipid metabolism, leading to improved insulin sensitivity. Other types of training,
such as yoga, pilaties, or intensive stretching, which also alter skeletal muscle metabolism
through contraction-mediated responses, may also lead to improvements in lipid metabolism;
however, this has not been examined. If found to improve lipid handling, resistance and
alternative types of training could prove to be an attractive alternative to endurance type training
in insulin resistant or obese individuals who may not otherwise engage in regular physical
activity.
Exercise does improve insulin sensitivity, regardless of training status, modality,
duration, or intensity. In terms of “the big picture”, for the general population this is the most
important outcome. This general idea has been known for years, the question has now become
“what are the primary mechanisms responsible for this improvement and is there a more ideal
exercise in terms of modality, time, intensity, and frequency?” In order to gain a better
understanding of the mechanisms behind this improvement, it will be necessary to develop more
specific pathways linking exercise to improved insulin sensitivity, particularly with regards to
lipid metabolism. This may be done by examining each step involved in lipid degradation and
synthesis in various populations and how these steps are affected by different types of exercise
training. The activity of LPL, ATGL, HSL, MAG lipase, G3P, and various enzymes β oxidative,
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TCA, and ETS enzymes, in healthy and insulin resistant individuals may allow researchers to
more accurately pinpoint where decrements in lipid metabolism occur both at rest and following
exercise.
*Note: All citations for Appendix 1 are included in the references list of the main
text.
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APPENDIX 2. PARTICIPANT QUESTIONNAIRES

All questions contained in this questionnaire are strictly confidential
Questionnaire
Name______________________
Gender__________________
Age___________________
Height___________________
Weight____________________
Date/Time_________________________
Resting Blood Glucose____________________
Has Father_______

Mother______ been diagnosed with type 2 diabetes? Mark all that apply

How many times/week do you drink coffee/tea_____ _
Soda_______

Energy drinks/shots______

How many times/week do you typically perform the following exercises?
Running__________ Walking_________
Weight Lifting________

Cycling_________

Swimming__________

Other (specify) __________

% BF from 7-site skinfold
Chest_____

Ab______

Thigh_______ Tricep_______

Suprailliac_______

Subscapular_______ Midaxilary________

1 mile run time____________

Estimated 1 RM bench____________1RM squat__________1RM deadlift___________
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3 Day Dietary Recall (Please be as specific as possible. What did you eat? How much? Where
was it from? What time? Also include all drinks except water.)
3 Days Ago
Morning

Afternoon

Evening

2 Days Ago
Morning

Afternoon

Evening

1 Day Ago
Morning

Afternoon

Evening

Notes:
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List your prescribed drugs and over-the-counter drugs, such as vitamins and inhalers

Name the Drug

Strength

Frequency Taken

Allergies to medications/foods

Name the Drug/Food

Reaction You Had

HEALTH HABITS AND PERSONAL SAFETY
ALL QUESTIONS CONTAINED IN THIS QUESTIONNAIRE WILL BE KEPT STRICTLY CONFIDENTIAL.
Exercise

 Sedentary (No exercise)
 Mild exercise (i.e., climb stairs, walk 3 blocks, golf)
 Occasional vigorous exercise (i.e., work or recreation, less than 4x/week for 30 min.)
 Regular vigorous exercise (i.e., work or recreation 4x/week for 30 minutes)

Diet

Are you dieting?



Yes



No

If yes, are you on a physician prescribed medical diet?



Yes



No

# of meals you eat in an average day?

Caffeine

Rank salt intake

 Hi

 Med

 Low

Rank fat intake

 Hi

 Med

 Low

 None

 Coffee

 Tea

 Cola

[] Energy Shots/Drinks

# of cups/cans per day?
Alcohol

Do you drink alcohol?



Yes



No



Yes



No

If yes, what kind?
How many drinks per week?
Tobacco

Do you use tobacco?
 Cigarettes – pks./day
 # of years

Drugs

 Chew - #/day

 Pipe - #/day

 Cigars - #/day

 Or year quit

Do you currently use recreational or street drugs?
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Yes



No
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APPENDIX 3. IRB/CONSENT FORMS
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182

183
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